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Abstract 
 Both diabetes and behavioral health disorders (mental and substance use 
disorders) are significant health issues in the United States.  While previous studies have 
shown worse health outcomes in people with diabetes and co-occurring behavioral health 
disorders (BHDs) than those with diabetes alone, it is unclear whether the quality of 
diabetes care was poorer in the presence of co-occurring BHDs.  Although previous 
research has observed a trend of positive outcomes in people with comprehensive 
diabetes care, there is a lack of evidence about whether that mode of care delivery can 
improve outcomes in people with co-occurring BHDs. Therefore, further studies are 
necessary. 
  Using a combined dataset from Medicare and Medicaid claims for Massachusetts 
residents, this study compared the quality of diabetes care (e.g., having at least 1 
hemoglobin A1c test) and diabetes outcomes (e.g., eye complications) among Medicare 
and Medicaid beneficiaries with diabetes and co-occurring BHDs to those with diabetes 
alone in Massachusetts in 2005. The results showed a mixed picture on the relationships 
between BHDs and diabetes outcomes. While substance use disorders had adverse impact 
on adherence to quality measures (e.g., 20% less likely to attain full adherence, p<0.001) 
and health outcomes (60% more likely to be hospitalized with a diabetes-related primary 
diagnosis, p<0.001), the relationship between mental health disorders and diabetes 
outcomes were not consistent.  For example, schizophrenia/ paranoid states was 
correlated with higher rates of full adherence to quality measures and lower rates of 
hospitalizations (p<0.01) whereas bipolar disorder and other mental health disorders were 
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not significantly associated with these outcomes.  The measure, comprehensive diabetes 
care, which indicated the adherence to multiple diabetes care measures within one visit 
was created to approximate the way that care was delivered by providers who specialized 
in managing diabetes in patients.  The adjusted analysis showed a trend for lower odds of 
diabetes-related complications and hospitalizations with this measure but the associations 
were not statistically significant (i.e., p>0.05).   
Findings from this dissertation research suggest that disparities exist in the quality 
of diabetes care and health outcomes between people with substance use disorders and 
those without.  The mode of care delivery needs to be further examined so that 
interventions can be designed to improve the outcomes of people with diabetes. 
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Preface 
 This study was conducted as part of a larger project, “Improving Community 
Based Mental Health Services for Elders in Massachusetts”, which was supported by the 
University of Massachusetts Medical School and the Massachusetts Executive Office of 
Elder Affairs.  The aim of the parent project was to investigate the prevalence of mental 
health disorders and treatment modalities for mental health disorders among elders in 
Massachusetts.  Consequently, the current study employed the definitions of disorders 
and measures from the parent project.  The objective of the current study was to 
investigate how co-occurring behavioral health disorders (BHDs) impact the quality of 
diabetes care and whether adherence to quality measures improves health outcomes. 
 This dissertation is presented in six chapters.  The first chapter provides a brief 
background and rationale for the study.  The second chapter explains the conceptual 
framework, measures and analytic methods used in the study.  The third chapter describes 
the characteristics of study population and the adherence to quality benchmarks for 
diabetes care across BHDs.  The fourth chapter explores various diabetes-related 
outcomes, such as complications and hospitalizations among people with BHDs.   The 
fifth chapter examines the relationships among BHDs, the mode of care delivery, 
adherence to quality measures and diabetes-related hospitalizations.  The final chapter 
discusses the significance of study findings, limitations of the study and implications for 
future studies.  
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Chapter I.  Introduction and Study Aims 
Background 
Diabetes has reached epidemic proportions in recent years.  The prevalence of 
diabetes was 7.8% in 2007, affecting about 23.6 million Americans.1 According to the 
Centers for Disease Control and Prevention, diabetes increases the risks for heart disease 
and hypertension, as well as blindness (diabetes retinopathy), kidney disease 
(nephropathy), nervous system damage and lower-limb amputations.  The risk of death 
for people with diabetes is at least twice that of people without diabetes.1  
Like diabetes, behavioral health disorders (or BHDs), which include anxiety, 
depression, schizophrenia, bipolar disorder, other mental health disorders (such as 
personality disorders) and substance use disorders (such as alcohol dependence, alcohol 
abuse, drug dependence and drug abuse), affect a large proportion of the US population.  
For example, about 6% of the US population had serious mental health disorders in 2004 
according to the National Institute of Mental Health.2  The Substance Abuse and Mental 
Health Services Administration estimated that about 22.9 million people over 12 years 
old, i.e., 8.9% of this population, had a substance use disorder in 2008.3 
High prevalence of Diabetes among people with Behavioral Health Disorders 
Previous studies have shown that persons with behavioral health disorders 
(BHDs) have a high co-occurrence of diabetes and most of them observed that the 
prevalence of diabetes among people with BHDs was double that of people with no 
BHDs.4-8  For example, Jiang and colleagues observed that diabetes was more prevalent 
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among people with a lifetime diagnosis of depression (14.4%, vs. 7.4% for no 
depression), post-traumatic stress disorder (12.0% vs. 7.2% for no PTSD) or alcohol 
dependence (18.4%, vs. 7.0% for no alcohol dependence) in two Native American 
reservation communities.8  In a case-control study using Blue Cross/Blue Shield claims 
data from Iowa between 1996 and 2001, Carney and colleagues found that the prevalence 
of diabetes was almost twice as high among people with schizophrenia (7.7%) than 
among those without mental illnesses (3.0%).5 A similar pattern has been observed in 
bipolar disorder.  Using a clinical sample, Cassidy and colleagues observed a higher 
frequency of diabetes among people with bipolar disorders (9.9%) than the general 
population (3.5%) in 1999.6 
Mortality associated with dual diagnoses of Diabetes and Behavioral Health 
Disorders  
There is evidence that people with diabetes and co-occurring BHDs suffer higher 
rates of mortality than those with diabetes alone. In a mortality report, the Massachusetts 
Department of Mental Health (DMH) compared the death rate due to diabetes of their 
clients statewide to that of an age-matched cohort in the general population during 2000.9  
The DMH observed that their clients with diabetes had a 120% higher risk of death than 
non-clients with diabetes.9 However, this observation may not be applicable to people 
with all BHDs because of possible selection bias in the eligibility criteria for DMH 
services.  In order to be a client of DMH, a person must have a persistent serious mental 
disorder, such as schizophrenia, major depression, anxiety disorders (excluding those of 
organic origins), multiple personality disorders, eating disorders and borderline 
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personality disorder, with significant functional impairment that limit one’s ability to 
meet basic needs in daily living.10  Currently, Massachusetts DMH serves approximately 
27,000 clients across the state but there are about 160,000 people with serious mental 
health disorders in the state.11  The restrictive selection criteria indicate that the general 
health of DMH clients may be worse than the overall population with BHDs; thus, the 
high mortality may not be generalizable to non-DMH clients with diabetes and BHDs.    
Other studies have used community samples and demonstrated similar patterns. In 
a longitudinal study, Katon and colleagues compared the mortality rates between people 
with diabetes and depression and those with diabetes alone.12 They observed that people 
with diabetes and major depression had a 43% higher risk of death than those with 
diabetes alone, after adjusting for age, gender, ethnicity, education, obesity, glycemic 
control, diabetes complications and co-morbidities.12  Notably, people with 2 or more 
complications had a 79% higher risk of mortality.12  However, the study was not able to 
assess the cause of death; therefore, it is uncertain if the high mortality is related to 
diabetes.  In a study of Medicaid population, Jackson and colleagues found people with 
psychotic and substance use disorders who had diabetes were more likely to die 
prematurely (40%) than those without diabetes (10%).13   
Unfortunately, studies to date have not been able to fully explain why people with 
diabetes and comorbid BHDs had higher rates of mortality, compared to those with 
diabetes alone.  One hypothesis attributes higher rates of mortality to poorer quality of 
diabetes care and management among people with diabetes and comorbid BHDs.13    
However, additional evidence is necessary to understand whether such health disparity 
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was due to the quality of diabetes care.  If it is true, interventions can be implemented to 
improve the quality of diabetes care and reduce diabetes-related mortality among people 
with diabetes and comorbid BHDs. 
Behavioral Health Disorders and Quality of Diabetes Care  
To date, there is no conclusive evidence that people with BHDs have poorer 
quality of diabetes care.  For example, in a meta-analysis of depression and glycemic 
control, Lustman and colleagues reported that depression had small to moderate effect 
(standardized effect size, r : 0.17, 95% confidence interval [CI]: 0.13, 0.21) on poor 
glycemic control for people with diabetes.14  In addition, in a cohort study using claims 
data from a private insurance company between 1996 and 2001, Jones and colleagues 
found that people with diabetes and any BHDs, i.e., depression, schizophrenia, bipolar 
disorder, anxiety disorders and substance use disorders, were less likely to receive 
hemoglobin A1c tests (adjusted Hazard Ratio: 0.92, 95%CI: 0.87, 0.97) and low-density 
lipoprotein tests (adjusted HR: 0.92, 95%CI: 0.86, 0.98) than those with diabetes alone.15  
Similar results were also reported by Frayne and colleagues using claims data from the 
Veterans Administration in 1999. 16 
In contrast, better quality of diabetes care was observed among people with BHDs 
than those without BHDs in other studies.  For example, Dixon and colleagues observed 
that those with diabetes and schizophrenia had lower HbA1c levels (7.73%±0.25%) than 
those with diabetes alone (9.03%±0.25%, p<0.001), indicating better glycemic control 
among people with schizophrenia after adjusting for age, gender, race/ethnicity, 
education, obesity, self-care activities and frequency of outpatient visits.17  
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Such inconsistency in current literature was further compounded by studies that 
observed no significant relationships between quality of diabetes care and BHDs.  For 
example, in a community-based study, Kreyenbhul and colleagues examined glycemic, 
lipid and blood pressure control among people with schizophrenia and depression.18  In 
the multivariate model adjusting for age, gender and race/ethnicity, they observed that 
glycemic control among people with BHDs (schizophrenia: 7.9±2.2; depression: 7.7±2.0) 
was not significantly different from those with diabetes alone (8.7±2.5, p=0.08) .18  
Similarly, in a cross-sectional study using a clinical sample, Geringer and colleagues 
showed that the presence of depression was not significantly associated with glycemic, 
lipid or blood pressure control (p=NS).19  Therefore, further studies are necessary to 
examine the relationship between BHDs and the quality of diabetes care. 
Comprehensive Diabetes Care and Diabetes-related Outcomes 
 Comprehensive diabetes care provides diabetes-focused care in a single setting.  
A multidisciplinary team is usually employed to coordinate care between physicians and 
patients with diabetes so that optimal results, such as adherence to quality measures, can 
be achieved.20    Such mode of care delivery has been shown to improve the quality of 
care among people with diabetes.  For example, Rubin and colleagues reported that the 
rates of hospitalization decreased from 239 per 1000 member years to 196 per 1000 
member years after implementing comprehensive diabetes care program in a managed 
care organization for a year.20 In a separate study, Huang et al. compared the quality of 
care between a diabetes center that provided comprehensive diabetes care and a general 
medical clinic.  Their analyses suggested that patients of the diabetes center might have 
 6 
lower odds of hospitalizations than those of the general medical clinic (adjusted OR: 
0.88, 95%CI: 0.52, 1.49) although the association was not statistically significant.21  
However, no studies to date have examined whether comprehensive diabetes care 
improves diabetes outcomes among people with diabetes and comorbid BHDs. 
Indicators for quality of diabetes care  
The goal of diabetes care is to prevent complications and death through proper 
clinical monitoring and self-management. This leads to the use of surrogate measures 
such as laboratory tests and clinical examinations in evaluating interim quality of care in 
diabetes because clinical outcomes, such as retinopathy, which indicate the failure of 
diabetes care, may not be appropriate tools to denote ongoing management of diabetes. In 
1997, the Diabetes Quality Improvement Project22 was established by the Centers for 
Medicare and Medicaid Services (CMS), the National Committee for Quality Assurance 
(NCQA) and the American Diabetes Association (ADA) to develop quality performance 
measures for diabetes care.  The objective of the project was to select a set of clinical 
procedures or processes that are both representative of diabetes care and amenable to be 
assessed accurately in clinical databases.  In 2000, the project team chose the frequencies 
and/or results of the following as quality indicators of diabetes care: 1) hemoglobin A1c 
test (HbA1c), 2) low-density lipoprotein test (LDL), 3) nephropathy screening, 4) eye 
examination in the past year, 5) foot examination and 6) blood pressure check in the past 
year.  These clinical tests and examinations are also Healthcare Effectiveness Data and 
Information Set (HEDIS) measures, which are indicators used to reliably compare the 
performance across different health plans,23 for the quality of diabetes care. 
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Behavioral Health Disorders and Adverse Health Outcomes in diabetes 
 Beside quality indicators, adverse diabetes outcomes, such as complications and 
hospitalizations have been investigated in previous research.  However, there were few 
studies that examined adverse diabetes outcomes in people with BHDs.24-27    These 
studies reported higher risks of diabetes-related complications and hospitalizations 
among people with BHDs and diabetes.  In a cross-sectional study, Black and colleagues 
compared the clinical outcomes for people with diabetes and depression to those with 
diabetes alone.24  When compared to those without mental health disorders, people with 
diabetes and depression had 61% higher odds of having vascular diseases (OR: 1.61, 
95%CI: 1.13, 2.31) and 86% higher risk for eye problems (OR: 1.86, 95%CI: 1.30, 
2.67).24 They were also more than twice as likely to have kidney disease (OR: 2.34, 
95%CI: 1.42, 3.86) and to be hospitalized (OR: 2.71, 95%CI: 1.84, 3.98).24  In addition, a 
meta-analysis of literature by de Groot and colleagues showed that depression was 
significantly correlated with diabetes complications (retinopathy, nephropathy, 
neuropathy and ischemic heart disease).25   
In a study using claims data from the Veterans Administration (VA) in 1998, 
Krein and colleagues showed that people with diabetes and BHDs (schizophrenia and 
bipolar disorder) were more than twice as likely to be hospitalized than those with 
diabetes alone (OR: 2.8, 95%CI: 2.67, 2.94).26 In a cohort study using claims data from 
the VA between 1991 and 1995, Fortney and colleagues showed that people with 
diabetes, depression and alcohol abuse (hospital days: 200.4), people with diabetes and 
depression (hospital days: 154.7) and people with diabetes and alcohol abuse (hospital 
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days: 125.3) had longer hospital stays than people with diabetes alone (hospital days: 
75.9).27  However, the aforementioned studies did not address any of the quality 
indicators for diabetes care or whether the hospitalizations were diabetes-related.  
Therefore, it is not certain if poor clinical outcomes are associated with poor quality of 
diabetes care. 
Significance of the study 
Despite evidence suggesting that co-occurring BHDs are associated with poorer 
quality of diabetes care and diabetes-related outcomes, there are gaps in the existing 
literature in terms of delineating relationships between quality of diabetes care and 
BHDs, and between quality of diabetes care and clinical outcomes.  This is because: 1) 
previous studies illustrated a mixed picture of behavioral health disorders and the quality 
of diabetes care; 2) few studies examined diabetes complications and hospitalization 
among people with diabetes and co-occurring BHDs, as well as the impact of adherence 
to quality measures on these outcomes24-28; and 3)  no studies to date investigated the 
effect of comprehensive diabetes care among people with diabetes and co-occurring 
BHDs.  Therefore, further research is needed.   This study attempts to fill these gaps in 
research through fulfilling the following objectives. 
• This study examines the rates at which people with diabetes and different BHDs 
meet quality measures for diabetes care among, compared to those with diabetes 
alone. 
• The associations between adherence to quality measures and BHDs are examined 
separately according to the type of BHD. 
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• This study compares the rates of diabetes-related complications and 
hospitalizations for those with BHDs to those with diabetes alone. 
• This study investigates whether and how the mode of diabetes care delivery (e.g., 
comprehensive diabetes care), as well as adherence to quality measures of 
diabetes care, affects diabetes-related outcomes in people with diabetes and co-
occurring BHDs.  
Study Aims 
 In order to accomplish the objectives above, this study is divided into three 
separate aims. 
Aim 1 
Aim 1 is to compare the rates of adherence to the quality measures for diabetes 
care (hemoglobin A1c tests, low-density lipoprotein (LDL-c) tests, nephropathy 
screening and eye examinations), as defined by Health Effectiveness Data and 
Information Set (HEDIS), among people with type 2 diabetes and co-occurring 
behavioral health disorders to those with diabetes alone.  In addition, the population 
characteristics are also compared.  
Aim 2 
Aim 2 is to investigate diabetes-related outcomes (complications and 
hospitalizations) in 2005 among people with diabetes and each major type of behavioral 
health disorder.  
Aim 3 
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Aim 3 is to investigate the impact of adherence to quality measures and mode of 
service delivery (i.e., Comprehensive diabetes care, defined by having 2 or more quality 
measures achieved in a visit during 2004) on diabetes-related outcomes in 2005 among 
people with diabetes and comorbid BHDs. 
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Chapter II.  Conceptual Framework and Study Design 
Conceptual Framework 
The study’s conceptual framework was based on the Anderson-Newman 
Behavioral Model (Phase 4),29 which is presented in figure 2.1.  The Behavioral Model is 
a widely used framework for evaluating health service utilization.30-32  In this model, 
health-related factors and outcomes are classified into five categories: 1) Predisposing, 2) 
Enabling, 3) Need, 4) Behavior and 5) Outcome.29  Predisposing factors, which include 
having a behavioral health disorder (BHD), gender and race/ethnicity, influence the 
individual’s ability to gain access to resources such as health coverage and perceptions of 
need to use health services. These factors may directly or indirectly affect the outcomes.  
Enabling factors, such as healthcare coverage and socioeconomic status, are social or 
physical resources that allow the individual to access services. Need factors are 
conditions that can directly influence health-seeking behavior in an individual, such as 
pre-existing diabetes complications. All three factors (Predisposing, Enabling and Need) 
affect behaviors of patient and provider (Behavior factors) such as having outpatient 
visits and referrals to specialists for certain procedures by a primary care physician.  In 
turn, Behavior factors directly influence the intermediate health outcomes (Proximal 
Outcomes), such as getting HbA1c, LDL-c and nephropathy tests.  Proximal Outcomes 
then predispose the individual to the eventual health outcomes (Distal Outcomes), such as 
newly diagnosed diabetes complications.  
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For example, an individual has diabetes and untreated depression. The individual 
may also have very high levels of blood sugar due to poor self-management.  He/ she 
may not visit a primary care physician for diabetes care because of depressive symptoms.  
Consequently, the individual does not receive the procedures for diabetes management, 
such as HbA1c tests and eye exams. Thus, no actions are taken to control the levels of 
blood sugar and the individual subsequently develops retinopathy. The Behavioral model 
(see figure 2.1) illustrates the complex relationships among psychological, physical and 
social factors in health behavior and outcomes. 
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Figure 2.1  Conceptual Model of the Study 
 
 
* Unable to assess in current dataset 
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Study Design 
This is a two-year cohort study.  In 2004, the index year, the population 
characteristics among people with type 2 diabetes were assessed.  In 2005, the study 
examined diabetes outcomes.  These outcomes include: 1) the rates of adherence to the 
quality measures for diabetes care (hemoglobin A1c tests, low-density lipoprotein (LDL-
c) tests, nephropathy screening and eye examinations); 2) the rates of diabetes-related 
complications (e.g., ischemic heart disease, blindness (diabetes retinopathy), kidney 
disease (nephropathy), nervous system damage (neuropathy) and lower-limb 
amputations) and 3) the rates of diabetes-related hospitalizations (defined by 
hospitalizations with primary diagnoses of diabetes-related conditions, such as diabetes 
and diabetes complications).  This study has been approved by the Institutional Review 
Board at the University of Massachusetts Medical School. 
Study Populations 
Rationale for the selection criteria of study populations 
The study identified beneficiaries in Massachusetts by the source of health 
coverage during 2004, i.e., Medicare only, Medicaid only and dually-eligible (both 
Medicare and Medicaid) because there are underlying differences in the socio-economic 
and medical conditions among beneficiaries with these 3 types of coverage.  According to 
an analysis by the Kaiser Commission on Medicaid and the Uninsured, dually-eligible 
beneficiaries are usually poorer and less well-educated, but more likely to have diabetes 
and disabilities than those who are only eligible for Medicare and other types of 
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insurance.33  Since Medicare eligibility requires a history (10 years in most cases) of 
payroll tax contributions to Medicare by the beneficiary or his/her spouse, people who 
have less work experience or are new immigrants may not be eligible for Medicare when 
they become disabled or reach age 65.34  Instead, they may be qualified for Medicaid if 
they are disabled or live in medical institutions and have monthly income up to 300% of 
the Federal poverty rate.35  Therefore, people with Medicaid only in the age group of 65 
years and older, are more likely to be poorer and less healthy than those with Medicare 
only.  Such differences may affect the quality of diabetes care across these types of health 
coverage. If such differences are not accounted for in the study, the associations between 
BHDs and quality of diabetes care may be biased towards the estimates for the group 
with the largest sample size. To demonstrate such differences exist, a separate analysis 
was performed.  For more information on the analysis, please refer to Appendix I on 
p.113.    
Criteria for Medicare eligibility in study 
 In this study, Medicare beneficiaries were enrolled in both Medicare Part A 
(hospital insurance) and Part B (ambulatory care) for at least 10 months during 2004 and 
2005. The requirement for 10 months in Medicare enrollment was to ensure that the 
coverage period for each beneficiary was long enough for the meaningful assessment of 
procedures performed.  This was because people with diabetes were expected to have the 
quality measures (i.e., having at least one occurrence of hemoglobin A1c tests, LDL-c 
tests, nephropathy screening and eye examinations) assessed annually as recommended. 
Those enrolled in Medicare Advantage (capitated) plans or with primary coverage from a 
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private health insurer were excluded because this study did not have access to complete 
claims from either source. 
Criteria for Medicaid eligibility in the study 
 Medicaid eligibility in the study was defined as an enrollment period of at least 10 
months during each year (2004 and 2005). The requirement for 10 months of Medicaid 
enrollment was to ensure the completeness of information regarding health coverage and 
service utilization.  Unlike Medicare, which is a health insurance program, Medicaid 
recipients can lose coverage when they fail to meet the requirements for Medicaid 
entitlement, for example, living above the preset poverty level (135% Federal Poverty 
Level for Medicare beneficiaries). However, this exclusion criterion limited the 
generalizability of the study because it excluded people with discontinuous enrollment.  
This exclusion might potentially bias the estimates of study outcomes because conditions 
such as homelessness and death, which are reasons of discontinuing enrollment, may be 
associated with poor quality of diabetes care.  A secondary analysis (see Chapter VI on 
p.101) was carried out to compare the characteristics between those who were excluded 
from the study and those who met the inclusion criteria.  
Criteria for Dual-eligibility in the study 
 In the study, Dual-eligible beneficiaries were enrolled in: 1) Medicare Part A for 
at least 10 months during 2004 and 2005; and 2) MassHealth (Massachusetts Medicaid) 
for at least 10 months during 2004 and 2005.  They did not have either Medicare 
Advantage coverage or other health insurance (i.e., third-party insurance) during these 2 
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years for the same reason as for those with Medicare alone.  The requirement for 10 
months in Medicaid enrollment was for the same rationale. 
Other selection criteria for study populations 
 Beneficiaries were at least 18 years of age or older. There are two reasons for the 
age selection. First, HEDIS measures for diabetes care used in this study, are intended for 
patients over 18 years of age;36 therefore, including pediatric patients was not 
appropriate.  Second, the age of onset for certain BHDs, such as depression, anxiety and 
substance use disorders, are usually at or after the age of 19 according to the National 
Comorbidity Survey.37  Thus, it was inappropriate to select study populations below the 
age of 18. Beneficiaries who had any stay in a nursing home or hospital for at least 90 
days in 2004 were excluded because they might have health services provided within 
institutional settings, which were not recorded in Medicare or Medicaid claims. HEDIS 
measures were developed for the evaluation of outpatient services38 and it may not be 
appropriate to apply HEDIS measures to institutionalized populations.  Beneficiaries in 
the study had 2 outpatient diagnoses or 1 inpatient diagnosis of type 2 diabetes in 2004.  
The selection process is described as followed.  First, all types of diabetes were identified 
by International Classification of Diseases- 9th Edition (ICD-9) codes.  Then the two 
types of diabetes (Type 1 and Type 2) were further classified.  If an individual had 
missing diabetes type, type 2 diabetes was assigned.  If an individual had both type 1 and 
type 2 in record, type 1 diabetes was assigned as diagnosis.  Only individuals with type 2 
diabetes were included in all of the analyses.  Further selection was applied so that the 
study population had no missing socioeconomic status data (see section on ‘Measures 
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assessed in the study: Enabling factors: Socioeconomic status’ on p.36).  An additional 
selection criterion was applied in the analysis of Aim 3 to include only people with any 
type of BHD.  As a result, the study included 106,174 individuals in Aims 1 and 2 while 
31,350 individuals were in the analysis of Aim 3.  Please refer to Figure 2.2 for the 
overall selection process and Appendix II on p.137 for diagnostic codes. 
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Figure 2.2 Selection of Study Population 
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Data source 
 This study used 2004 and 2005 paid insurance claims for Massachusetts Medicare 
and Medicaid beneficiaries.  Diabetes outcomes, such as adherence to quality measures 
for diabetes care and diabetes complications, were assessed with data from CY 2005.  
Data from CY 2004 were used for identifying study populations according to the 
selection criteria for the types of health coverage, diabetes and BHDs, as well as 
assessing other measures belonging to Predisposing, Enabling, Need and Behavior factors 
(see Figure 2.1). 
Medicare data were obtained from the Centers for Medicare and Medicaid 
Services in the form of Research Identifiable Files (RIFs).  RIFs contained individual-
level data and allowed researchers to identify the dates, providers and beneficiaries for 
services paid by Medicare .39   In this study, only two components of the RIFs were used 
to create the working datasets: 1) Standard Analytical Files (SAFs) and 2) Medicare 
enrollment and vital statistics files.39  
The SAFs contained claim-level data on seven types of services: Inpatient, Skilled 
Nursing Facility, Outpatient, Home Health Agency, Hospice, Carrier and Durable 
Medical Equipment.  Information in SAFs included diagnosis (ICD-9 diagnosis codes), 
procedure (ICD-9 procedure codes, Current Procedural Terminology (CPT) codes, and 
Common Procedure Coding System (HCPCS) codes), Diagnosis-Related Group (DRG), 
dates of service, reimbursement amount paid by Medicare, provider identification, and 
demographic data for beneficiaries.39   
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This study used the Denominator File, one of the three parts in the Medicare 
enrollment and vital statistics files.  This file contained information for all beneficiaries 
for the entitlement year, including beneficiary unique identifiers (Medicare Identification 
numbers), zip codes, date of birth, date of death, sex, race/ethnicity, state/county codes, 
entitlement indicators (i.e., part A and/or B) and reason for entitlement.39 
Medicaid data came from the Medicaid Management Information Systems of 
Massachusetts (MMIS). The MMIS data contained individual-level data.   These data 
were held in two files: 1) Medicaid eligibility file: beneficiary identifiers (Social Security 
Numbers), eligibility, sex, race/ethnicity and enrollment dates and participation of other 
insurance programs; and 2) claims file:  diagnosis (ICD-9 codes), inpatient and outpatient 
service use (ICD-9 procedure codes, CPT codes and HCPCS codes), prescription drug 
use (National Drug Codes [NDCs]) and payments by Medicaid. 
Data extraction 
  Medicare and Medicaid files were merged to: 1) identify the appropriate source 
of health coverage for each beneficiary, i.e., Medicare alone, Medicaid alone and Dual-
eligible; and 2) link the diagnoses and health service utilization of beneficiaries with the 
appropriate target populations. Three data files were used in identifying the target 
populations: 1) Medicare Denominator file, 2) Medicaid eligibility file and 3) Crosswalk 
file. The Crosswalk file was provided by JEN Associates, Inc., a research/consulting firm 
contracted by the Centers for Medicare and Medicaid Services and contained two types 
of identifiers for Medicare and Medicaid beneficiaries: 1) Medicare Identification 
numbers and 2) Social Security Numbers. 40 
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First, the Medicare denominator file and the Crosswalk file were merged using 
Medicare Identification numbers to identify beneficiaries who were potentially Dual-
eligible.  Those who were present only in the Medicare denominator file were classified 
as Medicare only and this information was stored as the identification file for Medicare 
alone. Then the merged file was combined with Medicaid eligibility file using Social 
Security Numbers.  Beneficiaries who were present in both files were Dual-eligibles and 
the information was stored as a separate identification file for Dual-eligibles. Those who 
only existed in Medicaid eligibility file were classified as Medicaid only and an 
identification file was created separately to store this information.  These identification 
files were also used for calculating age and length of enrollment for beneficiaries. 
Second, claims files from Medicare and Medicaid were sorted according to the 
coverage categories (Medicare only, Medicaid only and Dual-eligibles) to create working 
datasets.  Diagnoses, such as diabetes, BHDs and complications, and utilizations, such as 
hospitalizations, quality measures for diabetes care and frequencies of outpatient visits 
(ambulatory setting) were then assessed using the working datasets. Chronic Illness and 
Disability Payment System (CDPS) scores41 were also estimated using these datasets. 
Third, socioeconomic status data for beneficiaries’ zip code-based neighborhoods, 
i.e., median household income in 1999 and percentage of high school graduates, were 
obtained from Census 2000.  From the Dartmouth Atlas of Health Care, a cross-reference 
file for 2004 Hospital Service Areas was obtained to identify Hospital Service Areas in 
Massachusetts using residential zip codes.42  Using residential zip codes, socio-economic 
data and identification of Hospital Service Areas were merged with the identification 
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files. Hospital Service Areas were used for clustering beneficiaries in the analyses.  
Please refer to the section ‘Hospital Service Areas: Rationale’ on p.43 for details.   
Finally, the three populations in their respective identification files were then 
merged with the corresponding working datasets to create a combined dataset of all three 
populations.  SAS 9 for UNIX was used in all the procedures for sorting, extracting and 
merging data. 
Measures assessed in the study 
 Measures used in this study were selected based on the Behavioral Model.29  They 
were classified into five categories: 1) Predisposing factors, 2) Enabling factors, 3) Need 
factors, 4) Behavior factors and 5) Outcomes.   The Predisposing factors included 
behavioral health disorders, gender, age, race/ethnicity and physical comorbidities (as 
represented by Chronic Illness and Disability Payment System, or CDPS).  Enabling 
factors included types of health coverage, continuity of coverage, neighborhood 
socioeconomic status (median income and percentage of high school graduates).  Need 
factors included previous diabetes complications (e.g., eye complications, neuropathy, 
nephropathy, ischemic heart disease, cerebrovascular disease and lower-limb 
amputations).  Behavior factors consisted of comprehensive diabetes care, defined by 
having 2 or more quality measures achieved in a single visit during 2004, frequency of 
outpatient visits and number of quality measures met in 2004.   Outcomes included the 
quality measures for diabetes care in 2005 (i.e., hemoglobin A1c test, low-density 
lipoprotein test, nephropathy test and eye examination), diabetes complications in 2005 
(e.g., eye complications, neuropathy, nephropathy, ischemic heart disease, 
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cerebrovascular disease and lower-limb amputations) and diabetes-related 
hospitalizations, defined by hospitalizations with primary diagnoses of diabetes-related 
conditions (e.g., diabetes and diabetes complications), in 2005.  The following passage 
describes the rationale and assessment of each study measures.   
 Based on prior literature, some hypotheses can be made between study measures 
and outcomes.  For example, having a diagnosis of substance use disorders may 
negatively impacts the adherence to quality measures while it may increase the odds for 
diabetes-related hospitalizations.    Having a previous diabetes complication may increase 
the odds for adherence to quality measures; however, its effects on subsequent diabetes 
complications are unknown.  Please refer to table 2.1 for more information. 
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Table 2.1  Hypothesized associations between study factors and outcomes 
  Hypothesized associations with 
Factors Variables Adherence to quality 
measures 
Diabetes complications 
& hospitalizations 
Mental health disorders Unknown Unknown 
Substance use disorders - + 
Age + Unknown 
Male Gender + + 
Race/ethnicity -: for non-white +: for non-white 
Predisposing 
Burden of Co-morbidities 
(CDPS) 
+ Unknown 
No complications - Unknown 
Eye complications + Unknown 
Nephropathy  + Unknown 
Neuropathy + Unknown 
Lower Limb Amputation + Unknown 
Ischemic heart disease + Unknown 
Need (pre-
existing 
diabetes 
complications 
in 2004 data) 
Cerebrovascular disease + Unknown 
Type of coverage -: for Medicaid +: for Medicaid 
Continuity of coverage + Unknown 
Median household 
income 
+ Unknown 
Enabling 
Education level + Unknown 
Frequency of Outpatient 
Visit with physicians 
+ - Behavior 
Comprehensive diabetes 
care 
Not assessed - 
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Predisposing factors 
Behavioral health disorders (BHD) 
Rationale for BHD categorization 
Behavioral health disorders (BHDs) in the study included mental health disorders 
and substance use disorders.  Mental health disorders were assessed in five categories: 1) 
No mental health disorders, 2) schizophrenia/ paranoid states, 3) bipolar disorder, 4) 
depression/ anxiety and 5) other mental health disorders.  Substance use disorders 
consisted of: 1) alcohol abuse/ dependence and 2) drug abuse/ dependence.   
The categorization of mental health disorders was based on evidence from 
previous studies.  From a brief review of literature, no significant differences in the 
quality of diabetes care among people with depression and those with anxiety disorders 
were observed.  For example, 14 studies16,24,27,43-53 reported that the presence of 
depression was associated with poor diabetes management while eleven studies 18,19,54-62 
did not find significant associations between depression and quality of diabetes care.  
Similarly, four studies did not find significant relationships between the presence of 
anxiety and quality of diabetes care 51,52,61,62 while two studies  indicated poorer quality of 
diabetes care (in terms of glycemic control) among those with anxiety disorders 
compared to those without mental illnesses 16,63 and one showed better quality of care for 
people with anxiety disorders.64  In addition, Trief and colleagues showed that there was 
no significant associations between depression/ anxiety disorders and quality of diabetes 
care, no matter if depression and anxiety co-occurred together or exist separately.62  
Although bipolar disorder is a mood disorder, like depression, Frayne and colleagues 
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showed that people with bipolar disorder had poor quality of diabetes care and further 
studies are needed.16  
Therefore, mental health disorders, i.e., schizophrenia/ paranoid states, bipolar 
disorder, depression/ anxiety and other mental health disorders, were categorized based 
on a hierarchical system with no mental health disorders as the reference group because a 
beneficiary might have multiple mental health disorders.  In this system, any diagnosis of 
schizophrenia/ paranoid states superseded any other diagnoses while any diagnosis of 
bipolar disorder outranked depression/ anxiety disorders. In turn, depression/ anxiety 
disorders superseded other mental health disorders.  The system assumed more severe 
disease states and disabilities among people with schizophrenia or bipolar disorders than 
depression, anxiety or other mental health disorders.  There was no further breakdown 
between depression and anxiety disorders.  Similar systems have been used in previous 
studies of claims data to compare healthcare expenditures65 and quality of diabetes care15 
between people with mental health disorders and those with non-psychiatric illnesses.   
The diagnosis of substance use disorders (SUD) remained a separate measure.  
The reference category for this measure included people with no SUD.  This is because 
SUD frequently co-occur with mental health disorders and there is evidence that the 
quality of diabetes care is poorer for those with SUD or those with both mental health 
disorders and co-morbid SUD.16,66,67 
Assessment 
For Chapters III and IV:  
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Based on two outpatient or one inpatient ICD-9 diagnosis, behavioral health 
disorders were identified among study population: 1) schizophrenia/ paranoid states, 2) 
bipolar disorder, 3) depression/ anxiety disorders, 4) other mental health disorders, 5) any 
alcohol abuse/ dependence and 6) any drug abuse/ dependence.  Schizophrenia/ paranoid 
states included schizophrenia and paranoid states.  Bipolar disorder consisted of bipolar I 
disorder and other unspecified bipolar disorders.  Depression/ anxiety disorders included 
major depression, other depression, anxiety states and post-traumatic stress disorder. 
Other mental health disorders comprised of psychosis (excluding schizophrenia and 
paranoid states), hysteria, phobic disorders, obsessive compulsive disorders, 
neurasthenia, depersonalization syndrome, neurotic disorders, personality disorders, 
sexual deviations, physiological malfunction from mental factors, special syndrome, 
adjustment reactions, disturbance of conduct or emotions, hyperkinetic syndrome of 
childhood, specific delays in development and psychic factors.  
Substance use disorders (SUD) included any alcohol abuse/ dependence and any 
drug abuse/ dependence.  Any alcohol abuse/ dependence included alcoholic psychoses, 
alcoholic dependence, alcohol abuse, alcoholic gastritis, and alcoholic liver diseases.  
Any drug abuse/ dependence consisted of drug psychoses, drug dependence and drug 
abuse. These two types of substance use disorders were not mutually exclusive and thus 
an individual could have both at the same time.  In the unadjusted anaylses, substance use 
disorders were represented by one summary measure, namely SUD, for having any types 
of SUD and the reference group consisted of people without any SUD.  In the adjusted 
analyses, substance use disorders were represented by the two separate variables, ‘any 
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alcohol abuse/ dependence’ and ‘any drug abuse/ dependence’. The reference group for 
‘any alcohol abuse/ dependence’ included people without alcohol abuse/ dependence 
while the referenece group for ‘any drug abuse/ dependence’ consisted of people without 
drug abuse/ dependence.  These two variables were not mutually exclusive; therefore, 
they were allowed to co-occur with each other, as well as with mental health disorders.   
For Chapter V: 
 Since the study population was restricted to individuals with any types of BHDs, 
the reference group for mental health disorders included beneficiaries with any SUD but 
no mental health disorders.  Two new variables, ‘co-occurring alcohol abuse/ 
dependence’ and ‘co-occurring drug abuse/ dependence’, were created to represent 
substance use disorders co-occurring with mental health disorders.  The reference group 
for ‘co-occurring alcohol abuse/ dependence’ consisted of individuals with mental health 
disorders only as well as those with SUD only while the reference group for ‘co-
occurring drug abuse/ dependence’ included individuals with mental health disorders 
only and those with SUD only.   
Please refer to Appendix II on p.137 for diagnostic codes and table 2.2 for the 
classification scheme of mental health disorders. 
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Table 2.2  Hierarchical System for Mental health disorders 
Circumstances of Co-occurrence Decision on Mental Disorder 
Schizophrenia/ paranoid states and (depression/ anxiety, 
bipolar and/or other mental health disorders) 
Schizophrenia/ paranoid states 
Bipolar disorder and (depression/ anxiety and/or other 
mental health disorders) 
Bipolar disorder 
Depression/ anxiety and (other mental health disorders) Depression/ anxiety 
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Sub-analysis using Medication data to identify mental health disorders: 
 Besides ICD-9 codes, medication data can also be used in identifying mental 
health disorders.  One example is the Medicaid Rx models.68  Medicaid Rx is a SAS®-
based program using National Drug Code (NDC) to identify relevant medical diagnoses 
for each individual.68  A full description of this method and its impact on results can be 
found in Appendices III through XI (p.138-147).  
Rationale for using ICD-9 codes only in assessment of mental health disorders 
 There were two reasons for not using Medicaid Rx models in identifying mental 
health disorders.  First, the sub-analysis showed consistent relationships between mental 
health disorders and adherence to quality measures, regardless of case-identification 
methods.  Second, there were no medication data available for individuals with Medicare 
only during the study period and Medicaid Rx models were designed primarily for people 
with Medicaid coverage.  In order for the analyses to be consistent across individuals 
with different types of health coverage, this study only used ICD-9 codes in assessing 
mental health disorders. 
Concerns about the assessment method of BHDs 
This study defined beneficiaries with BHDs as having 2 outpatient diagnoses or 1 
inpatient diagnosis using ICD-9 codes in 2004.  All claims diagnoses were used for BHD 
assessment.  The reason for this assessment criterion was the high likelihood of false 
positives in identifying depression if only a single outpatient diagnosis was used.  In a 
study comparing claims and physician diagnoses of depression, Spettell and colleagues 
observed a false positive rate of 26% when only 1 outpatient or pharmacy claim was 
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used.69  However, if 2 outpatient diagnoses are required for depression, the false positive 
rate was reduced to 9%.69  In a separate study, Solberg and colleagues showed that using 
2 outpatient claims or 1 inpatient claim yielded high accuracy in case identification for 
depression (positive predictive value 99%).70   Therefore, using 2 outpatient diagnoses or 
1 inpatient diagnosis to identify BHDs can increase the specificity of case identification. 
Age 
Rationale 
 In a study examining glycemic control in people with diabetes and co-morbid 
depression, Paschalides and colleagues showed that older age was associated with better 
glycemic control in people with diabetes and co-occurring depression or anxiety 
disorders.71   Further, age was categorized based on a study by Frayne et al. 16  In their 
study, the prevalence of having any BHD varied significantly across different age groups. 
16  Therefore, age groups were created in this study to account for such variability. 
Assessment 
  Age in 2004 was calculated using date of birth.  No missing age or age greater 
than 110 was found in the study population. In adjusted analyses, age was further 
categorized into four groups: <55, 55-64, 65-74, 75 and older. 
Gender 
Rationale 
 Two previous studies have shown that female gender was associated with poorer 
glycemic control15,72 while two indicated the otherwise. 55,73 
Assessment 
 33 
 Gender was used unaltered from the existing Medicare/Medicaid data. 
Race/ethnicity 
Rationale 
 Three previous studies17,71,73 observed that white race was associated with better 
glycemic control while the study by Trief et al. showed the opposite. 74 
Assessment 
Race/ethnicity was reformatted to match the data from Medicare because a Dual-
eligible individual with missing data on race/ethnicity in Medicaid might have known 
race/ethnicity in Medicare data.  If an individual had unknown race/ethnicity in Medicare 
(for those covered by Medicare only), Medicaid (covered by Medicaid only), or both 
(Dual-eligible), the race/ethnicity variable was coded as ‘Unknown’.  People with 
race/ethnicity of Asian, Pacific Islander, Native Hawaiian, Alaskan native or Native 
American were coded as ‘Others’. 
Concerns about the assessment of race/ethnicity 
 A major concern in assessing race/ethnicity was the category of ‘Unknown’.  Due 
to limitations of data, it was not possible to further examine or determine the 
race/ethnicity of this group.  Overall, this group constituted approximately 4% of the 
study population.  The majority of people with ‘Unknown’ race/ethnicity had only 
Medicaid (16.5%) compared to those with Medicare only (0.1%) and Dual-eligibility 
(0.4%).  This is one of the weaknesses of the study. 
Burden of Physical Comorbidities 
Rationale 
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 In their study, Paschalides and colleagues observed that the presence of physical 
comorbidities was associated with improved glycemic control in people with diabetes and 
co-occurring depression or anxiety. 71  However, the type of comorbidity measure was 
not described. 71    
Description of Chronic Illness and Disability Payment System (CDPS) 
In this study, burden of physical comorbidities was represented by Chronic Illness 
and Disability Payment System (CDPS). The CDPS is a diagnostic classification system 
using ICD-9 diagnostic codes, developed by researchers at the University of California at 
San Diego.41 The CDPS was originally designed to allow the Medicaid program predict 
healthcare expenditures for its beneficiaries using ICD-9 based diagnoses.41  This is 
achieved by assigning weights to diagnoses according to their expected use of 
resources.41  Therefore, unlike a simple count of other co-morbid conditions to assess 
disease burden, the CDPS score may reflect the severity of co-morbid conditions by 
assigning more weights on more costly diseases, which are usually more severe.  There is 
also a modified version for Medicare.75  It has been previously adapted and used as a 
measure of co-morbidities.76  The major limitation of CDPS as measure of physical 
comorbidities was its reliance on ICD-9 based diagnoses.  Diseases not coded in the 
claims data (first 2 fields in Medicaid and first 10 in Medicare) could not be included in 
the estimation of CDPS score.  Therefore, an individual might have a low CDPS score 
but high disease burden in reality if the illnesses were not treated or recorded on the 
medical claim.   
Assessment 
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Chronic Illness and Disability Payment System (CDPS) score in 2004, the ICD-9 
based indicator for comorbidity, was estimated using a statistical algorithm developed by 
researchers at the University of California at San Diego.41  In estimating CDPS, the ICD-
9 codes of diabetes and behavioral health disorders were omitted from the measure so 
that the analyses can investigate the effect of behavioral health disorders on diabetes 
outcomes separate from that of other co-morbidities.  The scores were then categorized 
into quartiles for multivariate analyses. 
Enabling factors 
Types of coverage 
 Health coverage was classified into three types: 1) Medicare only, 2) Medicaid 
only and 3) Dual-eligible. 
Rationale 
 Please refer to the section ‘Rationale for the selection criteria for study 
populations’ on page 14. 
Assessment 
 Please refer to the section ‘Data extraction’ on page 21. 
Continuity of coverage 
Rationale 
 One of the selection criteria for the study populations was being enrolled for at 
least 10 months in Medicare Part B or Medicaid to ensure completeness of data.  
However, one of the requirements for using HEDIS (Health Effectiveness Data and 
Information Sets) measures of diabetes care is that beneficiaries/enrollees must be 
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covered for at least 320 days during a year. 36   Therefore, a measure was created to 
indicate continuous coverage during the study year. 
Assessment 
 Continuous coverage was defined as having at least 12-month enrollment in 
Medicare Part B or Medicaid. 
Socioeconomic status 
Rationale 
 Previous studies showed that both income and education level are associated with 
healthcare utilization and diabetes care.77,78  In addition, Zaslavsky and colleagues 
demonstrated that socioeconomic status (income and education) assessed in census data 
is significantly correlated with HEDIS measures of diabetes care.79,80  The use of census 
data for SES is due to the lack of such variables for individuals in the current 
administrative dataset.   
Assessment 
 Median household income and the percentage of college graduates in 
beneficiaries’ residential neighborhoods were obtained from Census 2000 data as a proxy 
measure of the beneficiaries’ socioeconomic status.  These measures were linked to each 
beneficiary using their residential zip codes.  These measures were further categorized by 
quartiles.   
Limitation of Census Socioeconomic status data 
 Census data for education level and income can only indicate the approximate 
socioeconomic status of the individuals’ neighborhood at the zip code level.  These data 
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do not represent the individuals’ income or education level because these were 
aggregated data from all the census participants in the zip code area.  Using such data to 
infer individuals’ socioeconomic status may be inappropriate. 
Concerns about missing Socioeconomic status (SES) data 
 Two thousand, two hundred and sixty three individuals (about 2% of study 
populations) had missing SES data.  There are 4 reasons for missing data.  First, some zip 
codes listed in Medicare/Medicaid data were of Post Office boxes or ‘unique business’ 
(as defined by the Census Bureau) for 1,753 individuals.  Second, the zip codes for 274 
individuals were not in Massachusetts.  Then, 221 individuals had valid residential zip 
codes in Massachusetts but no census information was collected on these zip codes.  
Finally, 15 individuals had non-existent zip codes, possibly due to transcription error.  
These individuals were excluded in the unadjusted analyses because extrapolation of data 
using imputation was not possible.   
Need factors 
Pre-existing Diabetes complications 
Rationale 
Previous studies observed that pre-existing diabetes complications were 
significantly associated with glycemic control.71,81  However, the two studies reported 
contradictory observations.  In the study by Paschalides and colleagues,71 positive 
correlation between pre-existing complications and improved glycemic control was 
observed while negative impact of previous complications on glycemic control was found 
in the study by Ciechanowski et al.81  The differences in the findings may be due to the 
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fact that Paschalides’ study examined only people with type 2 diabetes71 while 
Ciechanowski’s study included people with both type 1 and type 2 diabetes.81  It is 
possible that the association between glycemic control and diabetes complications is 
different in people with type 1 diabetes.  
Assessment 
 Pre-existing diabetes complications in 2004 were identified in inpatient, 
outpatient, physician, medical and mental health claims from Medicaid data, as well as 
claims files from inpatient, outpatient and physician services in Medicare data, using 
ICD-9 or CPT (Current Procedural Terminology) codes. They include: a) eye 
complications; b) nephropathy; c) ischemic heart disease; d) cerebrovascular disease; e) 
neuropathy; and f) lower-limb amputations.  Please refer to Appendix II on p.137 for 
diagnostic and procedural codes. 
Behavior factors 
Frequency of outpatient visits 
Rationale 
In a study using administrative data from Veteran Administration, Frayne and 
colleagues observed that frequency of outpatient visits was significantly associated with 
the quality of diabetes care among people with diabetes and co-occurring mental or 
substance use disorders. 16 
Assessment 
Information for this measure was obtained from physician medical services claims 
in Medicaid data as well as physician claims in Medicare data.  The frequency of 
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outpatient visits in 2004 was estimated by counting the number of claims that occurred in 
office settings, regardless of the type of healthcare provider. 
Comprehensive diabetes care 
Rationale 
 In the Behavioral Model, part of physician behavior is the provision of 4 tests for 
diabetes care during a single visit.  The rationale was that individuals who received 
services in a comprehensive diabetes care center were more likely to have multiple 
testing and examinations performed during a single visit.  In a study comparing the 
quality of care between a diabetes center and a general medical clinic, Huang and 
colleagues showed that patients of diabetes center were less likely to be hospitalized 
although the association was not statistically significant.21 
Assessment 
 Comprehensive diabetes care was defined as having met two or more quality 
measures for diabetes care (i.e., HbA1c test, LDL-c test, nephropathy test and eye 
examinations) within a day in 2004 (see Appendix II on p.137 for CPT codes). However, 
analysis showed that there was moderately high correlation between having HbA1c tests 
and LDL-c tests (Pearson correlation: 0.45).  Therefore, the co-occurrence of HbA1c and 
LDL-c tests was treated as having met one quality measure to account for this correlation. 
Concerns about the assessment of Comprehensive diabetes care 
 Originally, the measure was defined as having full adherence to all quality 
measures within a single visit.  However, there were too few individuals (i.e., <11, 
0.01%) meeting this criterion in the study population.  Therefore, the definition for the 
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measure was changed so that Comprehensive diabetes care was indicated by achieving at 
least 2 diabetes quality measures during the same visit. 
Number of quality measures met in 2004 
Rationale 
 This variable represented the level of care achieved during the entire year.  The 
analyses were adjusted for number of quality measures achieved in 2004 because the 
variable, comprehensive diabetes care might be proxy for both the setting and the level of 
care (see flow diagram on next page).  Therefore, a separate variable to represent levels 
of care was created. 
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Figure 2.3 Flow Diagram for the proposed relationship between Comprehensive 
Diabetes Care and Diabetes-related Outcomes 
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Assessment 
 The number of quality measures in 2004 was calculated by the sum of the 
different quality measures (see Appendix II on p.137 for CPT codes of quality measures) 
that occurred within 2004 for each individual. 
Outcomes  
Quality Measures for Diabetes Care in 2005 
Rationale 
 The aim of diabetes care is to prevent diabetes-related outcomes through proper 
clinical monitoring and self-management.  Surrogate measures such as laboratory tests 
and clinical examinations are chosen to evaluate interim quality of care in diabetes.  In 
2000, the Diabetes Quality Improvement Project22 team selected the frequencies and/or 
results of the following as quality measures of diabetes care: 1) hemoglobin A1c test 
(HbA1c), 2) low-density lipoprotein test (LDL-c), 3) nephropathy screening, 4) eye 
examination in the past year, 5) foot examination and 6) blood pressure check in the past 
year.  These clinical tests and examinations are also Healthcare Effectiveness Data and 
Information Set (HEDIS) measures23 for the quality of diabetes care.  Since HEDIS 
measures have been used in evaluating the quality of care among Medicare/ Medicaid 
beneficiaries, this study followed the convention in assessing quality of diabetes care. 
Assessment 
Using Current Procedural Terminology (CPT) codes, quality measures for 
diabetes care were identified by having at least one occurrence of the following 
assessments during CY 2005: hemoglobin A1c (HbA1c) tests, low-density lipoprotein 
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(LDL-c) tests, nephropathy screens and eye examinations. Please refer to Appendix II on 
p.137 for procedural codes.  A summary measure was created to indicate full adherence 
to quality benchmarks, defined by having all four procedures during CY 2005.   All 
quality measures were identified using claims files from outpatient, physician, medical 
and mental health services in Medicaid data, as well as claims files for outpatient and 
physician services in Medicare data. 
Diabetes Complications and Hospitalizations in 2005 
Rationale 
 The types of complications are selected based on information from the Centers for 
Disease Control and Prevention.82  They include heart disease, blindness (diabetes 
retinopathy), kidney disease (nephropathy), nervous system damage (neuropathy) and 
lower-limb amputations.82 
Assessment 
 Using ICD-9 and Current Procedural Terminology (CPT) codes (see Appendix II 
on p.137 for codes), diabetes-related outcomes were identified during CY 2005: a) eye 
complications; b) nephropathy; c) ischemic heart disease; d) cerebrovascular disease; and 
f) lower-limb amputations. Diabetes-related hospitalization was assessed by any inpatient 
claims with any diabetes-related ICD-9 codes, i.e., diabetes and complications, as the first 
diagnosis. 
Other Covariates 
Hospital Service Areas (HSA) 
Rationale  
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Poorer quality of diabetes care might be due to differences in clinical practice, 
rather than individuals’ characteristics such as the presence of BHDs because patterns of 
diabetes care were shown to be similar within a provider but variable across providers, 
according to a study by Krein and colleagues.83 Therefore, the heterogeneous patterns of 
care due to providers had to be addressed.  One potential solution was to cluster patients 
according to their care providers.  Providers could be identified in the current database; 
however, provider identifiers were different in Medicare and Medicaid data and a 
crosswalk of identifiers was not available. Without a way to uniquely identify providers, 
it was possible that the same provider could have one of each identification number.  
Therefore, the same provider could be counted twice if the patient was dually-eligible.  In 
addition, assigning a specific provider for one patient was problematic because one 
patient might visit several providers with similar frequencies during the study period.  As 
an alternative, Hospital Service Areas (HSAs) were used as proxy for the patterns of care 
due to patient-provider clustering.  
Even though a given HSA may contain multiple healthcare providers, service 
utilization represented by HSAs could potentially reflect physician care.  Patients usually 
sought care from local physicians, who were in turn affiliated with the local hospitals.84  
HSAs were defined by the areas where the local residents received most of their hospital 
care.84 
Several studies by John Wennberg and colleagues demonstrated that the patterns 
of inpatient and outpatient health care utilization varied greatly across HSAs but were 
generally more homogeneous within the area.85  Such variations were associated with the 
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quality of care from providers, independent of the rates of illnesses or a variety of other 
socioeconomic characteristics of the area.86,87  For example, Medicare reimbursement for 
outpatient services per enrollee in 2005 ranged from $648 in North Adams, MA to $1614 
in Melrose, MA, a difference of 149% within the same state.88  In addition, Sirovich and 
colleagues observed that providers in Hospital Referral Regions (aggregates of HSAs 
representing tertiary care service areas) with higher Medicare expenditures were more 
likely to advocate medical interventions than those in regions with lower Medicare 
expenditures.89   Therefore, in the absence of data on specific providers, HSAs might be a 
reasonable, partial substitute for provider-based variation in care as well as a practical 
solution to account for unmeasured correlation among patients within a catchment area of 
healthcare services. 
Assessment  
 Hospital Service Areas (HSAs) were identified using zip codes and cross-
referenced with data from the Dartmouth Atlas website.42  There were 64 Hospital 
Service Areas identified in Massachusetts for this study. 
Analytic approach 
Rationale 
 Unadjusted, descriptive analyses using chi-squared tests were performed to 
compare the outcomes (rates of adherence to quality measures, diabetes-related 
complications and hospitalizations) between people with mental health disorders and 
those with no mental health disorders, as well as those with substance use disorders 
(SUD) and those with no SUD, because SUD frequently co-occurs with mental health 
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disorders and there is evidence that the quality of diabetes care is poorer for those with 
SUD or those with both mental health disorders and co-morbid SUD.16,66 Because the 
study populations were not randomly selected, it was possible that people with BHDs 
were different from those without BHDs in terms of demographics, burden of co-
morbidities, source of health coverage, pre-existing diabetes complications and patterns 
of care. Previous studies had shown that these population characteristics were associated 
with the quality of diabetes care (please refer to sections on Predisposing, Enabling, Need 
and Behavior factors). 15-17,55,71-74,81   Therefore, case-mix adjustments were necessary to 
minimize bias. Multivariate logistic regression models with robust clustering were carried 
out to estimate the odds of outcomes for any given set of mental (e.g., Schizophrenia/ 
Paranoid State) or substance use disorders (e.g., Alcohol abuse/ dependence) relative to 
no BHDs while adjusting for case-mix and addressing the clustering of patients within 
Hospital Services Areas (please refer to section ‘Other Covariates: Hospital Services 
Areas’ on p.43 for rationale and assessment).  
Method 
Unadjusted analyses:  
For Aim 1, unadjusted analyses were performed using !2 tests, Kruskal-Wallis 
tests or ANOVA to compare the distributions of covariates (Predisposing, Enabling, 
Need and Behavior factors) and adherence to quality measures (Full Adherence, HbA1c 
test, LDL-c test, nephropathy test and eye examinations) across BHD categories.  For 
Aim 2, unadjusted analyses were performed using !2 tests to compare the distributions of 
diabetes outcomes (any complications, eye complications, neuropathy, nephropathy, 
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ischemic heart disease, cerebrovascular disease, lower-limb amputations and diabetes-
related hospitalizations) across BHD categories.  Pair-wise comparisons were also 
performed, e.g., no mental health disorders vs. schizophrenia/ paranoid states and no 
SUD vs. SUD within each mental disorder category. For Aim 3, !2 tests were carried out 
to compare diabetes outcomes between people with and without comprehensive diabetes 
care.  
Adjusted analyses: 
Logistic regressions with robust clustering of Hospital Service Areas were carried 
out for all aims to examine the effects of BHDs on the individual outcomes as well as the 
summary measures while adjusting for covariates.  Five separate regression models were 
performed for each outcome: 1) BHDs only; 2) BHDs and other Predisposing factors; 3) 
model 2 and Enabling factors; 4) model 3 and Need factors; and 5) model 4 and Behavior 
factor. Here is an example of a logistic model using Full Adherence as outcome:    
 
logit(Full Adherenceij) = log p(Full Adherence)ij1- p(Full Adherence)ij
" 
# 
$ 
% 
& 
' 
=
(1Mental_Disordersij + (2Alc _ abuseij + (3Drug_ abuseij  (Model 1)
+(4Ageij + (5Genderij + (6Ethnicityij + (7CDPSij                 (Model 2)
+(8Coverage_ typeij + (9Continuous_coverageij
+(10Education _ levelij + (11Household _ incomeij                            (Model 3)
+(12No_complication2004ij + (13Eye_complications2004ij
+(14Nephro2004ij + (15Neuro2004ij + (16IHD2004ij
+(17Leg / foot_amputation2004ij + (18CVD2004ij                             (Model 4)
+(19Freq_visitij +)i                                                                                                          (Model 5)
 
Where i = clusters, i.e., HSA, j = each beneficiary 
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Also, in adjusted analyses, age was categorized into four groups: <55, 55-64, 65-
74, 75 and older while CDPS was divided into quartiles.  Levels of statistical significance 
were set at: 1) !=0.05 for unadjusted analyses and adjusted analysis of summary 
measures such as full adherence; and 2) !=0.01 for adjusted analyses of individual 
outcomes due to multiple comparisons.  All statistical analyses were performed using 
STATA 10. 
For Aim 1: 
 The outcomes for this analysis were the individual quality measures for diabetes 
care (HbA1c test, LDL-c test, nephropathy test and eye examination) and the summary 
measure of full adherence. 
For Aim 2:  
The outcomes for this analysis were the individual diabetes complications (eye 
complications, nephropathy, ischemic heart disease, cerebrovascular disease and lower-
limb amputations) and the two summary measures (any diabetes complications and any 
diabetes-related hospitalizations). In these regression models, different population 
selection criteria were applied.  Individuals with a particular previous complication were 
excluded from the analyses using the complication as outcome.  For example, people 
with previous eye complications were excluded from the analysis of eye complications in 
2005 as outcome.  No individuals were excluded in the analysis with any diabetes 
complications or diabetes-related hospitalizations as outcome. 
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For Aim 3:  
 Logistic regressions with robust clustering of Hospital Service Areas were carried 
out to examine the effects of comprehensive diabetes care on the diabetes-related 
outcomes in Aim 2 among people with co-occurring BHDs, adjusting for all covariates.  
In this analysis, ‘co-occurring alcohol abuse/ dependence’ and ‘co-occurring drug abuse/ 
dependence’ were used to represent substance use disorders co-occurring with mental 
health disorders (see section on ‘Behavioral health disorders: Assessment: For Chapter 
V’ on p.29).  In addition to selecting only individuals with any types of BHDs, 
individuals with a particular previous complication were excluded from the analyses 
using the complication as outcome.  Two sets of regression models were performed for 
each outcome, i.e., one with comprehensive diabetes care and one without the variable.  
The analyses with comprehensive diabetes care were also adjusted for number of quality 
measures in 2004 because the variable, comprehensive diabetes care might be proxy for 
both the setting and the level of care (see section on Behavior factors: ‘Number of quality 
measures met in 2004’ for rationale and assessment).  The impact of comprehensive 
diabetes care was evaluated based on the changes in the effect size of BHDs between the 
two regression models.  Significant impact was defined as a change in effect size by 10%.  
Here is a sample model using any complication in 2005 as outcome: 
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logit(Any complicationsij) = log p(Any complications)ij1- p(Any complications)ij
" 
# 
$ 
% 
& 
' 
=
(1Mental_Disordersij + (2Co_ Alc _ abuseij + (3Co_Drug_ abuseij
+(4Ageij + (5Genderij + (6Ethnicityij + (7CDPSij + (8Coverage_ typeij
+(9Continuous_coverageij + (10Education _ levelij + (11Household _ incomeij 
+(12No_complication2004ij + (13Eye_complications2004ij + (14Nephro2004ij
+(15Neuro2004ij + (16IHD2004ij + (17Leg / foot_amputation2004ij
+(18CVD2004ij + (19Freq_visitij + (20Comprehensive_careij + (21# Measures_2004 ij +)i                                                                                                          
 
Where i = clusters, i.e., HSA, j = each beneficiary 
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Chapter III.  Behavioral health disorders and adherence to quality measures of 
diabetes care 
Aim 
 This chapter (Aim 1) describes the research findings on the relationship between 
BHDs and adherence to quality measures for diabetes care.  First, population 
characteristics were presented and compared across people with various BHDs.  Then the 
rates of adherence to quality measures were compared across the BHDs.  Finally, 
multivariate analyses were performed to illustrate the effects of BHDs on adherence 
while adjusting for potential confounders.  
Results  
In 2004, 31,350 or about 30% individuals of the study population with diabetes 
had any co-occurring BHDs.  Among them, 29,772, or 28% individuals in the overall 
population had co-occurring mental health disorders while the prevalence of substance 
use disorders was 5.1% (n=5,431). The majority of individuals with mental health 
disorders had depression/ anxiety (N=19,690, 18%)(see Table 3.1).   
 52 
Table 3.1  Prevalence of Mental health disorders 
 N (%) 
No mental health disorders 76,402 (72) 
Schizophrenia/ paranoid states 3,811 (4) 
Bipolar disorder 3,151 (3) 
Depression/ anxiety 19,690 (18) 
Other mental health disorders 3,120 (3) 
Total 106,174 (100) 
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Table 3.2 describes the proportions of people with co-occurring SUD within each 
mental disorder category. The prevalence of having comorbid SUD was the highest 
among people with bipolar disorder (26%) and schizophrenia/ paranoid states (22%).   
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Table 3.2  Proportions of Comorbid Substance use disorders in Mental Disorder 
Categories 
N=106,174 Types of Mental health disorders 
 No mental 
health 
disorders 
(%) 
 
Schizophrenia/ 
paranoid states 
(%) 
Bipolar 
disorder 
(%) 
Depression/ 
anxiety (%) 
Other 
mental 
health 
disorders 
(%) 
Overall 
(%) 
Any 
Substance 
use disorders 
1,578 (2) 866 (22) 830 (26) 1,995 (10) 172 (6) 5,431 (5) 
Alcohol 
abuse/ 
dependence 
1,008 (1) 542 (14) 505 (16) 1,076 (5) 103 (3) 3,234 (3) 
Drug abuse/ 
dependence 
688 (1) 586 (15) 591 (19) 1,280 (7) 89 (3) 3,234 (3) 
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Table 3.3 showed that on average, people with diabetes and mental health 
disorders were younger (average age ranged from 52 to 65) than those with diabetes 
alone (average age: 70±13).  Similarly, the average age of people with substance use 
disorders, SUD, (mean age: 52±14) was lower than those without (mean age: 68±14)(see 
Table 3.4).  The proportions of females with bipolar disorder (64%) and depression/ 
anxiety (69%) were higher than males (Bipolar: 36%; depression/ anxiety: 31%).  
However, the prevalence of co-occurring SUD within each mental disorder category was 
higher among males (see Table 3.4).   
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Table 3.3  Characteristics of Study Population by Mental Disorder Categories  
 Mental health disorders 
 No mental 
health disorders  
Schizophrenia 
/paranoid states 
Bipolar 
disorder  
Depression/ 
anxiety  
Other mental 
health disorders  
 
Overall  
No. of beneficiaries 76,402 3,811 3,151 19,690 3,120 106,174 
Mean age (SD)a,1 70 (13) 52 (13)2 53 (15)2 61 (16)2 65 (16)2 67 (14) 
Gender (%)b,1  3 2 2 2  
Female 41,394 (54) 1,956 (51) 2,020 (64) 13,569 (69) 1,582 (51) 60,521 
(57) 
Male  35,008 (46) 1,855 (49) 1,131 (36) 6,121 (31) 1,538 (49) 45,653 
(43) 
Race/ Ethnicity (%)b,1  2 2 2 2  
Non-Hispanic white 62,933 (82) 2,879 (76) 2,586 (82) 15,653 (80) 2,467 (79) 86,518 
(81) 
African American 5,534 (7) 570 (15) 236 (7) 1,359 (7) 284 (9) 7,983 (8) 
Hispanic 2,716 (4) 148 (4) 119 (4) 1,357 (7) 165 (5) 4,505 (4) 
Others 2,634 (3) 85 (2) 40 (1) 507 (3) 72 (2) 3,338 (3) 
Unknown 2,585 (3) 129 (3) 170 (5) 814 (4) 132 (4) 3,830 (4) 
Mean CDPS score (SD)c,1  1.5 (1.1) 1.5 (1.1)4 1.8 (1.3)2 1.8 (1.3)2 1.9 (1.4)2 1.6 (1.2) 
Disabled (%) b,1 16,087 (21) 3,313 (87)2 2,258 (72)2 9,461 (48)2 1,070 (34)2 32,189 
(30) 
Health Coverage (%)b,1  2 2 2 2  
Medicare only 50,376 (66) 375 (10) 588 (19) 7,205 (37) 1,593 (51) 60,137 
(57) 
Medicaid only 11,997 (16) 1,472 (39) 1,318 (42) 6,725 (34) 790 (25) 22,302 
(21) 
Dual-eligible 14,029 (18) 1,964 (52) 1,245 (40) 5,760 (29) 737 (24) 23,735 
(22) 
With continuous coverage 
for 12 months (%)b,1 
73,581 (96) 3,727 (98)2 2,969 (94)2 18,686 (95)2 2,947 (94)2 101,910 
(96) 
Average #Office visits 2004 
(SD)c,1 
7.4 (6.6) 6.5 (7.0)2 8.4 (9.1)4 8.7 (8.1)2 8.4 (7.7)2 7.7 (7.1) 
Comprehensive Diabetes 
Care (%)b,1 
1,445 (1.9) 21 (0.6)2 27 (0.9)2 217 (1.1)2 44 (1.4)2 1,754 (1.7) 
Any previous complications 
(%)b,1 
41,447 (54) 1,279 (34)2 1,237 (39)2 10,077 (51)2 1,806 (58)2 55,846 
(53) 
Eye complications in 2004 
(%)b,1 
13,189 (17) 343 (9)2 300 (10)2 2,943 (15)2 523 (17)9 17,298 
(16) 
Neuropathy in 2004 (%)b,1 10,697 (14) 413 (11)2 409 (13)7 3,138 (16)2 531 (17)2 15,188 
(14) 
Nephropathy in 2004 (%)b,1 3,946 (5) 126 (3)2 103 (3)2 984 (5)8 205 (7)3 5,364 (5) 
Lower-limb amputations in 
2004 (%)b,1, 
3,722 (5) 224 (6)3 206 (7)2 1,346 (7)2 286 (9)2 5,784 (5) 
Ischemic Heart disease in 
2004 (%)b,1 
25,564 (33) 515 (14)2 616 (20)2 5,785 (29)2 1,094 (35)6 33,574 
(32) 
Cerebrovascular disease in 
2004 (%)b,1 
8,117 (11) 150 (4)2 218 (7)2 2,099 (11)10 522 (17)2 11,106 
(10) 
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 Mental health disorders 
 No mental 
health disorders  
Schizophrenia 
/paranoid states 
Bipolar 
disorder  
Depression/ 
anxiety  
Other mental 
health disorders  
 
Overall  
Zip code-based neighborhood socioeconomic status 
Average Median Household 
Income (SD)a,1 
49,625 (17,605) 43,584 (15,234)2 44,928 
(15,539)2 
45,211 
(17,163)2 
48,839 (17,917)4 48,427 
(17,514) 
Average %High School 
Graduates (SD)a,1 
82 (11) 79 (12)2 80 (12)2 79 (12)2 82 (11)7 82 (11) 
 
Legend: 
a Student's t-test 
b !2 test 
c Kruskal-Wallis test 
1 p<0.001 across all mental/substance use disorder categories 
2 p<0.001 in pairwise comparisons with No mental health 
disorders  
3 p<0.01 in pairwise comparisons with No mental health 
disorders  
4 p<0.05 in pairwise comparisons with No mental health 
disorders  
5 p=0.05 in pairwise comparisons with No mental health 
disorders 
6 p=0.06 in pairwise comparisons with No mental health 
disorders 
7 p=0.1 in pairwise comparisons with No mental health 
disorders 
8 p=0.3 in pairwise comparisons with No mental health 
disorders 
9 p=0.5 in pairwise comparisons with No mental health 
disorders 
10 p=0.9 in pairwise comparisons with No mental health 
disorders 
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Mental health disorders were most prevalent among non-Hispanic whites (range: 
76%-82%).  However, among African Americans, the prevalence of schizophrenia/ 
paranoid states was almost twice as high (15%) as other types of mental health disorders 
(range: 7%-9%).  Higher prevalence of SUD was also observed among African 
Americans (9.6%) than non-Hispanic whites (4.5%), Hispanics (7.6%) and other 
race/ethnicity (2.2%).  Except for people with schizophrenia/ paranoid states (mean 
CDPS: 1.5±1.1), people with mental health disorders had higher physical disease burden 
(range of mean CDPS: 1.8-1.9) than those with no mental health disorders (mean CDPS: 
1.5±1.1).  Higher burden of physical disease was also found among people with SUD 
(mean CDPS: 2.1±1.6) than those without (mean CDPS: 1.6±1.1).  Higher rates of 
disability (range: 34%-87%) and Medicaid enrollment (range: 25%-42%) were observed 
in people with mental health disorders than those with no mental health disorders 
(disability: 21%; Medicaid enrollment: 16%).   Similarly, higher proportions of people 
with SUD had disability (70%) and Medicaid enrollment (51%) than those without 
(disability: 28%; Medicaid: 19%).  Except for people with schizophrenia/ paranoid states 
(98%), people with mental health disorders had lower rates of 12-month continuous 
coverage (94%-95%) than those with no mental health disorders (96%). 
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Table 3.4  Characteristics of Study Population by Mental and Substance Use 
Disorder Categories 
 Mental health disorders 
 No mental health 
disorders 
(n=76,402) 
Schizophrenia 
/paranoid states 
(n=3,811) 
Bipolar disorder 
(n=3,151) 
Depression/ 
anxiety (n=19,690) 
Other mental 
health disorders 
(n=3,120) 
Substance use 
disorders 
No Yes No Yes No Yes No Yes No Yes 
 
Overall  
No. of 
beneficiaries 
74,824 1,578 2,955 856 2,321 830 17,695 1,995 2,948 172 106,174 
Mean age (SD)a,1 70 (12) 59 (15)2 53 (13) 46 (10)2 54 (16) 47 (12)2 63 (16) 51 (13)2 66 (16) 58 (17)2 67 (14) 
Gender (%)b,1  2  2  2  2  2  
Female 40,938 
(55) 
456 (29) 1,646 
(56) 
310 (36) 1,598 
(69) 
422 (51) 12,634 
(71) 
935 (47) 1,534 
(52) 
48 (28) 60,521 
(57) 
Male  33,886 
(45) 
1,122 
(71) 
1,309 
(44) 
546 (64) 723 (31) 408 (49) 5,061 
(29) 
1,060 
(53) 
1,414 
(48) 
124 (72) 45,653 
(43) 
Race/ Ethnicity 
(%)b,1 
 2  2    2    
Non-Hispanic 
white 
61,819 
(83) 
1,114 
(71) 
2,287 
(77) 
592 (69) 1,960 
(84) 
626 (75) 14,212 
(80) 
1,441 
(72) 
2,342 
(79) 
125 (73) 86,518 
(81) 
African 
American 
5,286 
(7) 
248 (16) 406 (14) 164 (19) 136 (6) 100 (12) 1,133 
(6) 
226 (11) 255 (9) 29 (17) 7,983 
(8) 
Hispanic 2,627 
(4) 
89 (6) 97 (3) 51 (6) 87 (4) 32 (4) 1,194 
(7) 
163 (8) 158 (5) N/A* 4,505 
(4) 
Others 2,615 
(3) 
19 (1) 71 (2) 14 (2) 30 (1) N/A* 478 (3) 29 (1) 70 (2) N/A* 3,338 
(3) 
Unknown 2,477 
(3) 
108 (7) 94 (3) 35 (4) 108 (5) 62 (7) 678 (4) 136 (7) 123 (4) N/A* 3,830 
(4) 
Mean CDPS 
score (SD)c,1 
1.5 (1.1) 2.2 
(1.6)2 
1.5 (1.0) 1.7 
(1.2)2 
1.7 (1.2) 2.0 
(1.5)3 
1.8 (1.3) 2.2 
(1.8)2 
1.9 (1.4) 2.3 
(1.6)2 
1.6 (1.2) 
Disabled (%)b,1 15,279 
(20) 
808 
(51)2 
2,507 
(85) 
806 
(94)2 
1,599 
(69) 
659 
(79)2 
8,032 
(45) 
1,429 
(72)2 
984 (33) 86 (50)2 32,189 
(30) 
Health Coverage 
(%)b,1 
 2  2  2  2  2  
Medicare only 49,859 
(67) 
517 (33) 342 (12) 33 (4) 526 (23) 62 (7) 6,918 
(39) 
287 (14) 1,540 
(52) 
53 (31) 60,137 
(57) 
Medicaid only 11,288 
(15) 
709 (45) 1,078 
(36) 
394 (46) 842 (36) 476 (57) 5,602 
(32) 
1,123 
(56) 
714 (24) 76 (44) 22,302 
(21) 
Dual-eligible 13,677 
(18) 
352 (22) 1,535 
(52) 
429 (50) 953 (41) 292 (35) 5,175 
(29) 
585 (29) 694 (24) 43 (25) 23,735 
(22) 
With continuous 
coverage for 12 
months (%)b,1 
72,148 
(96) 
1,433 
(91)2 
2,902 
(98) 
825 
(96)3 
2,220 
(96) 
749 
(90)2 
16,871 
(95) 
1,815 
(91)2 
2,789 
(95) 
158 
(92)7 
101,910 
(96) 
Average #Office 
visits 2004 
(SD)c,1 
7.4 (6.6) 7.1 
(7.3)2 
6.5 (6.9) 6.3 
(7.2)6 
8.5 (8.2) 8.0 
(11.4)2 
8.7 (8.0) 8.2 
(8.9)2 
8.4 (7.6) 8.7 
(8.8)11 
7.7 (7.1) 
Comprehensive 
Diabetes Care 
(%)b,1 
1,424 
(1.9) 
21 (1.3)7 18 (0.6) N/A* 18 (0.8) N/A* 199 
(1.1) 
18 
(0.9)10 
41 (1.4) N/A* 1,754 
(1.7) 
Any previous 40,648 799 1,010 269 924 (40) 313 9,182 895 1,707 99 (58)14 55,846 
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 Mental health disorders 
 No mental health 
disorders 
(n=76,402) 
Schizophrenia 
/paranoid states 
(n=3,811) 
Bipolar disorder 
(n=3,151) 
Depression/ 
anxiety (n=19,690) 
Other mental 
health disorders 
(n=3,120) 
Substance use 
disorders 
No Yes No Yes No Yes No Yes No Yes 
 
Overall  
complications 
(%)b,1 
(54) (51)2 (34) (31)7 (38)9 (52) (45)2 (58) (53) 
Eye 
complications in 
2004 (%)b,1 
13,014 
(17) 
175 
(11)2 
280 (9) 63 (7)5 248 (11) 52 (6)2 2,745 
(16) 
198 
(10)2 
502 (17) 21 (12)7 17,298 
(16) 
Neuropathy in 
2004 (%)b,1 
10,444 
(14) 
253 
(16)2 
323 (11) 90 (11)12 294 (13) 115 
(14)10 
2,808 
(16) 
330 
(17)10 
498 (17) 33 (19)10 15,188 
(14) 
Nephropathy in 
2004 (%)b,1 
3,839 
(5) 
107 (7)2 108 (4) 18 (2)4 77 (3) 26 (3)13 883 (5) 101 
(5)14 
193 (7) 12 (7)13 5,364 
(5) 
Lower-limb 
amputations in 
2004 (%)b,1 
3,535 
(5) 
187 
(12)2 150 (5) 74 (9)2 127 (5) 79 (10)2 
1,135 
(6) 
211 
(11)2 258 (9) 28 (16)3 
5,784 
(5) 
Ischemic Heart 
disease in 2004 
(%)b,1 
25,137 
(34) 
427 
(27)2 
422 (14) 93 (11)4 482 (21) 134 
(16)3 
5,361 
(30) 
424 
(21)2 
1,040 
(35) 
54 (31)9 33,574 
(32) 
Cerebrovascular 
disease in 2004 
(%)b,1 
7,955 
(11) 
162 
(10)11 119 (4) 31 (4)11 175 (8) 43 (5)4 
1,948 
(11) 151 (8)2 499 (17) 23 (13)8 
11,106 
(10) 
Zip code-based neighborhood socioeconomic status 
Average Median 
Household 
Income (SD)a,1 
49,744 
(17,620) 
43,9592 
(15,909) 
44,196 
(15,428) 
41,4722 
(14,352) 
45,702 
(15,853) 
42,7612 
(14,414) 
45,637 
(17,326) 
41,4382 
(15,125) 
49,060 
(17,989) 
45,0413 
(16,202) 
48,427 
(17,514) 
Average %High 
School 
Graduates (SD)a,1 82 (11) 79 (12)2 79 (12) 77 (12)2 80 (12) 78 (12)2 79 (12) 77 (12)2 82 (11) 80 (11)3 82 (11) 
 
Legend: 
a Student's t-test 
b !2 test 
c Kruskal-Wallis test 
1  p<0.001 across all mental/substance use disorder categories 
In pairwise comparisons of Substance use disorders within each Mental Disorder Category: 
2  p<0.001, 3 p<0.01, 4 p<0.05, 5 p=0.06, 6  p=0.07, 7  p=0.1, 8 p=0.2, 9 p=0.3, 10 p=0.4, 11 p=0.6,  
12 p=0.7, 13 p=0.8, 14 p=0.9  
* Per Data Use Agreement, data suppressed due to small cell size (<11).  No comparison tests performed. 
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People with mental health disorders resided in neighborhoods with lower 
socioeconomic status (lower rates of high school graduates: 79%-82% and lower median 
household income in 1999: 43,584-48,839) than those with no mental health disorders 
(rate of high school graduates: 82%, median household income: 49,625). Similar findings 
were also observed among people with substance use disorders (SUD).  
Lower proportions of people with schizophrenia/ paranoid states (34%), bipolar 
disorder (39%) and depression/ anxiety (51%) had any previous diabetes complications 
than those with no mental health disorders (54%).  However, the rates of having lower-
limb amputations were higher among people with mental health disorders (6%-9%) than 
those with no mental health disorders (5%).  Similar observations were also noted in 
people with SUD. 
There were 36,065 (34%) beneficiaries with comprehensive diabetes care, as 
defined by having met 2 or more quality measures within a visit during 2004.  Except for 
people with schizophrenia/ paranoid states (29%), higher proportions of having 
comprehensive care were observed in people with bipolar disorder (36%), depression/ 
anxiety (38%) and other mental health disorders (36%) than those with no mental health 
disorders (33%).  However, the proportions of those having comprehensive care among 
people with SUD were not significantly different from those with no SUD. 
Table 3.5 illustrates the rates of adherence to quality measures for diabetes care 
across mental health disorders in 2005 and Table 3.6 compares the adherence rates 
between those with SUD and those without.  Table 3.5 shows that people with any mental 
health disorders were less likely to achieve full adherence (range: 19%-22%) than those 
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without (25%). The rates of adherence to the HbA1c test guideline were lower among 
people with any mental health disorders (64%-72%) than those with no mental health 
disorders (76%).  Lower proportions of people with any mental health disorders (61%-
65%) had at least one LDL-c tests in 2005 than those with no mental health disorders 
(73%).  Lower rates of adherence to eye examinations were also found among people 
with any mental health disorders (42%-54%) than those with no mental health disorders 
(61%).  However, a higher proportion of people with any mental health disorders (49%-
51%) than those with no mental health disorders (47%) had nephropathy tests.  People 
with SUD had lower rates of adherence to any given quality measures than those without 
SUD (see Table 3.6).  For example, only 13% of people with SUD achieved full 
adherence to quality measures, compared to the rate of full adherence at 24% for those 
without SUD.  After taking SUD into account, people with any mental health disorders 
but no SUD still had lower rates of having HbA1c test (67%-74%), LDL-c test (64%-
70%) and eye examinations (46%-55%) than those with no mental or substance use 
disorders (HbA1c: 76%, LDL-c: 73%, eye examinations: 62%). 
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Table 3.5  Adherence to Quality Measures for Diabetes Care in Study Population by 
Mental Disorder Categories 
 Mental health disorders 
 No mental health 
disorders  
Schizophrenia 
/paranoid states 
Bipolar 
disorder  
Depression/ 
anxiety  
Other mental health 
disorders 
 
Overall  
No. of beneficiaries 76,402 3,811 3,151 19,690 3,120 106,174 
Full adherence in 2005 
(%)a,1 
18,962 (25) 717 (19)2 586 (19)2 4,200 (21)2 678 (22)2 25,143 
(24) 
Any HbA1c test 2005 
(%)a,1 
58,175 (76) 2,750 (72)2 2,017 (64)2 13,405 (68)2 2,229 (71)3 78,576 
(74) 
Any Nephropathy test 
2005 (%)a,1 
35,987 (47) 1,903 (50)3 1,611 (51)2 9,558 (49)2 1,505 (48)4 50,564 
(48) 
Any LDL-c test 2005 
(%)a,1 
55,642 (73) 2,586 (68)2 1,914 (61)2 12,507 (64)2 2,013 (65)2 74,662 
(70) 
Any Eye exam 2005 
(%)a,1 
46,726 (61) 1,673 (44)2 1,316 (42)2 9,984 (51)2 1,689 (54)2 61,388 
(58) 
 
Legend: 
a !2 test 
1 p<0.001 across all mental/substance use disorder categories 
2 p<0.001 in pairwise comparisons with No mental health 
disorders 
3 p<0.01 in pairwise comparisons with No mental health 
disorders 
4 p=0.2 in pairwise comparisons with No mental health 
disorders 
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Table 3.6  Adherence to Quality Measures for Diabetes Care in Study Population by 
Mental and Substance Use Disorder Categories 
 Mental health disorders 
 No mental health 
disorders (n=76,402) 
Schizophrenia 
/paranoid states 
(n=3,811) 
Bipolar disorder 
(n=3,151) 
Depression/ 
anxiety 
(n=19,690) 
Other mental 
health disorders  
(n=3,120) 
Substance use 
disorders 
No Yes No Yes No Yes No Yes No Yes 
 
Overall  
No. of 
beneficiaries 
74,824 1,578 2,955 856 2,321 830 17,695 1,995 2,948 172 106,174 
Full adherence in 
2005 (%)a,1 
18,764 
(25) 
198 
(13)2 
570 (19) 147 (17)5 479 
(21) 
107 
(13)2 
3,968 
(22) 
232 
(12)2 
653 
(22) 
25 
(15)4 
25,143 
(24) 
Any HbA1c test 
2005 (%)a,1 
57,226 
(76) 
949 
(60)2 
2,181 (74) 569 (66)2 1,559 
(67) 
458 
(55)2 
12,278 
(69) 
1,127 
(56)2 
2,122 
(72) 
107 
(62)3 
78,576 
(74) 
Any Nephropathy 
test 2005 (%)a,1 
35,319 
(47) 
668 
(42)2 
1,422 (48) 481 (56)2 1,188 
(51) 
423 
(51)6 
8,641 
(49) 
917 
(46)4 
1,427 
(48) 
78 
(45)5 
50,564 
(48) 
Any LDL-c test 
2005 (%)a,1 
54,854 
(73) 
788 
(50)2 
2,068 (70) 518 (61)2 1,488 
(64) 
426 
(51)2 
11,529 
(65) 
978 
(49)2 
1,926 
(65) 
87 
(51)2 
74,662 
(70) 
Any Eye exam 
2005 (%)a,1 
46,146 
(62) 
580 
(37)2 
1,364 (46) 309 (36)2 1,068 
(46) 
248 
(30)2 
9,381 
(53) 
603 
(30)2 
1,624 
(55) 
65 
(38)2 
61,388 
(58) 
 
Legend: 
a !2 test 
Across all mental/substance use disorder categories: 
1 p<0.001 
In pairwise comparisons of Substance use disorders within each Mental Disorder Category: 
2 p<0.001, 3 p<0.01, 4 p<0.05, 5 p=0.4, 6p=0.9 
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In adjusted analyses, the addition of Need and Behavior factors had a significant 
impact on the relationship between BHDs and adherence to quality measures.  Therefore, 
only the estimates from the logistic regressions adjusted for all covariates (i.e., model 5) 
are presented in Tables 3.7 and 3.8. Please refer to Appendix XII on p.148 for estimates 
from other models.  After adjusting for covariates, lower rates of adherence to some 
quality measures persisted in certain BHDs, particularly substance use disorders.  
However, the associations between the rates of adherence and mental health disorders 
were not consistent.  For example, lower rates of full adherence in 2005 to quality 
measures were observed in individuals with depression/ anxiety (odds ratio [OR]: 0.95, 
95% confidence interval [CI]: 0.90, 1.00), other mental health disorders (odds ratio [OR]: 
0.88, 95% confidence interval [CI]: 0.79, 0.98), any alcohol abuse/ dependence (OR: 
0.79, 95%CI: 0.71, 0.86) or any drug abuse/ dependence (OR: 0.67, 95%CI: 0.59, 0.76).  
The odds of having at least one HbA1c test in 2005 were lower among people with 
depression/ anxiety (OR: 0.89, 95%CI: 0.83, 0.96) while the odds of having a HbA1c test 
were higher among those with schizophrenia/ paranoid states (OR: 1.51, 95%CI: 1.38, 
1.66).  Similarly, people with depression/ anxiety (OR: 0.91, 95%CI: 0.85, 0.98), other 
mental health disorders (OR: 0.84, 95%CI: 0.76, 0.92), any alcohol abuse/ dependence 
(OR: 0.82, 95%CI: 0.76, 0.89) or any drug abuse/ dependence (OR: 0.84, 95%CI: 0.74, 
0.95) had lower odds of LDL-c tests while higher odds of having the LDL-c test were 
shown among those with schizophrenia/ paranoid states (OR: 1.55, 95%CI: 1.42, 1.69).   
However, individuals with schizophrenia/ paranoid states (OR: 1.39, 95%CI: 1.28, 1.50), 
bipolar disorder (OR: 1.34, 95%CI: 1.23, 1.45), depression/ anxiety (OR: 1.10, 95%CI: 
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1.05, 1.15) or any drug abuse/ dependence (OR: 1.18, 95%CI: 1.09, 1.28) had higher 
odds of having a nephropathy test in 2005.  Finally, people with any alcohol abuse/ 
dependence (OR: 0.80, 95%CI: 0.74, 0.86) or any drug abuse/ dependence (OR: 0.71, 
95%CI: 0.65, 0.78) had lower likelihoods of having an eye examination while those with 
schizophrenia/ paranoid states had higher odds for eye examinations (OR: 1.19, 95%CI: 
1.06, 1.33). 
There were other factors that increased the likelihoods for adherence.  For 
example, having continuous health coverage for 12 months was associated with higher 
odds for adherence to any measures (OR for full adherence: 1.66, 95%CI 1.51, 1.83).  
Similarly, having previous eye complications or neuropathy was related to higher odds 
for adherence to most quality measures, except for nephropathy test, which was 
significantly associated with previous nephropathy (OR: 1.67, 95%CI: 1.52, 1.83).      
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Table 3.7  Estimates from logistic regression models for the associations between 
BHDs and adherence to quality measures 
N=106,174 Full Adherence HbA1c test LDL-c test 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 1.22** (1.08, 1.37) 1.51*** (1.38, 1.66) 1.55*** (1.42, 1.69) 
Bipolar disorder 1.05 (0.95, 1.15) 0.98 (0.89, 1.07) 1.08 (0.97, 1.19) 
Depression/ anxiety 0.95* (0.90, 1.00) 0.89** (0.83, 0.96) 0.91* (0.85, 0.98) 
Other mental health disorders 0.88* (0.79, 0.98) 0.94 (0.86, 1.02) 0.84*** (0.76, 0.92) 
Any alcohol abuse/ dependence 0.79*** (0.71, 0.86) 0.92 (0.84, 1.01) 0.82*** (0.76, 0.89) 
Any drug abuse/ dependence 0.67*** (0.59, 0.76) 0.90 (0.79, 1.02) 0.84** (0.74, 0.95) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.42*** (1.34, 1.51) 1.74*** (1.65, 1.84) 1.65*** (1.57, 1.73) 
65-74 1.62*** (1.52, 1.73) 1.89*** (1.76, 2.03) 1.90*** (1.79, 2.03) 
75 and older 1.39*** (1.30, 1.49) 1.52*** (1.41, 1.64) 1.08* (1.01, 1.17) 
Male Gender 1.04 (0.98, 1.10) 1.05* (1.00, 1.10) 1.09*** (1.04, 1.13) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 0.91* (0.84, 0.99) 1.00 (0.93, 1.07) 0.85*** (0.79, 0.92) 
Hispanic 1.03 (0.90, 1.19) 0.75*** (0.69, 0.83) 0.77*** (0.67, 0.89) 
Others 1.03 (0.94, 1.13) 1.19*** (1.08, 1.31) 1.22*** (1.12, 1.34) 
Unknown 0.77*** (0.67, 0.89) 0.82*** (0.74, 0.91) 0.82** (0.73, 0.93) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.27*** (1.21, 1.32) 0.88*** (0.85, 0.91) 0.92** (0.88, 0.97) 
1.3<=CDPS<=1.9 1.20*** (1.10, 1.30) 0.73*** (0.68, 0.79) 0.69*** (0.65, 0.73) 
CDPS>1.9 1.08 (1.00, 1.16) 0.52*** (0.48, 0.55) 0.47*** (0.44, 0.51) 
Health coverage type       
Medicare only (ref.) 1  1  1  
Medicaid only 0.53*** (0.46, 0.61) 0.48*** (0.41, 0.57) 0.41*** (0.36, 0.47) 
Dual-eligible 0.91* (0.84, 1.00) 1.23*** (1.12, 1.35) 0.93 (0.86, 1.00) 
Continuous 12-month coverage 1.66*** (1.52, 1.83) 1.32*** (1.18, 1.47) 1.63*** (1.51, 1.76) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.00 (0.90, 1.10) 0.95 (0.85, 1.08) 0.87 (0.73, 1.02) 
85-90% 1.00 (0.86, 1.17) 0.97 (0.82, 1.14) 0.83 (0.69, 1.01) 
>90% 1.07 (0.90, 1.26) 0.94 (0.76, 1.17) 0.83 (0.66, 1.03) 
Median Household income 1999       
<$36,44 (ref.) 1  1  1  
$36,448-$45,920 0.95 (0.88, 1.02) 1.10 (0.94, 1.28) 1.22 (0.98, 1.51) 
$45,921-$56,813 1.00 (0.90, 1.11) 1.12 (0.96, 1.32) 1.26 (0.97, 1.63) 
>$56,813 1.02 (0.89, 1.17) 1.06 (0.86, 1.30) 1.30 (0.98, 1.72) 
No Previous Complications 0.96 (0.92, 1.01) 0.92** (0.87, 0.97) 0.89*** (0.85, 0.93) 
Eye complications in 2004 1.63*** (1.53, 1.73) 2.19*** (0.98, 2.43) 1.22*** (1.15, 1.30) 
Nephropathy in 2004 1.29*** (1.21, 1.37) 1.60*** (1.43, 1.79) 0.86** (0.79, 0.95) 
Neuropathy in 2004 1.31*** (1.25, 1.38) 1.93*** (1.77, 2.10) 1.10** (1.03, 1.17) 
Ischemic Heart Disease in 2004 1.01 (0.95, 1.08) 0.94* (0.88, 0.99) 1.20*** (1.13, 1.28) 
Lower-limb amputations 2004 0.88*** (0.83, 0.94) 1.21*** (1.13, 1.31) 0.78*** (0.74, 0.83) 
Cerebrovascular diseases 2004 0.94* (0.90, 0.99) 0.93** (0.88, 0.98) 1.00 (0.95, 1.05) 
No. of outpatient visits 2004 1.05*** (1.05, 1.06) 1.07*** (1.06, 1.08) 1.07*** (1.06, 1.07) 
* p<0.05  **p<0.01 ***p<0.001       
 
 68 
Table 3.8  Estimates from logistic regression models for the associations between 
BHDs and adherence to quality measures  
N=106,174 Nephropathy test Eye Examination 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 1.39*** (1.28, 1.50) 1.19** (1.06, 1.33) 
Bipolar disorder 1.34*** (1.23, 1.45) 0.94 (0.87, 1.03) 
Depression/ anxiety 1.10*** (1.05, 1.15) 0.93* (0.87, 0.99) 
Other mental health disorders 1.02 (0.94, 1.11) 0.91* (0.85, 0.98) 
Any alcohol abuse/ dependence 1.06 (1.00, 1.14) 0.80*** (0.75, 0.86) 
Any drug abuse/ dependence 1.18*** (1.09, 1.28) 0.71*** (0.65, 0.78) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.20*** (1.15, 1.25) 1.59*** (1.50, 1.69) 
65-74 1.24*** (1.18, 1.31) 2.16*** (2.04, 2.29) 
75 and older 1.23*** (1.16, 1.30) 2.23*** (2.11, 2.37) 
Male Gender 1.04 (0.97, 1.10) 0.88*** (0.86, 0.91) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.00 (0.94, 1.05) 1.09* (1.01, 1.18) 
Hispanic 0.93 (0.86, 1.01) 0.98 (0.89, 1.08) 
Others 1.01 (0.91, 1.12) 0.91* (0.84, 0.99) 
Unknown 0.74*** (0.64, 0.85) 0.84*** (0.77, 0.92) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.22*** (1.16, 1.28) 1.14*** (1.08, 1.20) 
1.3<=CDPS<=1.9 1.29*** (1.18, 1.40) 1.06 (0.98, 1.14) 
CDPS>1.9 1.41*** (1.30, 1.53) 0.83*** (0.76, 0.90) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.55*** (0.48, 0.63) 0.38*** (0.33, 0.43) 
Dual-eligible 1.09** (1.02, 1.17) 0.81*** (0.73, 0.89) 
Continuous 12-month coverage 1.12** (1.04, 1.20) 1.52*** (1.42, 1.62) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.97 (0.85, 1.11) 1.04 (0.96, 1.14) 
85-90% 0.94 (0.79, 1.11) 1.07 (0.97, 1.18) 
>90% 0.98 (0.82, 1.17) 1.16** (1.04, 1.30) 
Median Household income 1999     
<$36,44 (ref.) 1  1  
$36,448-$45,920 0.97 (0.88, 1.08) 0.99 (0.92, 1.07) 
$45,921-$56,813 1.03 (0.91, 1.16) 1.01 (0.91, 1.12) 
>$56,813 1.09 (0.95, 1.27) 0.97 (0.86, 1.10) 
No Previous Complications 1.01 (0.97, 1.05) 0.98 (0.94, 1.03) 
Eye complications in 2004 1.00 (0.95, 1.05) 2.52*** (2.39, 2.67) 
Nephropathy in 2004 1.67*** (1.52, 1.83) 1.12** (1.04, 1.20) 
Neuropathy in 2004 1.03 (0.97, 1.08) 1.29*** (1.23, 1.35) 
Ischemic Heart Disease in 2004 1.02 (0.96, 1.08) 0.88*** (0.85, 0.92) 
Lower-limb amputations 2004 1.01 (0.95, 1.07) 0.84*** (0.79, 0.91) 
Cerebrovascular diseases 2004 0.97 (0.91, 1.02) 0.93*** (0.89, 0.97) 
No. of outpatient visits 2004 1.06*** (1.05, 1.07) 1.06*** (1.06, 1.07) 
* p<0.05  **p<0.01 ***p<0.001     
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Discussion 
The analyses showed mixed results of the associations between BHDs and 
adherence to quality measures.  First, the relationships between mental health disorders 
and adherence to quality measures were inconsistent and dependent on the outcomes of 
interest.  While individuals with schizophrenia/ paranoid states had increased odds of 
adherence to all quality measures, those with depression/ anxiety or other mental health 
disorders had lower odds of LDL-c tests and eye examinations. Having bipolar disorder 
was not significantly associated with adherence to most quality measures, except 
nephropathy tests. Likewise, no general trend could be drawn on the associations between 
substance use disorders (SUD) and adherence.  While people with substance use 
disorders had lower odds of having LDL-c tests and eye examinations, their likelihoods 
of having HbA1c tests were not significantly different from those with diabetes alone.  
Further, people with drug abuse/ dependence had higher odds of having nephropathy 
tests.  Similar findings on the associations between quality measures, such as LDL-c tests 
and eye examinations, and BHDs, such as substance use disorders,15,16,66 depression/ 
anxiety 15,16 and other mental health disorders 15 have also been reported in previous 
studies.   
Contrary to the findings reported in this study, Frayne and colleagues observed 
that people with schizophrenia were less likely to achieve adherence.16    It should be 
noted that the study population in Frayne’s study was from the Veterans Administration 
and the analysis of schizophrenia did not adjust for the presence of SUD.16  It is possible 
that SUD confounded the relationship between Schizophrenia and adherence to quality 
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measures.  Another possible reason is that Frayne and colleagues sampled the cohort in 
1999 and since then, clinicians were more aware of treating people with diabetes and co-
occurring schizophrenia.  For example, clinical practice guidelines for managing physical 
health among people with schizophrenia have been adopted by the American Diabetes 
Association and the American Psychiatric Association.90  
The study also showed that people with SUD had lower odds of adherence to 
quality measures, except for having nephropathy tests.  One possible reason is that 
managing diabetes may become secondary when an individual has co-morbid SUD.  For 
example, Redelmeier and colleagues observed that patients with chronic illnesses were 
less likely to receive treatments for other unrelated diseases.91. It is also possible that 
treating individuals with co-morbid SUD may be more difficult and thus full adherence to 
treatment guidelines may not be feasible.  For example, in a study by Krebs et al., 
physicians were three times as likely to regard a patient visit as difficult if the patient had 
SUD.92  In another study, Jackson and colleagues observed that patients were more likely 
to have unmet expectations, such as having tests or diagnoses, after a difficult encounter 
with physicians.93  However, individuals with co-morbid drug abuse/ dependence were 
more likely to have nephropathy tests.  It is possible that  physicians may be more 
inclined to monitor these individuals’ SUD with urine drug screen.  Since nephropathy 
tests are performed on urine samples, they may be ordered along with drug screens.  
Currently, treatment guidelines for medication-assisted treatments of opioid addiction 
recommended kidney function tests in individuals with both opioid addiction and 
diabetes.94 As the analysis suggests, the presence of drug abuse/ dependence was 
 71 
associated with higher odds for nephropathy tests. However, these patients might be less 
likely to receive care on other aspects of their diabetes.  Further studies will be helpful to 
understand whether individuals with both diabetes and SUD are more likely to adhere to 
quality measures of diabetes care after they receive treatments for SUD.  On the other 
hand, the analyses showed that people with previous complications (i.e., Need factors) 
were more likely to adhere to quality measures.   A similar observation was reported in a 
study by Paschalides et al.  It is possible that having previous diabetes complications 
increases an individual’s awareness of proper care and results in improved adherence.71  
Therefore, further research is needed to understand the factors that mediate the adherence 
to quality measures in people with SUD. 
In general, the adherence to quality measures for diabetes care was not optimal in 
this population.  In general, rates of adherence to quality measures were lower than 
national averages. 95  For example, the adherence rate for having at least one LDL-c test 
in 2005 was 70% for this population with Medicare/Medicaid in Massachusetts while the 
2005 national average rate of LDL-c test in Medicare and Medicaid populations was 
93.3% and 80.5% respectively.95  Therefore, efforts to improve adherence to quality 
measures are necessary. 
One limitation of this study was the use of administrative data. It is possible that 
the study underestimated the adherence rates to quality measures.  According to previous 
studies comparing the rates of adherence to quality measures between claims data and 
medical records, there was evidence for the under-detection of diabetes care services 
when only claims data were used.96,97  For example, the rates of HbA1c tests detected in 
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claims as a proportion of the gold standard (medical records) ranged from 47.6%97 to  
79.4%.96  It should be noted that the study by Maclean and colleagues used a population 
from one HMO with a sample size of 300 and yielded the result of 47.6% for HbA1c 
detection rate in claims .97  The low sensitivity may reflect insufficient power or poor 
reporting of encounters.  However, in a separate study, Fowles and colleagues observed 
high concordance in the rates of HbA1c (Kappa: 0.678) and microalbumin tests (Kappa: 
0.748) between claims data and medical records.98   In addition, they showed that claims 
data were more sensitive in identifying eye examinations (rate by claims: 46.6%, rate by 
medical records: 23.7%).98  Another limitation is the lack of data on HbA1c or LDL-c 
control.   Therefore, it is possible that the lower rates of tests to monitor diabetes may be 
due to more individuals with proper control in HbA1c or LDL-c.  Further investigation of 
data on HbA1c and LDL-c control is necessary to assess the quality of diabetes care in 
this population.  Another weakness was that the study was not able to assess the 
socioeconomic status of individual beneficiaries even though data from Census 2000 
were used as proxy for neighborhood socioeconomic conditions.  
The major strength of the current study is the use of population-based data. This is 
the first study to date that utilized an integrated Medicare/Medicaid database to examine 
the associations between behavioral health disorders and adherence to quality measures 
for diabetes care in a population with publicly sponsored health coverage. Since 
Medicare and Medicaid data were used, the results might be applicable to other Medicare 
and Medicaid populations with similar demographic composition and public insurance 
programs to those in Massachusetts. In addition, the size of study population, a total of 
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106,174 beneficiaries, provided sufficient confidence in detecting any significant 
relationships between the BHDs and adherence to quality measures.  
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Chapter IV. Behavioral health disorders and diabetes-related health outcomes 
Aim 
This chapter describes the findings from Aim 2 of the study: the relationship 
between BHDs and clinical outcomes of diabetes.  First, diabetes outcomes in 2005, such 
as eye complications, diabetic neuropathy, diabetic nephropathy, cerebrovascular 
diseases, ischemic heart disease, lower-limb complications and diabetes-related 
hospitalizations, were compared across the BHDs.  Finally, multivariate analyses were 
performed to demonstrate the effects of BHDs on having new diabetes complications and 
diabetes-related hospitalizations while adjusting for potential confounders. 
Results 
 Prevalent cases of diabetes outcomes were shown in Tables 4.1 and 4.2.  In Table 
4.1, diabetes outcomes were compared across the five categories of mental health 
disorders while Table 4.2 compared diabetes outcomes between those with substance use 
disorders (SUD) and those without.   
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Table 4.1 Health Outcomes in 2005 for Study Population by Mental Disorder 
Categories 
 Mental health disorders 
 No mental 
health 
disorders  
Schizophrenia 
/paranoid 
states 
Bipolar 
disorder  
Depression/ 
anxiety  
Other mental 
health 
disorders 
 
Overall  
No. of beneficiaries 76,402 3,811 3,151 19,690 3,120 106,174 
Any complications in 2005 
(%)a,1 
41,597 (54) 1,218 (32)2 1,154 (37)2 9,651 (49)2 1,687 (54)2 55,307 
(52) 
Eye complications in 2005 
(%)a,1 
13,001 (17) 342 (9)2 278 (9)2 2,831 (14)2 494 (16)2 16,946 
(16) 
Neuropathy in 2005 (%)a,1 11,655 (15) 419 (11)2 417 (13)3 3,120 (16)4 535 (17)2 16,146 
(15) 
Nephropathy in 2005 (%)a,1 4,487 (6) 122 (3)2 115 (4)2 1,057 (5)3 188 (6)2 5,969 
(6) 
Lower-limb amputations in 
2005 (%)a,1 
3,811 (5) 177 (5)6 182 (6)4 1,214 (6)2 217 (7)2 5,601 
(5) 
Ischemic Heart disease in 2005 
(%)a,1 
25,930 (34) 502 (13)2 586 (19)2 5,534 (28)2 1,024 (33)2 33,576 
(32) 
Cerebrovascular disease in 
2005 (%)a,1 
8,593 (11) 135 (4)2 200 (6)2 2,015 (10)2 423 (14)2 11,366 
(11) 
Diabetes-related 
hospitalizations in 2005 (%)a,1 
4,355 (6) 129 (3)2 174 (6)7 1,173 (6)5 214 (7)2 6,045 
(6) 
 
  
 
 
 
 
 
Legend: 
a  !2 test 
1 p<0.001 across all mental/substance use disorder categories 
2 p<0.001 in pairwise comparisons with No mental health disorders  
3 p<0.01 in pairwise comparisons with No mental health disorders 
4 p<0.05 in pairwise comparisons with No mental health disorders 
5 p=0.2 in pairwise comparisons with No mental health disorders 
6 p=0.3 in pairwise comparisons with No mental health disorders 
7 p=0.7 in pairwise comparisons with No mental health disorders 
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Compared to people with no mental health disorders (54%), the prevalence of any 
diabetes complications in 2005 was lower in people with schizophrenia/ paranoid states 
(32%), bipolar disorder (37%) or depression/ anxiety (49%).    The rates of eye 
complications in 2005 were lower among people with schizophrenia/ paranoid states 
(9%), bipolar disorder (9%), depression/ anxiety (14%) or other mental health disorders 
(16%) than that of no mental health disorders (17%).  Similarly, lower proportions of 
people with schizophrenia/ paranoid states (3%), bipolar disorder (4%) and depression/ 
anxiety (5%) had nephropathy in 2005 than those with no mental health disorders (6%).   
The rates of ischemic heart disease (IHD) and cerebrovascular disease (CVD) in 2005 
were also lower in people with schizophrenia/ paranoid states (IHD: 13%, CVD: 4%), 
bipolar disorder (IHD: 19%, CVD: 6%) and depression/ anxiety (IHD: 28, CVD: 10%) 
than that of no mental health disorders (IHD: 34%, CVD: 11%). However, there were 
instances where people with mental health disorders had higher rates of diabetes 
complications.  For example, the rates of neuropathy in 2005 were higher in people with 
depression/ anxiety (16%) and other mental health disorders (17%) than that of no mental 
health disorders (15%). The proportions of people having lower-limb amputations in 
2005 were higher in the bipolar disorder (6%), depression/ anxiety (6%) and other mental 
health disorders (7%) groups than that of no mental health disorders (5%). 
Except for lower-limb amputations (SUD: 9%, no SUD: 5%) and diabetes-related 
hospitalizations (SUD: 7%, no SUD: 6%), rates of diabetes complications were lower in 
people with SUD (5-40%) than those of no SUD (6-53%)(see Table 4.2).  After 
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accounting for SUD, the rates of diabetes complications and hospitalizations across 
mental disorder categories remained similar to the observations reported above. 
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Table 4.2 Health Outcomes in 2005 for Study Population by Mental and Substance 
Use Disorder Categories 
 Mental health disorders 
 No mental 
health disorders 
(n=76,402) 
Schizophrenia 
/paranoid states 
(n=3,811) 
Bipolar 
disorder 
(n=3,151) 
Depression/ 
anxiety 
(n=19,690) 
Other mental 
health disorders 
(n=3,120) 
Substance use 
disorders 
No Yes No Yes No Yes No Yes No Yes 
 
Overall  
No. of beneficiaries 74,824 1,578 2,955 856 2,321 830 17,695 1,995 2,948 172 106,174 
Any complications 
in 2005 (%)a,1 
40,855 
(55) 
742 
(47)2 
963 
(33) 
255 
(30)8 
874 
(38) 
280 
(34)4 
8,829 
(50) 
822 
(41)2 
1,600 
(54) 
87 
(51)9 
55,307 
(52) 
Eye complications in 
2005 (%)a,1 
12,832 
(17) 
169 
(11)2 
282 
(10) 
60 (7)4 231 
(10) 
47 (6)2 2,641 
(15) 
190 
(10)2 
474 
(16) 
20 
(12)8 
16,946 
(16) 
Neuropathy in 2005 
(%)a,1 
11,408 
(15) 
247 
(16)11 
324 
(11) 
95 
(11)13 
314 
(14) 
103 
(12)10 
2,827 
(16) 
293 
(15)8 
506 
(17) 
29 
(17)13 
16,146 
(15) 
Nephropathy in 2005 
(%)a,1 
4,392 
(6) 
95 
(6)12 
101 (3) 21 (2)8 92 
(4) 
23 (3)8 960 
(5) 
97 
(5)9 
179 (6) N/A* 5,969 
(6) 
Lower-limb 
amputations in 2005 
(%)a,1 
3,647 
(5) 
164 
(10)2 
119 (4) 58 (7)3 109 
(5) 
73 (9)2 1,031 
(6) 
183 
(9)2 
196 (7) 21 
(12)3 
5,601 
(5) 
Ischemic Heart 
disease in 2005 
(%)a,1 
25,522 
(34) 
408 
(26)2 
416 
(14) 
86 
(10)3 
450 
(19) 
136 
(16)5 
5,161 
(29) 
373 
(19)2 
981 
(33) 
43 
(25)4 
33,576 
(32) 
Cerebrovascular 
disease in 2005 
(%)a,1 
8,461 
(11) 
132 
(8)2 
111 (4) 24 (3)2 158 
(7) 
42 (5)7 1,861 
(11) 
154 
(8)2 
409 
(14) 
14 
(8)4 
11,366 
(11) 
Diabetes-related 
hospitalizations in 
2005(%)a,1 
4,227 
(6) 
128 
(8)2 
86 (3) 43 (5)3 118 
(5) 
56 (7)6 1,039 
(6) 
134 
(7)8 
206 (7) N/A* 6,045 
(6) 
 
a !2 test 
Across all mental/substance use disorder categories  
1  p<0.001 
In pairwise comparisons of Substance use disorders within each Mental Disorder Category: 
 2 p<0.001, 3 p<0.01, 4 p<0.05, 5 p=0.06, 6  p=0.07, 7  p=0.08, 8 p=0.1, 9 p=0.3, 10 p=0.4,  
11 p=0.7, 12 p=0.8, 13p=0.9  
* Per Data Use Agreement, data suppressed due to small cell size (<11).  No comparison tests performed. 
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 In adjusted analyses, the addition of Need and Behavior factors had a significant 
impact on the relationship between BHDs and diabetes outcomes.  Therefore, only the 
estimates from the logistic regressions adjusted for all covariates (i.e., model 5) are 
presented in Tables 4.3, 4.4 and 4.5. Please refer to Appendix XII on p.148 for estimates 
from other models. After adjusting for covariates, people with schizophrenia/ paranoid 
states (OR: 0.72, 95%CI: 0.67, 0.78), bipolar disorder (OR: 0.76, 95%CI: 0.69, 0.84), 
depression/ anxiety (OR: 0.94, 95%CI: 0.90, 0.98) or other mental health disorders (OR: 
0.88, 95%CI: 0.78, 1.00) were less likely to have any diabetes complications in 2005 than 
those with no mental health disorders.  People with bipolar disorder (OR: 0.69, 95%CI: 
0.57, 0.83) or any alcohol abuse/ dependence (OR: 0.77, 95%CI: 0.77, 0.91) had lower 
odds for new eye complications in 2005 than those without mental health disorders or 
alcohol abuse/ dependence.   Lower likelihoods for new nephropathy cases in 2005 were 
also observed among people with schizophrenia/ paranoid states (OR: 0.60, 95%CI: 0.44, 
0.83), bipolar disorder (OR: 0.70, 95%CI: 0.53, 0.91), depression/ anxiety (OR: 0.80, 
95%CI: 0.70, 0.90), other mental health disorders (OR: 0.70, 95%CI: 0.55, 0.89) or any 
alcohol abuse/ dependence (OR: 0.63, 95%CI: 0.50, 0.79) after adjusting for covariates. 
The presence of schizophrenia/ paranoid states was also associated with lower odds for 
new cases of ischemic heart disease (OR: 0.74, 95%CI: 0.63, 0.86) and cerebrovascular 
disease (OR: 0.61, 95%CI: 0.49, 0.77) in 2005.   On the contrary, the presence of either 
any alcohol abuse/ dependence (OR: 1.52, 95%CI 1.27, 1.81) or any drug abuse/ 
dependence (OR: 1.41, 95%CI 1.20, 1.65) was significantly associated with higher odds 
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for lower-limb amputations. People with any drug abuse/ dependence had higher odds for 
diabetes-related hospitalizations (OR: 1.64, 95%CI 1.41-1.92) in 2005.  
There were other factors associated with the odds of having diabetes 
complications and hospitalizations. For example, male gender was correlated with higher 
likelihoods of having any diabetes complications in 2005 (OR: 1.28, 95%CI: 1.24, 1.33) 
and having previous eye complications increased the odds for diabetes-related 
hospitalizations (OR: 1.24, 95%CI: 1.15, 1.34).  However, having continuous 12-month 
health coverage was associated with lower odds for diabetes-related hospitalizations (OR: 
0.55, 95%CI: 0.48, 0.62).   
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Table 4.3 Estimates from logistic regression models for the associations between 
BHDs and Diabetes Outcomes in 2005 
 Any complications Eye Complications Nephropathy 
 N=106,174 N=89,943 N=101,924 
 OR  95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.72*** (0.67, 0.78) 0.82* (0.69, 0.96) 0.58** (0.42, 0.81) 
Bipolar disorder 0.76*** (0.69, 0.84) 0.70*** (0.59, 0.84) 0.70** (0.53, 0.91) 
Depression/ anxiety 0.94** (0.90, 0.98) 0.93 (0.86, 1.01) 0.79*** (0.70, 0.90) 
Other mental health disorders 0.88* (0.78, 1.00) 0.87 (0.71, 1.05) 0.69** (0.55, 0.88) 
Any alcohol abuse/ dependence 1.04 (0.93, 1.15) 0.79** (0.67, 0.92) 0.64*** (0.50, 0.81) 
Any drug abuse/ dependence 0.97 (0.90, 1.05) 0.92 (0.78, 1.08) 0.81 (0.64, 1.03) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.65*** (1.54, 1.77) 1.45*** (1.29, 1.64) 1.37*** (1.20, 1.57) 
65-74 1.69*** (1.55, 1.85) 1.39*** (1.24, 1.56) 1.17 (1.00, 1.37) 
75 and older 1.90*** (1.77, 2.04) 1.12 (0.99, 1.26) 1.01 (0.86, 1.19) 
Male Gender 1.28*** (1.24, 1.33) 0.94 (0.87, 1.02) 1.39*** (1.28, 1.50) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.02 (0.95, 1.09) 1.36*** (1.20, 1.55) 1.64*** (1.47, 1.84) 
Hispanic 0.76*** (0.69, 0.85) 1.19 (0.93, 1.52) 1.03 (0.86, 1.24) 
Others 0.72*** (0.66, 0.79) 1.08 (0.92, 1.25) 1.34** (1.11, 1.63) 
Unknown 0.71*** (0.65, 0.78) 0.97 (0.84, 1.12) 0.62** (0.44, 0.88) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.20*** (1.15, 1.26) 0.97 (0.89, 1.05) 1.36** (1.13, 1.64) 
1.3<=CDPS<=1.9 1.33*** (1.28, 1.39) 0.99 (0.90, 1.08) 1.82*** (1.55, 2.12) 
CDPS>1.9 1.41*** (1.33, 1.48) 0.94 (0.85, 1.05) 3.67*** (3.18, 4.24) 
Health coverage type       
Medicare only (ref.) 1  1  1  
Medicaid only 0.64*** (0.59, 0.69) 0.68*** (0.57, 0.81) 0.59*** (0.47, 0.74) 
Dual-eligible 1.17*** (1.12, 1.23) 1.12** (1.04, 1.22) 1.51*** (1.38, 1.64) 
Continuous 12-month coverage 0.93 (0.85, 1.02) 1.10 (0.96, 1.27) 0.95 (0.79, 1.14) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.01 (0.94, 1.08) 0.83* (0.69, 0.99) 1.23* (1.02, 1.49) 
85-90% 1.01 (0.90, 1.12) 0.80* (0.68, 0.95) 1.19 (0.97, 1.47) 
>90% 1.00 (0.89, 1.13) 0.74** (0.60, 0.92) 1.26 (0.96, 1.67) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 1.01 (0.94, 1.09) 1.09 (0.94, 1.25) 0.83* (0.72, 0.96) 
$45,921-$56,813 1.01 (0.91, 1.12) 1.08 (0.91, 1.27) 0.88 (0.74, 1.04) 
>$56,813 1.01 (0.89, 1.15) 1.20 (0.98, 1.48) 0.84 (0.67, 1.06) 
No Previous Complications 0.43*** (0.39, 0.47) 0.97 (0.87, 1.07) 0.78*** (0.69, 0.88) 
Eye complications in 2004 2.99*** (2.75, 3.26) N/A  2.09*** (1.92, 2.28) 
Nephropathy in 2004 2.59*** (2.35, 2.85) 2.03*** (1.83, 2.25) N/A  
Neuropathy in 2004 3.39*** (3.11, 3.69) 1.88*** (1.74, 2.04) 1.74*** (1.59, 1.90) 
Ischemic Heart Disease in 2004 4.07*** (3.73, 4.45) 1.19*** (1.11, 1.28) 1.17** (1.05, 1.29) 
Lower-limb amputations 2004 1.22** (1.09, 1.37) 1.50*** (1.34, 1.68) 1.53*** (1.34, 1.73) 
Cerebrovascular diseases 2004 1.84*** (1.70, 1.98) 1.12* (1.01, 1.25) 0.90 (0.81, 1.00) 
No. of outpatient visits 2004 1.02*** (1.02, 1.03) 1.01* (1.00, 1.01) 1.01 (1.00, 1.01) 
*p<0.05, **p<0.01, ***p<0.001 
Note: 17,298 individuals previously had eye complications and were excluded in the analysis for eye complications. 5,364 individuals 
previously had nephropathy and were excluded in the analysis for nephropathy. 
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Table 4.4 Estimates from logistic regression models for the associations between 
BHDs and Diabetes Outcomes in 2005  
 Diabetic Neuropathy Lower-limb Amputations Ischemic Heart Disease 
 N=92,011 N=101,492 N=73,519 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.79** (0.67, 0.94) 0.85 (0.72, 1.00) 0.74*** (0.63, 0.87) 
Bipolar disorder 0.99 (0.84, 1.17) 0.87 (0.70, 1.10) 0.86 (0.73, 1.01) 
Depression/ anxiety 0.99 (0.93, 1.05) 1.00 (0.92, 1.08) 1.00 (0.94, 1.07) 
Other mental health disorders 1.00 (0.85, 1.18) 0.99 (0.83, 1.19) 0.98 (0.87, 1.11) 
Any alcohol abuse/ dependence 1.05 (0.92, 1.21) 1.53*** (1.29, 1.82) 0.99 (0.85, 1.16) 
Any drug abuse/ dependence 1.04 (0.85, 1.27) 1.41*** (1.20, 1.66) 0.91 (0.75, 1.10) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.40*** (1.27, 1.53) 1.16** (1.04, 1.29) 2.34*** (2.15, 2.56) 
65-74 1.08 (0.96, 1.21) 1.00 (0.86, 1.18) 2.68*** (2.42, 2.97) 
75 and older 1.05 (0.94, 1.17) 1.29** (1.11, 1.50) 3.46*** (3.09, 3.86) 
Male Gender 1.03 (0.97, 1.10) 1.11*** (1.05, 1.17) 1.39*** (1.32, 1.47) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.22 (1.00, 1.49) 1.03 (0.92, 1.16) 0.86* (0.76, 0.98) 
Hispanic 0.79** (0.66, 0.94) 0.76** (0.63, 0.91) 0.74*** (0.64, 0.85) 
Others 0.58*** (0.45, 0.74) 0.81* (0.68, 0.96) 0.70*** (0.60, 0.81) 
Unknown 0.67*** (0.56, 0.80) 0.81 (0.63, 1.06) 0.73** (0.58, 0.92) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.36*** (1.24, 1.49) 1.25*** (1.11, 1.41) 1.26*** (1.19, 1.34) 
1.3<=CDPS<=1.9 1.71*** (1.56, 1.88) 1.74*** (1.49, 2.03) 1.55*** (1.45, 1.66) 
CDPS>1.9 1.86*** (1.64, 2.11) 2.41*** (2.03, 2.86) 1.92*** (1.75, 2.11) 
Health coverage type       
Medicare only (ref.) 1  1  1  
Medicaid only 0.57*** (0.51, 0.64) 0.80* (0.67, 0.96) 0.62*** (0.56, 0.70) 
Dual-eligible 1.34*** (1.25, 1.44) 1.65*** (1.46, 1.85) 1.35*** (1.22, 1.51) 
Continuous 12-month coverage 0.95 (0.77, 1.18) 0.70*** (0.61, 0.81) 0.71*** (0.62, 0.82) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.15 (0.96, 1.37) 1.01 (0.86, 1.20) 1.04 (0.94, 1.15) 
85-90% 1.35* (1.00, 1.80) 0.88 (0.72, 1.08) 0.93 (0.82, 1.05) 
>90% 1.43* (1.08, 1.89) 0.86 (0.67, 1.09) 0.93 (0.80, 1.09) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 0.90 (0.77, 1.05) 1.04 (0.89, 1.20) 1.00 (0.93, 1.09) 
$45,921-$56,813 0.84* (0.72, 0.98) 1.05 (0.88, 1.26) 1.08 (0.97, 1.19) 
>$56,813 0.77* (0.64, 0.94) 1.01 (0.83, 1.22) 1.10 (0.96, 1.27) 
No Previous Complications 0.86** (0.78, 0.95) 0.87** (0.79, 0.96) 1.01 (0.90, 1.13) 
Eye complications in 2004 1.87*** (1.69, 2.07) 1.70*** (1.54, 1.88) 1.12** (1.04, 1.21) 
Nephropathy in 2004 1.82*** (1.60, 2.07) 1.40*** (1.24, 1.59) 1.30*** (1.15, 1.46) 
Neuropathy in 2004 N/A  1.75*** (1.58, 1.94) 1.10* (1.02, 1.18) 
Ischemic Heart Disease in 2004 1.01 (0.92, 1.11) 1.16*** (1.08, 1.24) N/A  
Lower-limb amputations 2004 1.79*** (1.58, 2.03) N/A  1.04 (0.89, 1.21) 
Cerebrovascular diseases 2004 0.97 (0.89, 1.06) 1.12* (1.01, 1.24) 1.37*** (1.21, 1.54) 
No. of outpatient visits 2004 1.02*** (1.01, 1.03) 1.01*** (1.00, 1.01) 1.02*** (1.02, 1.03) 
*p<0.05, **p<0.01, ***p<0.001 
Note: 15,188 individuals previously had neuropathy and were excluded in the analysis for neuropathy. 5,784 individuals previously 
had lower-limb amputations and were excluded in the analysis for lower-limb amputations. 33,574 individuals previously had 
ischemic heart disease and were excluded in the analysis for ischemic heart disease. 
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Table 4.5 Estimates from logistic regression models for the associations between 
BHDs and Diabetes Outcomes in 2005  
 Cerebrovascular Disease Diabetes-related Hospitalization  
 N=96,162 N=106,174 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.63*** (0.50, 0.80) 0.75** (0.63, 0.89) 
Bipolar disorder 0.97 (0.78, 1.19) 1.07 (0.91, 1.26) 
Depression/ anxiety 1.07 (0.97, 1.17) 1.03 (0.96, 1.10) 
Other mental health disorders 1.08 (0.91, 1.27) 1.01 (0.87, 1.17) 
Any alcohol abuse/ dependence 1.26* (1.04, 1.53) 1.08 (0.88, 1.33) 
Any drug abuse/ dependence 0.96 (0.78, 1.19) 1.60*** (1.38, 1.86) 
Age Groups     
<55 (ref.) 1  1  
55-64 2.27*** (1.96, 2.64) 1.11 (0.98, 1.25) 
65-74 2.76*** (2.37, 3.21) 1.13 (1.00, 1.28) 
75 and older 3.58*** (3.09, 4.15) 1.26*** (1.11, 1.44) 
Male Gender 1.05 (0.98, 1.13) 1.17*** (1.11, 1.24) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.83*** (0.75, 0.92) 1.00 (0.91, 1.11) 
Hispanic 0.77*** (0.67, 0.89) 0.77*** (0.66, 0.89) 
Others 0.72*** (0.61, 0.84) 0.88 (0.73, 1.07) 
Unknown 0.87 (0.66, 1.13) 0.85 (0.64, 1.13) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.26*** (1.15, 1.38) 1.09 (1.00, 1.18) 
1.3<=CDPS<=1.9 1.39*** (1.25, 1.54) 1.23*** (1.10, 1.37) 
CDPS>1.9 1.57*** (1.41, 1.76) 1.47*** (1.33, 1.63) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.53*** (0.45, 0.61) 0.65*** (0.52, 0.80) 
Dual-eligible 1.05 (0.96, 1.15) 1.32*** (1.24, 1.41) 
Continuous 12-month coverage 0.64*** (0.54, 0.76) 0.55*** (0.48, 0.62) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.99 (0.91, 1.09) 1.00 (0.90, 1.11) 
85-90% 1.02 (0.94, 1.12) 0.93 (0.83, 1.05) 
>90% 1.03 (0.91, 1.17) 0.87 (0.76, 1.00) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.93 (0.81, 1.08) 1.01 (0.89, 1.16) 
$45,921-$56,813 0.92 (0.78, 1.08) 1.12 (0.96, 1.30) 
>$56,813 0.95 (0.80, 1.12) 1.14 (0.99, 1.31) 
No Previous Complications 1.01 (0.91, 1.12) 0.70*** (0.63, 0.78) 
Eye complications in 2004 1.12* (1.05, 1.21) 1.24*** (1.15, 1.34) 
Nephropathy in 2004 1.23*** (1.11, 1.36) 1.45*** (1.34, 1.57) 
Neuropathy in 2004 1.13*** (1.06, 1.21) 1.25*** (1.15, 1.35) 
Ischemic Heart Disease in 2004 1.61*** (1.48, 1.75) 1.89*** (1.75, 2.03) 
Lower-limb amputations 2004 1.20** (1.08, 1.33) 1.97*** (1.84, 2.11) 
Cerebrovascular diseases 2004 N/A  1.47*** (1.35, 1.61) 
No. of outpatient visits 2004 1.02*** (1.01, 1.02) 1.01*** (1.01, 1.01) 
*p<0.05, **p<0.01, ***p<0.001 
Note: 11,106 individuals previously had cerebrovascular disease and were excluded in the analysis for cerebrovascular disease. 
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Discussion 
 Similar to the findings in Aim 1, the associations between BHDs and diabetes 
outcomes were inconsistent.  For example, while the adjusted analyses showed that 
substance use disorders had a negative impact, i.e., increased odds, on diabetes-related 
hospitalizations, the presence of schizophrenia/ paranoid states was associated with 
reduced odds for diabetes-related hospitalizations and the presence of bipolar disorder, 
depression/ anxiety or other mental health disorders were not associated with such 
outcome.  Further, the relationships between mental health disorders and diabetes 
outcomes were not consistent and such relationships were dependent on the outcomes of 
interest.  For example, mental health disorders were associated with lower odds for any 
new complications and nephropathy but they were not significantly correlated with 
lower-limb amputations.  While people with schizophrenia/ paranoid states had lower 
odds of neuropathy, ischemic heart disease and cerebrovascular disease, their likelihoods 
for having eye complications was not significant different from those with diabetes alone.  
Similar findings on substance use disorders and poor health outcomes in diabetes 
had been reported in previous studies.27,28  However, the results did not indicate that 
mental health disorders increased the likelihood of poor diabetes outcomes, contrary to 
previous studies.24,26,27  For example, in a study using administrative data, Krein and 
colleagues observed that people with diabetes and schizophrenia or bipolar disorder were 
more likely to be hospitalized (OR: 2.8, 95%CI 2.67-2.94).26  However, the study by 
Krein and colleagues did not assess or adjust for the presence of substance use disorders 
in the analysis.26   Therefore, the effects on diabetes outcomes in the study by Krein and 
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colleagues might be due to substance use disorders, which co-occur with schizophrenia 
and bipolar disorder at high rates (see Table 3.2).   
 It is worth noting that the prevalence of any new diabetes complications in this 
population with publicly sponsored healthcare coverage was about 50% in 2005.  In 
general, higher rates of diabetes outcomes were observed in the study population than the 
national average for people with diabetes.  For example, the prevalence of ischemic heart 
disease in 2005 was 32% in this population, compared to the national figure of 22.3% in 
2003. 99  Similarly, the rate of hospitalization with diabetes as the first diagnosis was 56.9 
per 1000 persons in the study population, compared to 35.9 per 1000 persons nationally 
in 2005. 100 
 The major limitation of this study was the short duration of observation (i.e., one 
year).  Diabetes complications are generally slow processes and take years to develop.  
Therefore, the study was unable to capture the natural history of diabetes complications 
and might have underestimated the incidence of complications.  For example, 40% of 
people with diabetes alone developed eye complications in a study by Black and 
colleagues 24 whereas only 17% people with diabetes alone had eye complications in the 
study population.  However, the estimates of cases from this study were similar, if not 
higher than those of national average.  Further studies with multi-year data are necessary 
to accurately estimate the occurrence of diabetes outcomes. 
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Chapter V. Impact of Comprehensive diabetes care on diabetes-related 
complications and hospitalizations  
Aim 
This chapter reports the findings from Aim 3: the impact of comprehensive 
diabetes care on diabetes-related outcomes (i.e., complications and hospitalizations).  
Multivariate analyses were performed to demonstrate the effects of comprehensive 
diabetes care on diabetes-related outcomes while adjusting for potential confounders. 
Results 
 Among people with any types of BHDs (n=31,350), only 330 individuals, or 1.1% 
had comprehensive diabetes care (see Table 5.1).  In unadjusted analysis, individuals 
with comprehensive care had a lower rate of cerebrovascular disease than those without 
comprehensive care (6% vs. 9%, p<0.05) (see Table 5.1).  However, there were no 
significant differences in the rates of any diabetes complications, eye complications, 
neuropathy, nephropathy, lower-limb amputations, ischemic heart disease and diabetes-
related hospitalizations between people with comprehensive diabetes care and those 
without. 
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Table 5.1 Comprehensive Diabetes Care and Diabetes-related Outcomes 
N=31,350 Comprehensive Diabetes Care 
 No Yes 
Overall 
Outcomes in 2005 N=31,020 N=330 N=31,350 
Any Complications (%)a  14,304 (46) 148 (45)6 14,452 (46) 
Eye Complications (%)a 4,067 (13) 47 (14)5 4,114 (13) 
Neuropathy (%)a 4,696 (15) 42 (13)3 4,738 (15) 
Nephropathy (%)a 1,560 (5) 17 (5)7 1,577 (5) 
Lower-limb amputations (%)a 1,936 (6) 18 (5)6 1,954 (6) 
Ischemic Heart disease (%)a 7,976 (26) 78 (24)4 8,054 (26) 
Cerebrovascular disease (%)a 2,885 (9) 20 (6)1 2,905 (9) 
Diabetes-related Hospitalizations (%)a 1,805 (6) 13 (4)2 1,818 (6) 
a !2 tests 
Compared to no Comprehensive Diabetes Care: 
1 p<0.05, 2 p=0.1, 3 p=0.2, 4 p=0.4, 5 p=0.5, 6 p=0.6, 7 p=0.9 
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The adjusted analysis indicated a general trend for lower odds of adverse diabetes 
outcomes in 2005 for people with comprehensive diabetes care (for example, odds ratio 
[OR] for new cases of eye complications: 0.93, 95% confidence interval [CI]: 0.58, 1.48; 
OR for neuropathy: 0.64, 95%CI: 0.40, 1.03; OR for lower-limb amputations: 0.81, 
95%CI: 0.36, 1.83; and OR for diabetes-related hospitalizations in 2005: 0.71, 95%CI: 
0.41, 1.24) although the associations were not statistically significant. However, 
adherence to quality measures was associated with increased odds of any complications 
(OR for full adherence: 1.48, 95%CI: 1.31, 1.68), eye complications (OR for full 
adherence: 2.52, 95%CI: 1.92, 3.31) and neuropathy (OR for full adherence: 2.20, 
95%CI: 1.60, 3.03) (see Tables 5.2 to 5.9).  
The analysis also showed that comprehensive diabetes care did not significantly 
affect the relationship between BHDs and diabetes outcomes. For example, after the 
addition of comprehensive diabetes care, schizophrenia/ paranoid states remained 
significantly associated with lower odds for any complications (OR: 0.76, no change), 
nephropathy (OR: 0.82 vs. 0.81), lower-limb amputations (OR: 0.47, no change) and 
diabetes-related hospitalizations (OR: 0.53, no change) (see tables 5.2 through 5.9).  
Similarly, no significant changes, i.e., 10% or greater differences in the odds, were 
observed in the associations between other types of mental health disorders and diabetes 
outcomes after comprehensive diabetes care was added (see tables 5.2 through 5.9). The 
presence of co-occurring alcohol abuse/ dependence was significantly associated with 
higher odds for lower-limb amputations (OR: 1.39, no change) (see table 5.6) and the 
presence of co-occurring drug abuse/ dependence was correlated with higher odds for 
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lower-limb amputations (OR: 1.37, no change) and diabetes-related hospitalizations (OR: 
1.53, no change) (see tables 5.6 to 5.9). 
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Table 5.2 Effect of Comprehensive Care on Any Complications in 2005  
N=31,350 Any Complications in 2005 
 Modeled with Comprehensive Care Modeled without Comprehensive Care 
 OR 95%CI OR 95%CI 
Comprehensive Diabetes Care 1.00 (0.78, 1.27) N/A  
Quality Measures met in 2004     
0 (ref.) 1  1  
1 1.12* (1.00, 1.25) 1.12* (1.00, 1.25) 
2 1.31*** (1.16, 1.48) 1.31*** (1.17, 1.48) 
3 1.45*** (1.20, 1.63) 1.45*** (1.30, 1.63) 
4 1.48*** (1.31, 1.68) 1.48*** (1.31, 1.68) 
Mental health disorders     
SUD without mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.76*** (0.66, 0.88) 0.76*** (0.66, 0.88) 
Bipolar disorder 0.82** (0.72, 0.94) 0.82** (0.72, 0.94) 
Depression/ anxiety 1.04 (0.91, 1.20) 1.04 (0.91, 1.20) 
Other mental health disorders 0.99 (0.85, 1.16) 0.99 (0.85, 1.16) 
Co-occurring alcohol abuse/ dependence 1.10 (0.98, 1.22) 1.10 (0.98, 1.22) 
Co-occurring drug abuse/ dependence 0.97 (0.88, 1.05) 0.97 (0.88, 1.05) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.57*** (1.44, 1.72) 1.57*** (1.44, 1.72) 
65-74 1.68*** (1.49, 1.90) 1.68*** (1.49, 1.90) 
75 and older 2.04*** (1.81, 2.30) 2.04*** (1.81, 2.30) 
Male Gender 1.23*** (1.16, 1.30) 1.23*** (1.16, 1.30) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.05 (0.95, 1.16) 1.05 (0.95, 1.16) 
Hispanic 0.69*** (0.62, 0.78) 0.69*** (0.62, 0.78) 
Others 0.81* (0.70, 0.95) 0.81* (0.70, 0.95) 
Unknown 0.75*** (0.65, 0.88) 0.75*** (0.65, 0.88) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.26** (1.10, 1.44) 1.26** (1.10, 1.44) 
1.3<=CDPS<=1.9 1.51*** (1.32, 1.74) 1.51*** (1.32, 1.74) 
CDPS>1.9 1.64*** (1.45, 1.85) 1.64*** (1.45, 1.85) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.80*** (0.72, 0.88) 0.80*** (0.72, 0.88) 
Dual-eligible 1.23*** (1.13, 1.34) 1.23*** (1.13, 1.34) 
Continuous 12-month coverage 0.95 (0.83, 1.09) 0.95 (0.83, 1.09) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.00 (0.91, 1.10) 1.00 (0.91, 1.10) 
85-90% 0.94 (0.81, 1.08) 0.94 (0.81, 1.08) 
>90% 0.94 (0.81, 1.09) 0.94 (0.81, 1.09) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.08 (0.96, 1.21) 1.08 (0.96, 1.21) 
$45,921-$56,813 1.01 (0.89, 1.15) 1.01 (0.89, 1.15) 
>$56,813 1.06 (0.91, 1.25) 1.06 (0.91, 1.25) 
No Previous Complications 0.50*** (0.43, 0.57) 0.50*** (0.43, 0.57) 
Eye complications in 2004 2.94*** (2.67, 3.23) 2.94*** (2.67, 3.23) 
Nephropathy in 2004 2.70*** (2.25, 3.65) 2.70*** (2.25, 3.24) 
Neuropathy in 2004 3.24*** (2.88, 3.65) 3.24*** (2.88, 3.65) 
Ischemic Heart Disease in 2004 3.65*** (3.27, 4.08) 3.65*** (3.27, 4.08) 
Lower-limb amputations 2004 1.36*** (1.17, 1.58) 1.36*** (1.17, 1.58) 
Cerebrovascular diseases 2004 2.07*** (1.86, 2.30) 2.07*** (1.86, 2.30) 
No. of outpatient visits 2004 1.01*** (1.01, 1.02) 1.01*** (1.01, 1.02) 
* p<0.05  **p<0.01 ***p<0.001     
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Table 5.3 Effect of Comprehensive Care on New Eye Complications in 2005 
N=27,066 Eye Complications in 2005 
 Modeled with Comprehensive Care Modeled without Comprehensive Care 
 OR 95%CI OR 95%CI 
Comprehensive Diabetes Care 0.93 (0.58, 1.48) N/A  
Quality Measures met in 2004     
0 (ref.) 1  1  
1 2.07*** (1.57, 2.74) 2.07*** (1.57, 2.74) 
2 2.23*** (1.69, 2.94) 2.23*** (1.69, 2.94) 
3 2.37*** (1.77, 3.18) 2.37*** (1.77, 3.18) 
4 2.52*** (1.92, 3.31) 2.52*** (1.92, 3.30) 
Mental health disorders     
SUD without mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.97 (0.69, 1.38) 0.97 (0.69, 1.38) 
Bipolar disorder 0.86 (0.59, 1.25) 0.86 (0.59, 1.25) 
Depression/ anxiety 1.17 (0.86, 1.57) 1.17 (0.86, 1.57) 
Other mental health disorders 1.10 (0.75, 1.61) 1.10 (0.75, 1.61) 
Co-occurring alcohol abuse/ dependence 0.85 (0.69, 1.04) 0.85 (0.69, 1.04) 
Co-occurring drug abuse/ dependence 0.95 (0.80, 1.13) 0.95 (0.80, 1.13) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.26** (1.09, 1.45) 1.26** (1.09, 1.45) 
65-74 1.27** (1.10, 1.48) 1.27** (1.10, 1.48) 
75 and older 0.99 (0.84, 1.17) 0.99 (0.84, 1.17) 
Male Gender 0.89 (0.78, 1.01) 0.89 (0.78, 1.01) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.19* (1.03, 1.38) 1.19* (1.03, 1.38) 
Hispanic 1.19 (0.88, 1.60) 1.19 (0.88, 1.60) 
Others 1.07 (0.80, 1.43) 1.07 (0.80, 1.43) 
Unknown 1.05 (0.83, 1.32) 1.05 (0.83, 1.32) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.20* (1.00, 1.43) 1.20* (1.00, 1.43) 
1.3<=CDPS<=1.9 1.27* (1.06, 1.53) 1.27* (1.06, 1.53) 
CDPS>1.9 1.10 (0.91, 1.34) 1.10 (0.91, 1.34) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.77* (0.62, 0.96) 0.77* (0.62, 0.96) 
Dual-eligible 1.03 (0.89, 1.19) 1.03 (0.89, 1.19) 
Continuous 12-month coverage 1.02 (0.79, 1.31) 1.02 (0.79, 1.31) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.79 (0.60, 1.03) 0.79 (0.60, 1.03) 
85-90% 0.65** (0.48, 0.87) 0.65** (0.48, 0.87) 
>90% 0.67* (0.46, 0.97) 0.67* (0.46, 0.97) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.10 (0.87, 1.37) 1.10 (0.87, 1.37) 
$45,921-$56,813 1.15 (0.93, 1.42) 1.15 (0.93, 1.42) 
>$56,813 1.25 (0.88, 1.76) 1.25 (0.88, 1.76) 
No Previous Complications 1.02 (0.89, 1.18) 1.02 (0.89, 1.17) 
Eye complications in 2004 N/A  N/A  
Nephropathy in 2004 2.19*** (1.70, 2.81) 2.19*** (1.70, 2.81) 
Neuropathy in 2004 1.91*** (1.64, 2.22) 1.91*** (1.64, 2.22) 
Ischemic Heart Disease in 2004 1.31*** (1.15, 1.48) 1.31*** (1.15, 1.48) 
Lower-limb amputations 2004 1.54*** (1.26, 1.89) 1.54*** (1.26, 1.89) 
Cerebrovascular diseases 2004 1.11 (0.94, 1.30) 1.11 (0.94, 1.30) 
No. of outpatient visits 2004 1.00 (0.99, 1.01) 1.00 (0.99, 1.01) 
* p<0.05  **p<0.01 ***p<0.001     
Note: 4,284 individuals excluded from the analysis previously had eye complications. 
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Table 5.4 Effect of Comprehensive Care on New Nephropathy cases in 2005 
N=29,825 Nephropathy in 2005 
 Modeled with Comprehensive Care Modeled without Comprehensive Care 
 OR 95%CI OR 95%CI 
Comprehensive Diabetes Care 1.38 (0.85, 2.24) N/A  
Quality Measures met in 2004     
0 (ref.) 1  1  
1 0.99 (0.74, 1.31) 0.99 (0.74, 1.31) 
2 1.16 (0.83, 1.61) 1.16 (0.83, 1.62) 
3 1.33 (0.94, 1.88) 1.34 (0.95, 1.90) 
4 1.32 (0.92, 1.88) 1.33 (0.93, 1.90) 
Mental health disorders     
SUD without mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.82 (0.59, 1.13) 0.81 (0.59, 1.13) 
Bipolar disorder 0.96 (0.61, 1.50) 0.95 (0.61, 1.49) 
Depression/ anxiety 1.04 (0.76, 1.42) 1.04 (0.76, 1.42) 
Other mental health disorders 0.90 (0.63, 1.27) 0.90 (0.64, 1.27) 
Co-occurring alcohol abuse/ dependence 0.57** (0.40, 0.80) 0.57** (0.41, 0.80) 
Co-occurring drug abuse/ dependence 0.97 (0.67, 1.41) 0.97 (0.67, 1.41) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.35** (1.14, 1.59) 1.34** (1.14, 1.59) 
65-74 1.42** (1.10, 1.82) 1.42** (1.10, 1.83) 
75 and older 1.18 (0.81, 1.73) 1.19 (0.81, 1.73) 
Male Gender 1.36*** (1.19, 1.55) 1.36*** (1.19, 1.55) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.68*** (1.37, 2.04) 1.67*** (1.37, 2.04) 
Hispanic 0.89 (0.62, 1.27) 0.89 (0.62, 1.27) 
Others 1.28 (0.83, 1.98) 1.28 (0.83, 1.97) 
Unknown 0.65 (0.42, 1.02) 0.66 (0.42, 1.03) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.23 (0.84, 1.78) 1.22 (0.84, 1.78) 
1.3<=CDPS<=1.9 1.44 (0.96, 2.18) 1.44 (0.95, 2.17) 
CDPS>1.9 2.62*** (1.81, 3.78) 2.61*** (1.80, 3.77) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.82 (0.52, 1.27) 0.82 (0.53, 1.27) 
Dual-eligible 1.54*** (1.26, 1.88) 1.54*** (1.26, 1.88) 
Continuous 12-month coverage 0.96 (0.68, 1.36) 0.96 (0.68, 1.36) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.27 (0.90, 1.78) 1.27 (0.90, 1.78) 
85-90% 1.30 (0.91, 1.86) 1.31 (0.92, 1.86) 
>90% 1.36 (0.88, 2.10) 1.36 (0.88, 2.10) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.76 (0.58, 1.00) 0.76* (0.57, 1.00) 
$45,921-$56,813 0.87 (0.63, 1.18) 0.86 (0.63, 1.18) 
>$56,813 0.78 (0.51, 1.17) 0.78 (0.51, 1.17) 
No Previous Complications 0.72** (0.59, 0.89) 0.73** (0.59, 0.89) 
Eye complications in 2004 2.05*** (1.73, 2.44) 2.05*** (1.73, 2.43) 
Nephropathy in 2004 N/A  N/A  
Neuropathy in 2004 1.86*** (1.62, 2.15) 1.86*** (1.62, 2.15) 
Ischemic Heart Disease in 2004 1.30** (1.10, 1.54) 1.30** (1.10, 1.54) 
Lower-limb amputations 2004 1.77*** (1.52, 2.07) 1.78*** (1.52, 2.08) 
Cerebrovascular diseases 2004 0.82 (0.63, 1.07) 0.82 (0.63, 1.07) 
No. of outpatient visits 2004 1.01 (1.00, 1.02) 1.01 (1.00, 1.02) 
* p<0.05  **p<0.01 ***p<0.001     
Note: 1,525 individuals excluded from the analysis previously had nephropathy. 
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Table 5.5 Effect of Comprehensive Care on New Neuropathy cases in 2005 
N=26,606 Neuropathy in 2005 
 Modeled with Comprehensive Care Modeled without Comprehensive Care 
 OR 95%CI OR 95%CI 
Comprehensive Diabetes Care 0.64 (0.40, 1.03) N/A  
Quality Measures met in 2004     
0 (ref.) 1  1  
1 1.46* (1.09, 1.97) 1.46* (1.08, 1.97) 
2 1.79*** (1.33, 2.42) 1.79*** (1.32, 2.42) 
3 2.15*** (1.56, 2.97) 2.14*** (1.55, 2.95) 
4 2.20*** (1.60, 3.03) 2.18*** (1.58, 3.01) 
Mental health disorders     
SUD without mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.73* (0.54, 0.97) 0.73* (0.54, 0.98) 
Bipolar disorder 0.94 (0.73, 1.22) 0.94 (0.73, 1.22) 
Depression/ anxiety 0.98 (0.80, 1.22) 0.99 (0.80, 1.22) 
Other mental health disorders 1.00 (0.77, 1.29) 1.00 (0.77, 1.29) 
Co-occurring alcohol abuse/ dependence 1.06 (0.90, 1.25) 1.06 (0.90, 1.25) 
Co-occurring drug abuse/ dependence 1.04 (0.87, 1.25) 1.04 (0.87, 1.25) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.28*** (1.12, 1.45) 1.28*** (1.12, 1.45) 
65-74 0.99 (0.83, 1.19) 0.99 (0.83, 1.19) 
75 and older 0.93 (0.77, 1.12) 0.93 (0.77, 1.12) 
Male Gender 1.05 (0.94, 1.17) 1.05 (0.94, 1.17) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.15 (0.98, 1.34) 1.15 (0.98, 1.34) 
Hispanic 0.61*** (0.47, 0.78) 0.61*** (0.47, 0.78) 
Others 0.45* (0.24, 0.85) 0.45* (0.24, 0.85) 
Unknown 0.75 (0.52, 1.09) 0.75 (0.51, 1.09) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.40** (1.15, 1.70) 1.40** (1.15, 1.70) 
1.3<=CDPS<=1.9 2.16*** (1.83, 2.55) 2.17*** (1.83, 2.56) 
CDPS>1.9 2.27*** (1.83, 2.81) 2.28*** (1.83, 2.83) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.71*** (0.59, 0.85) 0.71*** (0.59, 0.85) 
Dual-eligible 1.41*** (1.26, 1.58) 1.42*** (1.26, 1.59) 
Continuous 12-month coverage 1.05 (0.71, 1.55) 1.05 (0.71, 1.55) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.03 (0.85, 1.25) 1.03 (0.85, 1.24) 
85-90% 1.13 (0.82, 1.55) 1.13 (0.82, 1.55) 
>90% 1.25 (0.92, 1.69) 1.25 (0.92, 1.68) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.11 (0.91, 1.37) 1.12 (0.91, 1.37) 
$45,921-$56,813 0.95 (0.75, 1.21) 0.96 (0.75, 1.22) 
>$56,813 0.94 (0.72, 1.23) 0.94 (0.72, 1.23) 
No Previous Complications 0.80* (0.68, 0.95) 0.80* (0.68, 0.95) 
Eye complications in 2004 1.55*** (1.36, 1.75) 1.55*** (1.36, 1.76) 
Nephropathy in 2004 1.75*** (1.44, 2.13) 1.75*** (1.44, 2.13) 
Neuropathy in 2004 N/A  N/A  
Ischemic Heart Disease in 2004 1.03 (0.87, 1.21) 1.03 (0.87, 1.21) 
Lower-limb amputations 2004 1.82*** (1.47, 2.27) 1.82*** (1.46, 2.26) 
Cerebrovascular diseases 2004 1.10 (0.94, 1.29) 1.10 (0.94, 1.29) 
No. of outpatient visits 2004 1.01 (1.00, 1.02) 1.01 (1.00, 1.02) 
* p<0.05  **p<0.01 ***p<0.001     
Note: 4,744 individuals excluded from the analysis previously had neuropathy. 
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Table 5.6 Effect of Comprehensive Care on New cases of Lower-limb Amputations 
in 2005 
N=29,101 Lower-limb Amputations in 2005 
 Modeled with Comprehensive Care Modeled without Comprehensive Care 
 OR 95%CI OR 95%CI 
Comprehensive Diabetes Care 0.81 (0.36, 1.83) N/A  
Quality Measures met in 2004     
0 (ref.) 1  1  
1 2.15*** (1.47, 3.15) 2.15*** (1.47, 3.15) 
2 2.40*** (1.65, 3.48) 2.39*** (1.65, 3.47) 
3 2.63*** (1.86, 3.73) 2.63*** (1.86, 3.70) 
4 2.47*** (1.77, 3.45) 2.46*** (1.77, 3.42) 
Mental health disorders     
SUD without mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.47*** (0.35, 0.62) 0.47*** (0.36, 0.62) 
Bipolar disorder 0.52*** (0.38, 0.69) 0.52*** (0.39, 0.69) 
Depression/ anxiety 0.58*** (0.43, 0.78) 0.58*** (0.43, 0.78) 
Other mental health disorders 0.56*** (0.42, 0.76) 0.56*** (0.42, 0.76) 
Co-occurring alcohol abuse/ dependence 1.39** (1.15, 1.68) 1.39** (1.15, 1.68) 
Co-occurring drug abuse/ dependence 1.37** (1.10, 1.70) 1.37** (1.10, 1.70) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.16 (0.96, 1.38) 1.16 (0.96, 1.39) 
65-74 1.14 (0.92, 1.42) 1.14 (0.92, 1.42) 
75 and older 1.41* (1.08, 1.83) 1.41* (1.08, 1.83) 
Male Gender 1.24*** (1.12, 1.37) 1.24*** (1.12, 1.37) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.10 (0.91, 1.33) 1.10 (0.91, 1.33) 
Hispanic 0.85 (0.66, 1.10) 0.85 (0.66, 1.10) 
Others 0.96 (0.70, 1.31) 0.96 (0.70, 1.31) 
Unknown 0.82 (0.55, 1.21) 0.82 (0.55, 1.21) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.16 (0.90, 1.51) 1.16 (0.90, 1.51) 
1.3<=CDPS<=1.9 1.77*** (1.36, 2.30) 1.77*** (1.37, 2.30) 
CDPS>1.9 2.28*** (1.65, 3.16) 2.28*** (1.65, 3.16) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 1.29* (1.03, 1.61) 1.29* (1.03, 1.61) 
Dual-eligible 1.78*** (1.48, 2.14) 1.78*** (1.48, 2.14) 
Continuous 12-month coverage 0.80* (0.66, 0.98) 0.80* (0.66, 0.98) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.22 (0.99, 1.51) 1.22 (0.99, 1.51) 
85-90% 0.92 (0.73, 1.17) 0.92 (0.73, 1.17) 
>90% 1.05 (0.74, 1.51) 1.05 (0.74, 1.51) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.92 (0.73, 1.15) 0.92 (0.73, 1.15) 
$45,921-$56,813 0.87 (0.68, 1.11) 0.87 (0.68, 1.11) 
>$56,813 0.81 (0.58, 1.13) 0.81 (0.58, 1.12) 
No Previous Complications 0.80** (0.67, 0.94) 0.80** (0.67, 0.94) 
Eye complications in 2004 1.61*** (1.37, 1.88) 1.61*** (1.37, 1.88) 
Nephropathy in 2004 1.36** (1.11, 1.68) 1.36** (1.11, 1.68) 
Neuropathy in 2004 1.72*** (1.50, 1.97) 1.72*** (1.50, 1.97) 
Ischemic Heart Disease in 2004 1.18* (1.03, 1.35) 1.18* (1.03, 1.35) 
Lower-limb amputations 2004 N/A  N/A  
Cerebrovascular diseases 2004 1.10 (0.93, 1.31) 1.10 (0.93, 1.31) 
No. of outpatient visits 2004 1.00 (1.00, 1.01) 1.00 (1.00, 1.01) 
* p<0.05  **p<0.01 ***p<0.001     
Note: 2,249 individuals excluded from the analysis previously had lower-limb amputations. 
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Table 5.7 Effect of Comprehensive Care on New Ischemic Heart Disease in 2005 
N=22,913 Ischemic Heart Disease in 2005 
 Modeled with Comprehensive Care Modeled without Comprehensive Care 
 OR 95%CI OR 95%CI 
Comprehensive Diabetes Care 0.86 (0.50, 1.50) N/A  
Quality Measures met in 2004     
0 (ref.) 1  1  
1 1.18 (0.87, 1.60) 1.18 (0.87, 1.59) 
2 1.28* (1.00, 1.63) 1.28* (1.00, 1.63) 
3 1.35** (1.08, 1.70) 1.35* (1.07, 1.69) 
4 1.36* (1.08, 1.72) 1.35* (1.07, 1.71) 
Mental health disorders     
SUD without mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.82 (0.62, 1.09) 0.82 (0.62, 1.09) 
Bipolar disorder 0.95 (0.75, 1.21) 0.95 (0.75, 1.22) 
Depression/ anxiety 1.11 (0.89, 1.37) 1.11 (0.89, 1.37) 
Other mental health disorders 1.13 (0.92, 1.39) 1.13 (0.92, 1.39) 
Co-occurring alcohol abuse/ dependence 1.20 (0.98, 1.47) 1.20 (0.98, 1.47) 
Co-occurring drug abuse/ dependence 0.86 (0.71, 1.03) 0.86 (0.71, 1.03) 
Age Groups     
<55 (ref.) 1  1  
55-64 2.32*** (2.07, 2.60) 2.32*** (2.07, 2.60) 
65-74 2.77*** (2.38, 3.22) 2.77*** (2.38, 3.22) 
75 and older 3.98*** (3.39, 4.68) 3.98*** (3.39, 4.68) 
Male Gender 1.18*** (1.09, 1.27) 1.18*** (1.09, 1.27) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.96 (0.76, 1.26) 0.96 (0.74, 1.26) 
Hispanic 0.75** (0.61, 0.92) 0.75** (0.61, 0.92) 
Others 0.84 (0.63, 1.11) 0.84 (0.63, 1.11) 
Unknown 0.88 (0.63, 1.25) 0.88 (0.63, 1.25) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.11 (0.91, 1.35) 1.11 (0.91, 1.35) 
1.3<=CDPS<=1.9 1.46** (1.17, 1.83) 1.46** (1.17, 1.83) 
CDPS>1.9 1.86*** (1.55, 2.23) 1.86*** (1.55, 2.24) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.79** (0.67, 0.92) 0.78** (0.67, 0.92) 
Dual-eligible 1.44*** (1.20, 1.73) 1.44*** (1.20, 1.73) 
Continuous 12-month coverage 0.78* (0.64, 0.96) 0.78* (0.64, 0.96) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.16 (0.98, 1.37) 1.16 (0.97, 1.37) 
85-90% 0.98 (0.84, 1.15) 0.98 (0.84, 1.15) 
>90% 0.99 (0.80, 1.22) 0.99 (0.80, 1.22) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.98 (0.82, 1.16) 0.98 (0.82, 1.16) 
$45,921-$56,813 0.93 (0.77, 1.13) 0.93 (0.77, 1.13) 
>$56,813 0.96 (0.80, 1.17) 0.96 (0.79, 1.17) 
No Previous Complications 1.11 (0.94, 1.32) 1.11 (0.94, 1.32) 
Eye complications in 2004 1.10 (0.93, 1.29) 1.10 (0.93, 1.30) 
Nephropathy in 2004 1.49*** (1.23, 1.79) 1.49*** (1.23, 1.79) 
Neuropathy in 2004 1.18* (1.04, 1.34) 1.18* (1.04, 1.34) 
Ischemic Heart Disease in 2004 N/A  N/A  
Lower-limb amputations 2004 1.04 (0.84, 1.29) 1.04 (0.84, 1.29) 
Cerebrovascular diseases 2004 1.35*** (1.17, 1.55) 1.35*** (1.17, 1.55) 
No. of outpatient visits 2004 1.02*** (1.02, 1.03) 1.02*** (1.02, 1.03) 
* p<0.05  **p<0.01 ***p<0.001     
Note: 8,437 individuals excluded from the analysis previously had ischemic heart disease. 
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Table 5.8 Effect of Comprehensive Care on New Cerebrovascular Disease in 2005 
N=28,199 Cerebrovascular Disease in 2005 
 Modeled with Comprehensive Care Modeled without Comprehensive Care 
 OR 95%CI OR 95%CI 
Comprehensive Diabetes Care 0.76 (0.43, 1.37) N/A  
Quality Measures met in 2004     
0 (ref.) 1  1  
1 0.89 (0.65, 1.22) 0.89 (0.65, 1.22) 
2 1.02 (0.81, 1.27) 1.01 (0.81, 1.27) 
3 0.96 (0.74, 1.23) 0.95 (0.74, 1.23) 
4 1.04 (0.81, 1.33) 1.03 (0.81, 1.32) 
Mental health disorders     
SUD without mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.61** (0.44, 0.85) 0.61** (0.44, 0.85) 
Bipolar disorder 0.92 (0.67, 1.25) 0.92 (0.67, 1.25) 
Depression/ anxiety 1.02 (0.80, 1.30) 1.02 (0.80, 1.30) 
Other mental health disorders 1.05 (0.84, 1.31) 1.05 (0.84, 1.31) 
Co-occurring alcohol abuse/ dependence 1.29* (1.02, 1.64) 1.29* (1.02, 1.64) 
Co-occurring drug abuse/ dependence 1.12 (0.85, 1.48) 1.12 (0.85, 1.48) 
Age Groups     
<55 (ref.) 1  1  
55-64 2.25*** (1.81, 2.80) 2.25*** (1.81, 2.80) 
65-74 3.34*** (2.62, 4.26) 3.34*** (2.62, 4.26) 
75 and older 3.80*** (3.01, 4.78) 3.80*** (3.01, 4.78) 
Male Gender 1.01 (0.90, 1.13) 1.01 (0.90, 1.13) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.79** (0.67, 0.94) 0.80** (0.67, 0.94) 
Hispanic 0.82 (0.67, 1.01) 0.82 (0.67, 1.01) 
Others 0.67 (0.42, 1.07) 0.67 (0.42, 1.07) 
Unknown 1.01 (0.75, 1.37) 1.01 (0.75, 1.37) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.68*** (1.26, 2.25) 1.68*** (1.26, 2.25) 
1.3<=CDPS<=1.9 1.92*** (1.45, 2.55) 1.93*** (1.45, 2.56) 
CDPS>1.9 2.22*** (1.62, 3.05) 2.22*** (1.62, 3.05) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.50*** (0.40, 0.62) 0.50*** (0.40, 0.62) 
Dual-eligible 1.01 (0.87, 1.17) 1.01 (0.87, 1.17) 
Continuous 12-month coverage 0.69** (0.55, 0.87) 0.69** (0.54, 0.87) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.89 (0.75, 1.06) 0.89 (0.75, 1.05) 
85-90% 0.93 (0.77, 1.12) 0.93 (0.77, 1.12) 
>90% 0.89 (0.69, 1.15) 0.89 (0.69, 1.15) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.01 (0.80, 1.26) 1.01 (0.80, 1.26) 
$45,921-$56,813 0.88 (0.68, 1.13) 0.88 (0.68, 1.13) 
>$56,813 1.00 (0.73, 1.35) 1.00 (0.73, 1.35) 
No Previous Complications 1.12 (0.94, 1.32) 1.12 (0.94, 1.32) 
Eye complications in 2004 1.11 (0.93, 1.33) 1.11 (0.93, 1.33) 
Nephropathy in 2004 0.95 (0.79, 1.15) 0.95 (0.79, 1.15) 
Neuropathy in 2004 1.17* (1.04, 1.32) 1.17* (1.04, 1.32) 
Ischemic Heart Disease in 2004 1.61*** (1.43, 1.82) 1.61*** (1.43, 1.82) 
Lower-limb amputations 2004 1.29* (1.04, 1.60) 1.29* (1.03, 1.60) 
Cerebrovascular diseases 2004 N/A  N/A  
No. of outpatient visits 2004 1.01*** (1.01, 1.02) 1.01*** (1.01, 1.02) 
* p<0.05  **p<0.01 ***p<0.001     
Note: 3,151 individuals excluded from the analysis previously had cerebrovascular disease. 
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Table 5.9 Effect of Comprehensive Care on Diabetes-related Hospitalizations in 
2005 
N=31,350 Diabetes-related Hospitalizations in 2005 
 Modeled with Comprehensive Care Modeled without Comprehensive Care 
 OR 95%CI OR 95%CI 
Comprehensive Diabetes Care 0.71 (0.41, 1.24) N/A  
Quality Measures met in 2004     
0 (ref.) 1  1  
1 2.05*** (1.41, 2.98) 2.05*** (1.41, 2.98) 
2 2.19*** (1.54, 3.10) 2.19*** (1.54, 3.10) 
3 2.11*** (1.54, 2.89) 2.10*** (1.54, 2.88) 
4 1.86*** (1.34, 2.59) 1.85*** (1.33, 2.57) 
Mental health disorders     
SUD without mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.53*** (0.40, 0.69) 0.53*** (0.41, 0.69) 
Bipolar disorder 0.78 (0.57, 1.09) 0.79 (0.57, 1.09) 
Depression/ anxiety 0.75 (0.56, 1.01) 0.75 (0.56, 1.01) 
Other mental health disorders 0.73* (0.53, 1.00) 0.73* (0.53, 1.00) 
Co-occurring alcohol abuse/ dependence 0.90 (0.72, 1.12) 0.90 (0.72, 1.12) 
Co-occurring drug abuse/ dependence 1.53*** (1.27, 1.84) 1.53*** (1.27, 1.84) 
Age Groups     
<55 (ref.) 1  1  
55-64 0.95 (0.81, 1.12) 0.95 (0.81, 1.12) 
65-74 1.01 (0.89, 1.14) 1.01 (0.89, 1.14) 
75 and older 1.04 (0.89, 1.22) 1.04 (0.89, 1.22) 
Male Gender 1.20*** (1.10, 1.32) 1.20*** (1.09, 1.32) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.19 (0.97, 1.46) 1.19 (0.97, 1.47) 
Hispanic 0.61*** (0.48, 0.77) 0.61*** (0.48, 0.76) 
Others 0.93 (0.69, 1.26) 0.93 (0.69, 1.26) 
Unknown 0.95 (0.69, 1.33) 0.95 (0.69, 1.33) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.22 (0.99, 1.50) 1.22 (0.99, 1.50) 
1.3<=CDPS<=1.9 1.52** (1.20, 1.92) 1.52*** (1.20, 1.92) 
CDPS>1.9 1.69*** (1.36, 2.10) 1.70*** (1.37, 2.11) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.83 (0.67, 1.01) 0.83 (0.67, 1.01) 
Dual-eligible 1.27*** (1.12, 1.45) 1.27*** (1.12, 1.45) 
Continuous 12-month coverage 0.66*** (0.54, 0.81) 0.66*** (0.54, 0.81) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.01 (0.86, 1.19) 1.01 (0.86, 1.19) 
85-90% 0.91 (0.77, 1.08) 0.91 (0.76, 1.08) 
>90% 0.88 (0.74, 1.06) 0.88 (0.74, 1.06) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.98 (0.80, 1.19) 0.98 (0.80, 1.19) 
$45,921-$56,813 1.01 (0.82, 1.25) 1.02 (0.82, 1.25) 
>$56,813 1.06 (0.87, 1.29) 1.06 (0.87, 1.29) 
No Previous Complications 0.67*** (0.56, 0.80) 0.67*** (0.56, 0.80) 
Eye complications in 2004 1.29*** (1.13, 1.48) 1.29*** (1.13, 1.48) 
Nephropathy in 2004 1.49*** (1.32, 1.69) 1.49*** (1.32, 1.69) 
Neuropathy in 2004 1.37*** (1.20, 1.56) 1.37*** (1.20, 1.56) 
Ischemic Heart Disease in 2004 2.09*** (1.83, 2.38) 2.09*** (1.83, 2.38) 
Lower-limb amputations 2004 2.28*** (2.07, 2.50) 2.28*** (2.07, 2.50) 
Cerebrovascular diseases 2004 1.50*** (1.28, 1.75) 1.50*** (1.29, 1.75) 
No. of outpatient visits 2004 1.01*** (1.01, 1.02) 1.01*** (1.01, 1.02) 
* p<0.05  **p<0.01 ***p<0.001     
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Discussion 
 The prevalence of people with comprehensive diabetes care, as defined by the 
study criteria, was low in this study population. The analysis showed that there was a 
general trend of lower odds for adverse diabetes outcomes in people with comprehensive 
diabetes care but the associations were not statistically significant.   Such findings were 
consistent with those in the study by Huang et al., in which patients treated at the diabetes 
center had lower, though not statistically significant, odds of hospitalizations than those 
of the general medical clinic (adjusted OR: 0.88, 95%CI: 0.52, 1.49).21  Although in a 
previous study, Rubin and colleagues observed that people with comprehensive diabetes 
care had improved adherence to quality measures of diabetes care in a managed care 
population,20 this was not part of the aim in the current study and thus no analysis was 
conducted to examine the association between comprehensive diabetes care and 
adherence to quality measures. Therefore, further investigations are necessary. 
It is noticed that the adherence to quality measures in the previous year was not 
associated with better health outcomes.  In fact, it was linked to increased odds for some 
diabetes complications.  Since the measure, ‘Quality measures met in 2004’, was created 
to indicate the intensity of care, it is possible that individuals who were adherent had 
worse health and thus required higher levels of care.  For example, this study reported 
that people with previous eye complications, neuropathy or nephropathy were more likely 
to adhere to quality measures (see Chapter III, section ‘Results’ on p.51).   Other studies 
have also observed that people with higher disease burden were more likely to have 
higher levels of care. 67,101   
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Aside from comprehensive diabetes care, there are others factors influencing 
adverse diabetes outcomes.  One such factor is diabetes self-care, which is essential in 
maintaining proper level of HbA1c.102-104  However, the current study was not able to 
assess self-care due to the lack of data.  Aside from patient self-care behaviors, physician 
attitudes may also affect how diabetes is managed in people with behavioral health 
disorders.  In a study by Krebs et al., physicians were three times as likely to regard a 
patient visit as difficult if the patient had substance use disorders.92  In another study, 
Jackson and colleagues observed that patients were more likely to have unmet 
expectations, such as having tests or diagnoses, after a difficult encounter with 
physicians.93 Therefore, it is possible that early signs of diabetes complications may be 
overlooked by physicians during ambulatory visits with patients with SUD and diabetes if 
difficult physician-patient encounters occur on a regular basis for patients with SUD.  
Consequently, such patients may not receive the necessary interventions and may have 
needed to be hospitalized when complications worsened. 
The current study had several limitations.  First, comprehensive diabetes care was 
a proxy measure because it was not possible to identify the type of care facilities that 
provided comprehensive diabetes care, e.g., Joslin Diabetes Clinic, in the current data.  
Second, the study was unable to assess health data such as HbA1c and LDL-c levels, 
which had been shown associated with diabetes complications.105,106  Third, information 
on self-care behavior, an important part of diabetes care, was not assessed as mentioned 
above.  Last, the study period of one year might not be sufficient to assess diabetes 
complications, which usually take years to develop.  Therefore, the non-significant results 
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might be due to lack of outcomes and further studies using multi-year longitudinal data 
are necessary.   
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Chapter VI. Final Summary and Discussion 
Summary of Evidence 
 This study examined the quality of diabetes care as well as diabetes-related 
outcomes among people with diabetes and co-occurring behavioral health disorders 
(BHDs) in a population with publicly sponsored health coverage.  Results showed that 
individuals with schizophrenia/ paranoid states were more likely to attain adherence to all 
quality measures (p<0.01) and less likely to have adverse diabetes outcomes (p<0.05) 
while those with substance use disorders had poorer adherence to having LDL-c tests and 
eye examinations (p<0.001) and higher rates of diabetes-related hospitalizations 
(p<0.001), even after adjusting for demographics, comorbidities and healthcare 
utilization.  There is some evidence that the mode of care delivery, as represented by the 
measure “Comprehensive Diabetes Care”, might be associated with lower odds for 
adverse diabetes outcomes while adherence to quality measures was associated with 
increased odds of certain diabetes complications (p<0.05) (see Chapter V, p.86).   The 
analysis of comprehensive diabetes care failed to completely explain the disparity in 
health outcomes, especially for individuals with SUD.  It is possible that having 
comprehensive diabetes care alone may not be sufficient to improve health outcomes in 
diabetes.  In addition, such observation indicates that unmeasured confounders exist.  For 
example, this study was unable to assess self-care activities such as smoking and 
adherence to diabetes medications. Proper control of HbA1c through medications and 
smoking cessation are crucial in preventing diabetes-related complications. 55,105,107   
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The analyses also showed that the addition of previous diabetes complications 
(Need factors) reduced the significance of association between mental health disorders 
and full adherence to quality measures while increasing the odds of diabetes-related 
hospitalizations for drug abuse/ dependence (see Appendix XII, p.148).  It is possible that 
such a change in association was related to the lower prevalence of previous diabetes 
complications among people with mental and substance use disorders (see Tables 3.1 on 
p.52 and 3.2 on p.54).  Because having previous complications increased the odds of 
adherence, lower odds of adherence among individuals with mental health disorders 
might have been confounded by lower rates of previous complications.  However, 
previous complications could also indicate poorly managed diabetes and increase the 
odds for new complications (see Chapter IV, p.74).  Therefore, the unadjusted, lower 
odds of diabetes-related hospitalizations in the drug abuse/ dependence group were 
possibly confounded by lower prevalence of previous complications.  
Study Limitations 
 The limitations of this study were related to the use of administrative data.  First, 
the exclusion of Medicare beneficiaries with other health coverage (except Medicaid) 
might underestimate the adherence to quality benchmarks among Medicare beneficiaries.  
The rates of adherence to quality measures might have been different if beneficiaries with 
Medicare Advantage plans were included.  However, the data for service use under HMO 
plans were not available in this dataset.  Therefore, generalizability of this study is 
limited to those with Medicare fee-for-service coverage alone.  Further, the exclusion of 
individuals with less than 300 days of enrollment in Medicare Part B or Medicaid also 
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limited the study’s generalizability.  As observed in Table 6.1, all of the individual 
characteristics (except age) were significantly different between those enrolled for 300 
days or more and those with less than 300-day enrollment.  Individuals excluded from 
this study might have significantly adverse outcomes.  Therefore, the observations from 
this study can only be applied to individuals with stable healthcare coverage.  
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Table 6.1 Comparison of Characteristics between Populations with different lengths 
of enrollment 
 Length of Enrollment 
 <300 days (n=23,235) "300 days (n=112,535) 
Overall (n=135,770) 
Mean age (SD)a,3 67 (16) 67 (15) 67 (15) 
Gender (%)b,1    
Female 12,447 (54) 64,481 (57) 76,928 (57) 
Male  10,788 (46) 48,054 (43) 58,842 (43) 
Race/ Ethnicity (%)b,1    
Non-Hispanic white 17,380 (75) 91,866 (82) 109,266 (80) 
African American 2,072 (9) 8,430 (7) 10,502 (8) 
Hispanic 1,274 (5) 4,708 (4) 5,982 (4) 
Others 1,088 (5) 3,464 (3) 4,552 (3) 
Unknown 1,421 (6) 4,047 (4) 5,468 (4) 
Mean CDPS score (SD)c,1  2.5 (2.2) 1.6 (1.2) 1.8 (1.4) 
Disabled (%)b,1 5,924 (26) 34,055 (30) 39,979 (29) 
Health Coverage (%)b,1    
Medicare 8,565 (37) 61,573 (55) 70,138 (52) 
Medicaid 4,428 (19) 23,445 (21) 27,873 (21) 
Dual-eligible 10,242 (44) 27,517 (24) 37,759 (28) 
Average #Office visits 2004 (SD)c,1 5.1 (6.5) 7.5 (7.0) 7.1 (7.0) 
Average length of stay in nursing homes in 
days (SD)c,1 
32.5 (83.8) 12.9 (61.6) 16.2 (66.4) 
Mental health disorders b,1    
Schizophrenia/ paranoid states 698 (3) 4,684 (4) 5,382 (4) 
Bipolar disorder 779 (3) 3,551 (3) 4,330 (3) 
Depression/ anxiety 5,773 (25) 21,733 (19) 27,506 (20) 
Other mental health disorders 1,162 (5) 3,452 (3) 4,614 (3) 
No mental health disorders 14,823 (64) 79,115 (70) 93,938 (69) 
Substance use disordersb,1 1,591 (7) 5,870 (5) 7,461 (6) 
Any previous complications (%)b,1 13,206 (57) 59,717 (53) 72,923 (54) 
Eye complications in 2004 (%)b,1 2,896 (12) 18,318 (16) 21,214 (16) 
Neuropathy in 2004 (%)b,2 3,272 (14) 16,080 (14) 19,352 (14) 
Nephropathy in 2004 (%)b,1 1,736 (7) 5,715 (5) 7,451 (5) 
Lower-limb complications in 2004 (%)b,1 2,294 (10) 6,380 (6) 8.674 (6) 
Ischemic Heart disease in 2004 (%)b,1 8,813 (38) 35,912 (32) 44,725 (33) 
Cerebrovascular disease in 2004 (%)b,1 3,604 (16) 12,406 (11) 16,010 (12) 
Zip code-based neighborhood socioeconomic status 
Average Median Household Income (SD)a,1 47,393 (17,098) 48,436 (17,525) 48,257 (17,457) 
Average %High School Graduates (SD)a,1 81 (11) 82 (11) 81 (11) 
a Student's t-test  b !2 test  c Kruskal-Wallis test 
1 p<0.001, 2 p=0.4, 3p=1.0 
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Second, it was possible that those classified as ‘no BHDs’ might actually have 
BHDs because their BHDs were undiagnosed by clinicians,108 recorded inaccurately in 
the database109 or substituted by other medical diagnoses in coding.110  Therefore, it was 
very likely that the study might underestimate the prevalence of BHDs.  For example, 
Kessler and colleagues observed that patients who tended to consider their psychiatric 
symptoms as manifestations of somatic diseases were less likely to be diagnosed with 
mental health disorders in primary care settings.108 If claims data were less sensitive in 
case detection, the associations between BHDs and outcomes would have been biased 
towards the null because the effect of having no BHDs, e.g., better adherence rates, 
would be reduced by those with BHDs.  However, the study attempted to compensate for 
the low diagnostic sensitivity of ICD-9 codes by using any claims diagnoses in case 
detection, instead of using only primary diagnoses.  For example, about 30% of the 
Medicaid population in this study is identified as having depression/anxiety, compared to 
13% in Gilmer’s study.111  In addition, this study explored other case detection methods, 
such as Medicaid Rx models, whether they could  improve sensitivity.  The analyses 
showed that both methods, Medicaid Rx and ICD-9 codes, identified different cases (see 
Appendices III through XI, p.138-147).  Further study using a gold standard is needed to 
determine the sensitivity and specificity of case detection methods. 
Low specificity due to false positives was also possible, especially when 
pharmacy data are used in case detection.69  However, the associations between BHDs 
and outcomes would be biased towards the null.  This was because the effect of BHDs on 
the outcomes would have been diluted if some people without BHDs were grouped into 
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those with BHDs and their rates of adherence and complications were different from 
those of people with BHDs.  Furthermore, other studies have suggested the accuracy of 
diagnoses in claims data is comparable to clinical assessments or medical chart review.  
In a study that examined the accuracy of diagnoses in Medicaid claims data, Lurie and 
colleagues used the same assessment method as in this study.112  They observed that 
about 87% of patients with treatments for schizophrenia in claims data were classified as 
having schizophrenia by psychiatrists’ assessments.112  In addition, Walkup and 
colleagues compared psychiatric diagnoses (schizophrenia and affective disorders) 
identified in New York Medicaid claims data to those in medical records.113 They found 
that 96% of psychiatric diagnoses from medical records were correctly identified with 
primary and secondary diagnoses in claims data.113 Therefore, misclassification bias due 
to wrong diagnoses might be minimal.  
Third, the use of the hierarchical system assumed that particular groups of mental 
health disorders, such as schizophrenia/paranoid, were more severe and hence had more 
influence on the quality of care.  For example, people who were classified as having 
schizophrenia/paranoid disorders might also have other comorbid mental health 
disorders. If poor quality of diabetes care was actually associated with the higher burden 
of comorbidities in schizophrenia/paranoid, the use of hierarchical system would bias the 
relationship between schizophrenia/paranoid and quality of diabetes care towards 
association.  However, the analysis adjusted for the burden of comorbidities using the 
Chronic Illness and Disability Payment System (CDPS).  Therefore, the confounding 
effects by comorbidities were minimized.   
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Similarly, the combined grouping of depression and anxiety may have been 
problematic.  The two diseases might have different influences on the quality of diabetes 
care and other diabetes outcomes.  Thus combining them in analysis might bias the 
results towards the null.  However, literature to date did not indicate significant 
differences between depression and anxiety on the quality of diabetes care (see Chapter 
II, section on ‘Behavioral Health Disorders: the Rationale for BHD categorization’ on 
p.26). Therefore, the categorization of BHDs was appropriate in addressing the study 
objectives.   
 Fourth, the study was unable to assess the quality of diabetes care among more 
specific BHD diagnoses, e.g., major depression versus dysthymia, due to the hierarchical 
system of classifying mental health disorders (see Chapter II, section on Behavioral 
Health Disorders on p.26 for rationale).  An additional weakness of the study was the 
inability to address patient self-care.  Since part of proper diabetes care relies on patients’ 
own self-care activities, such as self-monitoring of blood glucose, the clinical outcomes 
of diabetes may also be influenced by self-management.  However, self-care could not be 
assessed in this study because there was no information about self-care available in the 
database.  
Fifth, the measures for neighborhood socioeconomic status might not be 
appropriate to address the effects of SES on the quality of diabetes care as evidenced in 
their lack of associations with the outcomes.   In addition, the assessment of Hospital 
Service Areas (HSAs) might not fully account for provider differences in the patterns of 
health care.  Heterogeneity of health care might persist among beneficiaries after 
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adjustment because HSAs did not represent individual providers and each provider might 
have different practice pattern. However, patients usually sought care from local 
physicians, who were in turn affiliated with the local hospitals.84  HSAs are defined by 
the areas where the local residents receive most of their hospital care.84  Service 
utilization represented by HSAs could potentially reflect similarity in physician care 
practices.   
Several studies by John Wennberg and colleagues demonstrated that the patterns 
of inpatient and outpatient health care utilization varied greatly across HSAs but are 
generally more homogeneous within the area.85  Such variations were associated with the 
quality of care from providers, independent of the rates of illnesses or a variety of other 
socioeconomic characteristics of the area.86,87  For example, Medicare reimbursement for 
outpatient services per enrollee in 2005 ranged from $648 in North Adams, MA to $1614 
in Melrose, MA, a difference of 149%.88  In addition, Sirovich and colleagues observed 
that providers in Hospital Referral Regions (aggregates of HSAs) with higher Medicare 
expenditures were more likely to advocate medical interventions than those in regions 
with lower Medicare expenditures.89   Therefore, in the absence of data on specific 
providers, HSAs might be a reasonable, partial substitute for provider-based variation in 
care as well as a practical solution to account for unmeasured correlation among patients 
within a catchment area of healthcare services. 
 Last, the study was limited by the short observation period of one year.  More 
powerful statistical inference could be made to examine the incidence rates of 
complications and hospitalizations with longitudinal data because diabetes outcomes, 
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such as complications, are time-dependent.  However, the objective of the study was to 
determine whether having BHDs and meeting quality benchmarks for diabetes care were 
associated with diabetes complications and hospitalizations.  The study did not aim to 
assess any temporal relationships.  Thus, the design was sufficient to address the specific 
aims. 
Strengths of the Study 
Despite the limitations, this study had several methodological strengths.  The 
main strength of this study was the use of population-based data. Since Medicare and 
Medicaid data were used, the results might be applicable to other Medicare and Medicaid 
populations with demographic composition and public insurance programs similar to 
those in Massachusetts. The likelihood of selection bias was reduced since the entire 
populations of Medicare, Medicaid and Dual-eligibles with diabetes were included in the 
study. In addition, the size of study population, a total of 106,174 beneficiaries, provided 
sufficient confidence in detecting any significant relationships between the BHDs and 
diabetes outcomes.   
In summary, this study investigated the adherence to quality benchmarks for 
diabetes care and diabetes complications among people with BHDs, compared to those 
without BHDs in the Medicare and Medicaid populations of Massachusetts.  Such 
analysis had not been carried out in studies to date.  Therefore, the results from this study 
will increase our understanding of diabetes care.  
Conclusion 
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Despite study limitations, some conclusions can be made from the analyses with 
confidence. In this population with relatively stable health coverage, having the 
diagnoses of substance use disorders (SUD) adversely impacted the odds of having LDL-
c tests, as well as eye examinations, while it increased the likelihoods of poor diabetes 
outcomes, such as lower-limb amputations and diabetes-related hospitalizations (p<0.05).  
However, individuals with schizophrenia/ paraoid states consistently had higher 
likelihoods of adherence to quality measures and lower odds of having nephropathy, 
neuropathy, ischemic heart disease, cerebrovascular disease and diabetes-related 
hospitalizations (p<0.01).  While the observations of people with SUD in this study were 
consistent with previous studies15,16,27,66, the results of individuals with schizophrenia/ 
paranoid states were unexpected and warranted further investigation.   
It is unlikely that such results were caused by misidentification of BHDs because 
in most cases, the misclassification of BHDs or outcomes will bias the results towards the 
null and the analyses showed consistently significant associations between SUD and 
outcome measures, as well as those between schizophrenia/ paranoid states and 
outcomes.  However, there are other possible reasons for these observations.  For 
example, there has been growing awareness of managing diabetes in people with 
schizophrenia, as demonstrated by the clinical practice guidelines put forth by the 
American Psychiatric Association and the American Diabetes Association.90   Thus, 
providers were more inclined to monitor diabetes in people with schizophrenia/ paranoid 
states.  It is also possible that beneficiairies with Medicaid in Massachusetts had better 
access to physical or mental health care through case management for mental health 
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patients.114  Consequently, the quality of diabetes care and health outcomes improved 
among people with schizophrenia/ paranoid states.   In contrast, the reasons for poorer 
quality of diabetes care and health outcomes among individuals with SUD are different.  
First, people with SUD might be less adherent to treatment guidelines of diabetes, such as 
self-care activities.115    Therefore, their diabetes was not properly managed and they 
developed complications as a result.  Another possible explanation is that the presence of 
SUD among these people created difficulties in patient-provider communications92 and 
thus the quality of care suffered.93 
Implications for Future Studies 
 Future studies should further investigate the underlying factors between people 
with diabetes and co-occurring substance use disorders (SUD) or schizophrenia/ paranoid 
states and diabetes outcomes because factors such as self-care activities and treatments 
for SUD or schizophrenia/ paranoid states were not accounted for in this study.  It is also 
essential for future studies to examine data from other states because observations made 
in this study may only reflect healthcare access and quality of care in Massachusetts.  
Therefore, the quality of diabetes care for people with SUD or schizophrenia/ paranoid 
states may be different in other states with fewer behavioral health services.  The results 
from this study suggested that the mode of care delivery might improve diabetes 
outcomes; however, it did not completely mediate the relationship between substance use 
disorders and poor diabetes outcomes.  Longitudinal studies should be conducted to 
examine how comprehensive diabetes care, delivered by specialty providers such as the 
Joslin Diabetes Clinic, improves diabetes outcomes.   Future studies should also examine 
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how the treatments of behavioral health disorders (e.g., SUD and schizophrenia/ paranoid 
states), as well as the types of treatment (e.g., methadone for SUD and antipsychotics for 
schizophrenia), among people with diabetes and co-morbid BHDs affect the quality of 
diabetes care and diabetes outcomes.  If study results show improvements in diabetes 
(quality of care and outcomes) following treatment of SUD, policies should be developed 
to encourage broader access to SUD treatment, such as opioid-substitution therapies for 
individuals with opioid addiction.    
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicare Only 
N=60,137 Full Adherence 2005 HbA1c test 2005 LDL-c test 2005 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.74* (0.58, 0.96) 0.80 (0.63, 1.02) 0.79 (0.62, 1.00) 
Bipolar disorder 0.81 (0.66, 1.01) 0.82 (0.67, 1.02) 0.83 (0.69, 1.00) 
Depression/ anxiety 0.84*** (0.78, 0.90) 0.81*** (0.77, 0.85) 0.81*** (0.77, 0.86) 
Other mental health disorders 0.82** (0.72, 0.93) 0.98 (0.86, 1.13) 0.84* (0.74, 0.96) 
Any alcohol abuse/ dependence 0.63*** (0.50, 0.80) 0.69*** (0.58, 0.82) 0.59*** (0.50, 0.70) 
Any drug abuse/ dependence 0.60** (0.44, 0.81) 0.66** (0.51, 0.84) 0.62*** (0.47, 0.81) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.52*** (1.27, 1.82) 1.69*** (1.36, 2.11) 1.84*** (1.51, 2.23) 
65-74 2.06*** (1.76, 2.42) 1.99*** (1.65, 2.41) 2.48*** (2.08, 2.95) 
75 and older 1.74*** (1.49, 2.04) 1.60*** (1.32, 1.94) 1.37*** (1.16, 1.62) 
Male Gender 1.10*** (1.04, 1.15) 1.04 (0.99, 1.09) 1.05* (1.00, 1.09) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 0.88* (0.78, 0.99) 0.95 (0.86, 1.06) 0.73*** (0.62, 0.86) 
Hispanic 0.75 (0.55, 1.03) 0.71 (0.46, 1.09) 0.67* (0.45, 0.99) 
Others 0.82* (0.69, 0.98) 0.91 (0.73, 1.15) 1.07 (0.89, 1.28) 
Unknown 1.16 (0.69, 1.96) 1.39 (0.67, 2.90) 0.79 (0.45, 1.40) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.31*** (1.25, 1.37) 0.97 (0.92, 1.03) 1.05 (0.99, 1.12) 
1.3<=CDPS<=1.9 1.30*** (1.20, 1.41) 0.87** (0.80, 0.95) 0.81*** (0.75, 0.88) 
CDPS>1.9 1.21*** (1.12, 1.32) 0.66*** (0.59, 0.74) 0.56*** (0.50, 0.62) 
Continuous 12-month coverage 2.86*** (2.19, 3.75) 1.87*** (1.48, 2.36) 3.55*** (2.91, 4.32) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.04 (0.95, 1.13) 1.02 (0.82, 1.28) 0.80 (0.63, 1.01) 
85-90% 1.02 (0.86, 1.20) 1.02 (0.77, 1.36) 0.73* (0.55, 0.96) 
>90% 1.11 (0.92, 1.33) 1.00 (0.72, 1.40) 0.72* (0.52, 0.99) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 0.94 (0.83, 1.06) 1.00 (0.81, 1.24) 1.36 (0.99, 1.88) 
$45,921-$56,813 1.01 (0.87, 1.18) 1.00 (0.81, 1.23) 1.42* (1.01, 2.00) 
>$56,813 1.03 (0.85, 1.25) 0.93 (0.71, 1.23) 1.48 (1.00, 2.18) 
No Previous Complications 0.96 (0.90, 1.03) 0.84*** (0.77, 0.92) 0.90** (0.85, 0.96) 
Eye complications in 2004 1.59*** (1.50, 1.69) 3.07*** (2.77, 3.41) 1.26*** (1.18, 1.36) 
Nephropathy in 2004 1.36*** (1.24, 1.49) 2.06*** (1.78, 2.38) 0.93 (0.81, 1.07) 
Neuropathy in 2004 1.33*** (1.24, 1.41) 2.35*** (2.13, 2.60) 1.17*** (1.09, 1.25) 
Ischemic Heart Disease in 2004 0.99 (0.92, 1.06) 0.94 (0.86, 1.03) 1.32*** (1.23, 0.42) 
Lower-limb amputations 2004 0.82*** (0.75, 0.89) 1.10 (0.97, 1.25) 0.72*** (0.66, 0.78) 
Cerebrovascular diseases 2004 0.94* (0.88, 1.00) 0.91** (0.85, 0.97) 1.04 (0.98, 1.11) 
No. of outpatient visits 2004 1.05*** (1.04, 1.05) 1.03*** (1.03, 1.04) 1.04*** (1.03, 1.05) 
*p<0.05 **p<0.01 ***p<0.001       
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicare Only 
N= Nephropathy test 2005 Eye examination 2005 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 1.26* (1.05, 1.51) 0.64*** (0.51, 0.80) 
Bipolar disorder 1.15 (0.98, 1.35) 0.70** (0.56, 0.88) 
Depression/ anxiety 1.03 (0.97, 1.09) 0.80*** (0.76, 0.85) 
Other mental health disorders 0.97 (0.88, 1.07) 0.83** (0.73, 0.95) 
Any alcohol abuse/ dependence 0.80** (0.70, 0.91) 0.68*** (0.57, 0.81) 
Any drug abuse/ dependence 0.93 (0.72, 1.20) 0.70** (0.54, 0.91) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.31** (1.12, 1.52) 1.65*** (1.39, 1.96) 
65-74 1.51*** (1.31, 1.73) 2.74*** (2.34, 3.21) 
75 and older 1.46*** (1.27, 1.68) 2.84*** (2.44, 3.30) 
Male Gender 1.16*** (1.09, 1.24) 0.83*** (0.81, 0.86) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.98 (0.92, 1.04) 0.95 (0.86, 1.05) 
Hispanic 0.86 (0.65, 1.14) 0.80 (0.57, 1.13) 
Others 0.81** (0.70, 0.95) 0.78** (0.66, 0.93) 
Unknown 1.45 (0.85, 2.50) 1.10 (0.66, 1.85) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.26*** (1.20, 1.33) 1.24*** (1.17, 1.31) 
1.3<=CDPS<=1.9 1.41*** (1.31, 1.52) 1.28*** (1.19, 1.39) 
CDPS>1.9 1.72*** (1.59, 1.86) 1.04 (0.97, 1.12) 
Continuous 12-month coverage 0.92 (0.79, 1.07) 2.72*** (2.32, 3.18) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.02 (0.88, 1.18) 1.13** (1.04, 1.23) 
85-90% 0.95 (0.79, 1.14) 1.20*** (1.09, 1.32) 
>90% 1.04 (0.86, 1.26) 1.33*** (1.18, 1.49) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.92 (0.79, 1.07) 0.95 (0.86, 1.04) 
$45,921-$56,813 0.98 (0.83, 1.15) 0.95 (0.86, 1.04) 
>$56,813 1.05 (0.87, 1.25) 0.91 (0.82, 1.02) 
No Previous Complications 1.03 (0.97, 1.10) 1.01 (0.95, 1.08) 
Eye complications in 2004 1.01 (0.96, 1.07) 2.72*** (2.52, 2.94) 
Nephropathy in 2004 1.60*** (1.40, 1.83) 1.20*** (1.09, 1.32) 
Neuropathy in 2004 1.04 (0.99, 1.11) 1.31*** (1.23, 1.40) 
Ischemic Heart Disease in 2004 0.98 (0.92, 1.04) 0.90*** (0.84, 0.95) 
Lower-limb amputations 2004 0.84*** (0.77, 0.92) 0.75*** (0.66, 0.84) 
Cerebrovascular diseases 2004 0.96 (0.90, 1.02) 0.92** (0.87, 0.97) 
No. of outpatient visits 2004 1.04*** (1.04, 1.05) 1.05*** (1.04, 1.06) 
*p<0.05 **p<0.01 ***p<0.001     
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicare Only 
 Any complications 2005 Eye Complications 2005 Nephropathy 2005 
 N=60,137 N=49,674 N=57,095 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.78* (0.61, 0.98) 0.70* (0.49, 0.99) 0.29** (0.14, 0.63) 
Bipolar disorder 0.66*** (0.54, 0.81) 0.90 (0.69, 1.19) 0.53 (0.23, 1.19) 
Depression/ anxiety 0.89*** (0.83, 0.95) 0.91 (0.82, 1.01) 0.80** (0.70, 0.91) 
Other mental health disorders 0.88 (0.74, 1.03) 0.84 (0.65, 1.07) 0.79 (0.60, 1.04) 
Any alcohol abuse/ dependence 0.87 (0.70, 1.08) 0.73 (0.53, 1.02) 0.54** (0.37, 0.79) 
Any drug abuse/ dependence 0.57*** (0.42, 0.78) 0.77 (0.51, 1.17) 0.54 (0.27, 1.06) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.53*** (1.27, 1.84) 1.63** (1.16, 2.30) 0.71 (0.45, 1.13) 
65-74 1.55*** (1.28, 1.89) 1.39 (0.98, 1.96) 0.60* (0.39, 0.90) 
75 and older 1.75*** (1.46, 2.09) 1.12 (0.78, 1.60) 0.51** (0.34, 0.75) 
Male Gender 1.38*** (1.32, 1.44) 0.93 (0.86, 1.01) 1.39*** (1.25, 1.54) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.03 (0.92, 1.16) 1.49*** (1.27, 1.76) 1.70*** (1.31, 2.21) 
Hispanic 0.98 (0.62, 1.54) 1.55 (0.67, 3.60) 0.79 (0.30, 2.08) 
Others 0.78* (0.64, 0.95) 1.19 (0.87, 1.63) 1.63* (1.06, 2.51) 
Unknown 1.02 (0.53, 1.97) 1.01 (0.35, 2.86) 2.19 (0.83, 5.79) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.22*** (1.15, 1.29) 0.98 (0.88, 1.09) 1.68*** (1.32, 2.14) 
1.3<=CDPS<=1.9 1.34*** (1.26, 1.43) 1.06 (0.94, 1.19) 2.39*** (1.91, 3.01) 
CDPS>1.9 1.43*** (1.33, 1.53) 1.08 (0.94, 1.24) 5.06*** (4.03, 6.36) 
Continuous 12-month coverage 0.38*** (0.31, 0.48) 1.67** (1.16, 2.39) 0.59** (0.41, 0.84) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.03 (0.94, 1.12) 0.90 (0.72, 1.11) 1.29* (1.04, 1.60) 
85-90% 1.03 (0.91, 1.17) 0.86 (0.70, 1.05) 1.23 (0.98, 1.56) 
>90% 1.03 (0.90, 1.18) 0.77* (0.61, 0.98) 1.32 (0.97, 1.80) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 1.00 (0.91, 1.09) 1.04 (0.87, 1.24) 0.89 (0.72, 1.09) 
$45,921-$56,813 1.00 (0.89, 1.12) 1.01 (0.81, 1.27) 0.88 (0.69, 1.14) 
>$56,813 1.01 (0.87, 1.16) 1.17 (0.90, 1.52) 0.86 (0.63, 1.16) 
No Previous Complications 0.45*** (0.41, 0.51) 0.98 (0.86, 1.11) 0.87 (0.72, 1.04) 
Eye complications in 2004 3.29*** (2.98, 3.63) N/A  2.05*** (1.81, 2.31) 
Nephropathy in 2004 2.58*** (2.21, 3.00) 2.02*** (1.75, 2.32) N/A  
Neuropathy in 2004 3.62*** (3.23, 4.05) 1.89*** (1.70, 2.09) 1.69*** (1.49, 1.92) 
Ischemic Heart Disease in 2004 4.68*** (4.22, 5.19) 1.19** (1.08, 1.31) 1.12 (0.99, 1.27) 
Lower-limb amputations 2004 1.06 (0.90, 1.24) 1.39*** (1.24, 1.57) 1.48*** (1.23, 1.77) 
Cerebrovascular diseases 2004 1.87*** (1.69, 2.08) 1.12 (1.00, 1.25) 0.88 (0.78, 1.00) 
No. of outpatient visits 2004 1.03*** (1.02, 1.03) 1.00 (1.00, 1.01) 1.00 (0.99, 1.01) 
*p<0.05 **p<0.01 ***p<0.001       
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicare Only 
 Diabetic Neuropathy 
2005 
Lower-limb Amputations 
2005 
Ischemic Heart Disease 
2005 
 N=50,594 N=57,092 N=36,332 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.94 (0.65, 1.35) 0.84 (0.46, 1.56) 1.28 (0.83, 1.99) 
Bipolar disorder 1.22 (0.89, 1.67) 0.87 (0.59, 1.29) 0.66* (0.48, 0.91) 
Depression/ anxiety 0.97 (0.88, 1.07) 0.94 (0.80, 1.09) 0.96 (0.87, 1.05) 
Other mental health disorders 1.09 (0.91, 1.29) 0.93 (0.74, 1.17) 0.95 (0.78, 1.15) 
Any alcohol abuse/ dependence 0.75 (0.53, 1.07) 1.37 (0.95, 1.97) 0.75* (0.59, 0.95) 
Any drug abuse/ dependence 0.69 (0.42, 1.13) 1.02 (0.57, 1.84) 0.63* (0.43, 0.94) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.05 (0.76, 1.44) 0.83 (0.56, 1.23) 2.03*** (1.48, 2.78) 
65-74 0.85 (0.67, 1.08) 0.64** (0.45, 0.89) 2.40*** (1.80, 3.20) 
75 and older 0.84 (0.65, 1.09) 0.84 (0.60, 1.17) 3.09*** (2.34, 4.08) 
Male Gender 1.08 (1.00, 1.16) 1.11** (1.03, 1.20) 1.48*** (1.40, 1.58) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.28 (1.03, 1.60) 1.12 (0.83, 1.51) 0.83 (0.66, 1.04) 
Hispanic 1.36 (0.68, 2.72) 0.90 (0.44, 1.83) 0.40* (0.18, 0.88) 
Others 0.53** (0.36, 0.78) 1.22 (0.82, 1.83) 0.94 (0.73, 1.19) 
Unknown 0.61 (0.20, 1.84) 1.62 (0.56, 4.64) 1.25 (0.58, 2.67) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.36*** (1.20, 1.54) 1.17 (0.99, 1.39) 1.24*** (1.15, 1.34) 
1.3<=CDPS<=1.9 1.74*** (1.48, 2.06) 1.66*** (1.35, 2.04) 1.52*** (1.40, 1.66) 
CDPS>1.9 1.97*** (1.67, 2.33) 2.52*** (2.03, 3.12) 1.89*** (1.71, 2.09) 
Continuous 12-month coverage 0.91 (0.67, 1.24) 0.38*** (0.29, 0.49) 0.27*** (0.22, 0.35) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.19 (0.96, 1.47) 0.96 (0.78, 1.19) 1.02 (0.89, 1.17) 
85-90% 1.45* (1.09, 1.93) 0.87 (0.67, 1.15) 0.92 (0.78, 1.07) 
>90% 1.53** (1.14, 2.04) 0.88 (0.65, 1.19) 0.93 (0.78, 1.11) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 0.81* (0.67, 0.99) 0.94 (0.75, 1.19) 1.03 (0.91, 1.16) 
$45,921-$56,813 0.77** (0.64, 0.93) 0.96 (0.75, 1.24) 1.11 (0.97, 1.27) 
>$56,813 0.69*** (0.56, 0.86) 0.93 (0.71, 1.22) 1.17 (0.99, 1.38) 
No Previous Complications 0.88* (0.79, 0.99) 0.85* (0.72, 0.99) 1.02 (0.89, 1.18) 
Eye complications in 2004 1.97*** (1.77, 2.21) 1.77*** (1.57, 1.99) 1.17** (1.05, 1.30) 
Nephropathy in 2004 1.82*** (1.58, 2.11) 1.41*** (1.19, 1.69) 1.23* (1.03, 1.45) 
Neuropathy in 2004 N/A  1.69*** (1.49, 1.93) 1.07 (0.98, 1.18) 
Ischemic Heart Disease in 2004 0.99 (0.88, 1.12) 1.14** (1.04, 1.25) N/A  
Lower-limb amputations 2004 1.53*** (1.29, 1.80) N/A  1.05 (0.90, 1.23) 
Cerebrovascular diseases 2004 0.93 (0.84, 1.03) 1.06 (0.94, 1.19) 1.34*** (1.17, 1.53) 
No. of outpatient visits 2004 1.02*** (1.02, 1.02) 1.00 (1.00, 1.01) 1.02*** (1.02, 1.03) 
*p<0.05 **p<0.01 ***p<0.001       
 
 117 
Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicare Only 
 Cerebrovascular Disease 
2005 
Diabetes-related 
Hospitalizations 2005 
 N=51,972 N=60,137 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 1.04 (0.72, 1.48) 0.91 (0.59, 1.40) 
Bipolar disorder 0.98 (0.68, 1.41) 1.23 (0.92, 1.64) 
Depression/ anxiety 1.10 (0.99, 1.23) 1.04 (0.95, 1.14) 
Other mental health disorders 1.16 (0.90, 1.49) 1.06 (0.89, 1.28) 
Any alcohol abuse/ dependence 1.13 (0.86, 1.48) 0.91 (0.69, 1.19) 
Any drug abuse/ dependence 0.89 (0.58, 1.35) 1.17 (0.82, 1.67) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.57* (1.10, 2.23) 1.08 (0.72, 1.62) 
65-74 2.02*** (1.45, 2.82) 1.09 (0.75, 1.58) 
75 and older 2.62*** (1.89, 3.63) 1.22 (0.85, 1.76) 
Male Gender 1.09* (1.02, 1.16) 1.14*** (1.07, 1.22) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.83** (0.74, 0.94) 0.86 (0.73, 1.00) 
Hispanic 1.38 (0.79, 2.40) 1.52 (0.96, 2.40) 
Others 0.93 (0.62, 1.38) 0.95 (0.67, 1.35) 
Unknown 1.64 (0.82, 3.30) 1.60 (0.62, 4.12) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.30*** (1.18, 1.44) 1.07 (0.95, 1.21) 
1.3<=CDPS<=1.9 1.45*** (1.27, 1.65) 1.25** (1.09, 1.43) 
CDPS>1.9 1.62*** (1.38, 1.89) 1.50*** (1.31, 1.71) 
Continuous 12-month coverage 0.41*** (0.33, 0.51) 0.26*** (0.21, 0.33) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.06 (0.92, 1.23) 1.03 (0.86, 1.22) 
85-90% 1.14 (0.99, 1.30) 0.96 (0.78, 1.20) 
>90% 1.14 (1.00, 1.30) 0.93 (0.75, 1.16) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.85* (0.74, 0.99) 0.92 (0.79, 1.08) 
$45,921-$56,813 0.82* (0.70, 0.97) 0.98 (0.82, 1.17) 
>$56,813 0.84* (0.72, 0.99) 1.02 (0.83, 1.24) 
No Previous Complications 1.05 (0.92, 1.20) 0.78** (0.66, 0.93) 
Eye complications in 2004 1.09 (0.99, 1.18) 1.25*** (1.13, 1.38) 
Nephropathy in 2004 1.29*** (1.13, 1.48) 1.33*** (1.17, 1.53) 
Neuropathy in 2004 1.14** (1.05, 1.25) 1.22*** (1.10, 1.35) 
Ischemic Heart Disease in 2004 1.63*** (1.46, 1.82) 1.89*** (1.72, 2.08) 
Lower-limb amputations 2004 1.10 (0.97, 1.26) 1.69*** (1.48, 1.94) 
Cerebrovascular diseases 2004 N/A  1.54*** (1.41, 1.69) 
No. of outpatient visits 2004 1.01*** (1.01, 1.02) 1.00 (1.00, 1.01) 
*p<0.05 **p<0.01 ***p<0.001     
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicare Only 
 Any Complications in 2005 Eye Complications in 2005 Nephropathy in 2005 
 N=60,137 N=49,674 N=57,095 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.79 (0.63, 1.01) 0.71 (0.49, 1.02) 0.30** (0.14, 0.64) 
Bipolar disorder 0.67*** (0.54, 0.81) 0.91 (0.69, 1.20) 0.53 (0.23, 1.20) 
Depression/ anxiety 0.90** (1.86, 0.95) 0.92 (0.83, 1.02) 0.81** (0.70, 0.92) 
Other mental health disorders 0.88 (0.75, 1.04) 0.84 (0.66, 1.07) 0.79 (0.60, 1.04) 
Any alcohol abuse/ dependence 0.91 (0.73, 1.12) 0.76 (0.54, 1.05) 0.56** (0.38, 0.82) 
Any drug abuse/ dependence 0.58** (0.43, 0.80) 0.78 (0.52, 1.18) 0.55 (0.28, 1.10) 
Comprehensive Diabetes Care 0.86 (0.74, 1.00) 1.03 (0.85, 1.25) 1.23 (0.90, 1.68) 
Quality Measures met in 2004       
0 (ref.) 1  1  1  
1 1.32** (1.09, 1.59) 1.13 (0.83, 1.54) 1.06 (0.72, 1.56) 
2 1.76*** (1.49, 2.09) 1.57** (1.22, 2.04) 1.29 (0.85, 1.95) 
3 1.88*** (1.60, 2.20) 1.56** (1.20, 2.01) 1.55* (1.05, 2.28) 
4 1.89*** (1.61, 2.21) 1.65*** (1.28, 2.14) 1.50 (1.00, 2.27) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.48*** (1.23, 1.79) 1.59** (1.13, 2.24) 0.69 (0.43, 1.09) 
65-74 1.46*** (1.20, 1.77) 1.32 (0.93, 1.85) 1.56** (0.38, 0.85) 
75 and older 1.66*** (1.39, 1.98) 1.07 (0.75, 1.53) 0.48*** (0.33, 0.72) 
Male Gender 1.39*** (1.33, 1.45) 0.93 (0.87, 1.01) 1.39*** (1.25, 1.54) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.05 (0.94, 1.17) 1.51*** (1.28, 1.78) 1.72*** (1.32, 2.24) 
Hispanic 1.00 (0.64, 1.56) 1.58 (0.68, 3.64) 0.80 (0.30, 2.11) 
Others 0.79* (0.65, 0.95) 1.19 (0.87, 1.63) 1.63* (1.05, 2.53) 
Unknown 1.02 (0.53, 1.97) 0.99 (0.35, 2.82) 2.17 (0.81, 5.80) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.21*** (1.14, 1.28) 0.97 (0.87, 1.08) 1.65*** (1.29, 2.12) 
1.3<=CDPS<=1.9 1.34*** (1.26, 1.42) 1.05 (0.93, 1.18) 2.36*** (1.88, 2.97) 
CDPS>1.9 1.44*** (1.34, 1.55) 1.08 (0.94, 1.24) 5.07*** (4.03, 6.37) 
Continuous 12-month coverage 0.37*** (0.30, 0.47) 1.63** (1.13, 2.34) 0.57** (0.39, 0.82) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.03 (0.93, 1.12) 0.90 (0.72, 1.12) 1.30* (1.05, 1.60) 
85-90% 1.03 (0.92, 1.17) 0.86 (0.70, 1.05) 1.24 (0.98, 1.56) 
>90% 1.03 (0.90, 1.18) 0.77* (0.60, 0.98) 1.32 (0.97, 1.79) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 0.99 (0.90, 1.08) 1.03 (0.87, 1.23) 0.88 (0.72, 1.08) 
$45,921-$56,813 0.99 (0.88, 1.11) 1.00 (0.80, 1.26) 0.88 (0.68, 1.13) 
>$56,813 1.00 (0.87, 1.15) 1.17 (0.90, 1.51) 0.85 (0.63, 1.15) 
No Previous Complications 0.45*** (0.40, 0.50) 0.98 (0.86, 1.11) 0.87 (0.73, 1.04) 
Eye complications in 2004 3.15*** (2.85, 3.49) N/A  1.96*** (1.48, 1.90) 
Nephropathy in 2004 2.52*** (2.16, 2.93) 1.98*** (1.72, 2.28) N/A  
Neuropathy in 2004 3.58*** (3.20, 4.01) 1.87*** (1.68, 2.08) 1.68*** (0.99, 1.27) 
Ischemic Heart Disease in 2004 4.70*** (4.23, 5.21) 1.19** (1.08, 1.31) 1.12 (1.25, 1.80) 
Lower-limb amputations 2004 1.08 (0.93, 1.27) 1.42*** (1.26, 1.60) 1.50*** (0.78, 1.00) 
Cerebrovascular diseases 2004 1.87*** (1.69, 2.08) 1.12 (1.00, 1.25) 0.88* (0.39, 0.82) 
No. of outpatient visits 2004 1.02*** (1.02, 1.03) 1.00 (1.00, 1.01) 1.00 (0.99, 1.01) 
*p<0.05 **p<0.01 ***p<0.001       
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicare Only 
 Diabetic Neuropathy in 
2005 
Lower-limb Amputations in 
2005 
Ischemic Heart Disease in 
2005 
 N=50,594 N=57,092 N=36,332 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders 
(ref.) 
1  1  1  
Schizophrenia/ paranoid states 0.96 (0.67, 1.39) 0.83 (0.45, 1.54) 1.27 (0.82, 1.97) 
Bipolar disorder 1.22 (0.89, 1.68) 0.88 (0.60, 1.28) 0.66* (0.48, 0.91) 
Depression/ anxiety 0.98 (0.88, 1.08) 0.93 (0.80, 1.09) 0.95 (0.87, 1.05) 
Other mental health disorders 1.09 (0.92, 1.29) 0.93 (0.73, 1.17) 0.95 (0.78, 1.15) 
Any alcohol abuse/ dependence 0.78 (0.55, 1.12) 1.35 (0.94, 1.95) 0.74* (0.58, 0.95) 
Any drug abuse/ dependence 0.71 (0.43, 1.16) 1.01 (0.56, 1.80) 0.63* (0.43, 0.93) 
Comprehensive Diabetes Care 0.79 (0.61, 1.03) 0.72 (0.46, 1.13) 0.85 (0.66, 1.07) 
Quality Measures met in 2004       
0 (ref.) 1  1  1  
1 1.17 (0.84, 1.62) 1.42 (0.94, 2.15) 0.92 (0.70, 1.23) 
2 1.49* (1.09, 2.04) 1.32 (0.87, 2.02) 0.98 (0.74, 1.28) 
3 1.66** (1.24, 2.24) 1.26 (0.86, 1.86) 0.95 (0.74, 1.21) 
4 1.71*** (1.27, 2.31) 1.14 (0.76, 1.72) 0.93 (0.70, 1.23) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.02 (0.74, 1.40) 0.83 (0.56, 1.24) 2.03*** (1.48, 2.79) 
65-74 0.80 (0.63, 1.02) 0.65* (0.46, 0.90) 2.42*** (1.81, 3.23) 
75 and older 0.80 (0.62, 1.04) 0.85 (0.61, 1.17) 3.11*** (2.36, 4.12) 
Male Gender 1.08* (1.00, 1.16) 1.11** (1.03, 1.20) 1.49*** (1.40, 1.58) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.30* (1.04, 1.62) 1.12 (0.82, 1.51) 0.83 (0.66, 1.04) 
Hispanic 1.39 (0.70, 2.77) 0.88 (0.44, 1.79) 0.40* (0.18, 0.88) 
Others 0.53** (0.36, 0.78) 1.23 (0.82, 1.83) 0.93 (0.73, 1.19) 
Unknown 0.60 (0.20, 1.80) 1.64 (0.57, 4.74) 1.27 (0.59, 2.72) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.34*** (1.17, 1.52) 1.18 (0.99, 1.41) 1.25*** (1.16, 1.35) 
1.3<=CDPS<=1.9 1.71*** (1.45, 2.03) 1.68*** (1.37, 2.07) 1.53*** (1.40, 1.67) 
CDPS>1.9 1.96*** (1.65, 2.33) 2.54*** (2.05, 3.14) 1.90*** (1.71, 2.10) 
Continuous 12-month coverage 0.89 (0.65, 1.21) 0.39*** (0.30, 0.51) 0.27*** (0.22, 0.35) 
Percent of High School 
Graduate 
      
<75% (ref.) 1  1  1  
75-84% 1.19 (0.96, 1.47) 0.97 (0.78, 1.20) 1.02 (0.89, 1.17) 
85-90% 1.45* (1.08, 1.92) 0.88 (0.67, 1.15) 0.92 (0.79, 1.07) 
>90% 1.52** (1.14, 2.03) 0.88 (0.65, 1.19) 0.93 (0.78, 1.11) 
Median Household income 
1999 
      
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 0.81* (0.67, 0.98) 0.94 (0.74, 1.19) 1.03 (0.91, 1.16) 
$45,921-$56,813 0.77** (0.63, 0.93) 0.97 (0.75, 1.25) 1.11 (0.97, 1.27) 
>$56,813 0.69** (0.56, 0.86) 0.93 (0.71, 1.22) 1.17 (1.00, 1.38) 
No Previous Complications 0.88* (0.79, 0.99) 0.84* (0.72, 0.99) 1.02 (0.89, 1.18) 
Eye complications in 2004 1.89*** (1.69, 2.11) 1.81*** (1.60, 2.04) 1.18** (1.06, 1.31) 
Nephropathy in 2004 1.80*** (1.55, 2.08) 1.42*** (1.19, 1.70) 1.23* (1.03, 1.46) 
Neuropathy in 2004 N/A  1.70*** (1.50, 1.94) 1.07 (0.98, 1.18) 
Ischemic Heart Disease in 2004 0.99 (0.88, 1.11) 1.14** (1.04, 1.25) N/A  
Lower-limb amputations 2004 1.54*** (1.30, 1.82) N/A  1.05 (0.90, 1.23) 
Cerebrovascular diseases 2004 0.93 (0.84, 1.03) 1.06 (0.94, 1.19) 1.34*** (1.17, 1.53) 
No. of outpatient visits 2004 1.02*** (1.01, 1.02) 1.00 (1.00, 1.01) 1.02*** (1.02, 1.03) 
*p<0.05 **p<0.01 ***p<0.001       
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicare Only 
 Cerebrovascular Disease in 2005 Diabetes-related Hospitalizations in 2005 
 N=51,972 N=60,137 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 1.03 (0.71, 1.48) 0.90 (0.59, 1.38) 
Bipolar disorder 0.98 (0.68, 1.40) 1.22 (0.91, 1.64) 
Depression/ anxiety 1.10 (0.99, 1.23) 1.04 (0.94, 1.14) 
Other mental health disorders 1.16 (0.90, 1.49) 1.06 (0.88, 1.27) 
Any alcohol abuse/ dependence 1.12 (0.85, 1.47) 0.89 (0.68, 1.17) 
Any drug abuse/ dependence 0.89 (0.59, 1.35) 1.16 (0.82, 1.65) 
Comprehensive Diabetes Care 1.14 (0.95, 1.35) 0.79 (0.57, 1.10) 
Quality Measures met in 2004     
0 (ref.) 1  1  
1 0.68** (0.52, 0.90) 1.09 (0.82, 1.45) 
2 0.78 (0.61, 1.00) 1.01 (0.78, 1.31) 
3 0.74* (0.57, 0.95) 0.96 (0.75, 1.21) 
4 0.73** (0.57, 0.92) 0.93 (0.73, 1.18) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.58* (1.12, 2.25) 1.09 (0.73, 1.64) 
65-74 2.08*** (1.50, 2.88) 1.11 (0.76, 1.61) 
75 and older 2.68*** (1.94, 3.71) 1.24 (0.86, 1.79) 
Male Gender 1.09* (1.02, 1.16) 1.14*** (1.07, 1.22) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.83** (0.74, 0.94) 0.86 (0.73, 1.00) 
Hispanic 1.39 (0.79, 2.43) 1.50 (0.95, 2.39) 
Others 0.93 (0.62, 1.38) 0.95 (0.67, 1.35) 
Unknown 1.65 (0.82, 3.30) 1.62 (0.63, 4.19) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.31*** (1.18, 1.46) 1.08 (0.95, 1.22) 
1.3<=CDPS<=1.9 1.46*** (1.28, 1.66) 1.26** (1.10, 1.44) 
CDPS>1.9 1.63*** (1.39, 1.90) 1.50*** (1.31, 1.72) 
Continuous 12-month coverage 0.41*** (0.33, 0.52) 0.38*** (0.21, 0.34) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.06 (0.91, 1.23) 1.03 (0.86, 1.22) 
85-90% 1.14 (0.99, 1.30) 0.96 (0.78, 1.20) 
>90% 1.14 (1.00, 1.30) 0.93 (0.75, 1.16) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.85* (0.74, 0.99) 0.92 (0.79, 1.08) 
$45,921-$56,813 0.82* (0.70, 0.97) 0.98 (0.82, 1.17) 
>$56,813 0.84* (0.72, 0.99) 1.02 (0.83, 1.25) 
No Previous Complications 1.05 (0.92, 1.20) 0.78** (0.66, 0.93) 
Eye complications in 2004 1.10* (1.00, 1.20) 1.27*** (1.14, 1.41) 
Nephropathy in 2004 1.30*** (1.13, 1.49) 1.34*** (1.17, 1.53) 
Neuropathy in 2004 1.15** (1.05, 1.25) 1.22*** (1.10, 1.36) 
Ischemic Heart Disease in 2004 1.63*** (1.46, 1.82) 1.89*** (1.71, 2.07) 
Lower-limb amputations 2004 1.10 (0.97, 1.25) 1.69*** (1.48, 1.93) 
Cerebrovascular diseases 2004 N/A  1.54*** (1.40, 1.69) 
No. of outpatient visits 2004 1.01*** (1.01, 1.02) 1.01* (1.00, 1.01) 
*p<0.05 **p<0.01 ***p<0.001    
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicaid Only 
N=22,302 Full Adherence 2005 HbA1c test 2005 LDL-c test 2005 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 1.83*** (1.47, 2.28) 1.85*** (1.61, 2.12) 2.00*** (1.76, 2.27) 
Bipolar disorder 1.21* (1.03, 1.42) 1.02 (0.86, 1.20) 1.26** (1.07, 1.47) 
Depression/ anxiety 1.15* (1.02, 1.29) 0.95 (0.82, 1.10) 1.04 (0.90, 1.21) 
Other mental health disorders 1.00 (0.73, 1.37) 0.89 (0.75, 1.04) 0.99 (0.82, 1.19) 
Any alcohol abuse/ dependence 0.94 (0.78, 1.14) 1.11 (0.99, 1.25) 1.02 (0.91, 1.13) 
Any drug abuse/ dependence 0.61*** (0.49, 0.75) 0.92 (0.77, 1.11) 0.79*** (0.69, 0.89) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.58*** (1.45, 1.74) 1.76*** (1.66, 1.87) 1.72*** (1.59, 1.86) 
65-74 2.15*** (1.83, 2.54) 2.75*** (2.22, 3.40) 2.74*** (2.29, 3.27) 
75 and older 1.85*** (1.34, 2.53) 2.26*** (1.82, 2.80) 2.05*** (1.72, 2.44) 
Male Gender 0.77** (0.64, 0.93) 1.14** (1.04, 1.24) 1.15*** (1.07, 1.25) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 0.82** (0.70, 0.95) 1.00 (0.91, 1.10) 0.86** (0.76, 0.96) 
Hispanic 0.92 (0.75, 1.13) 0.72*** (0.65, 0.80) 0.69*** (0.57, 0.84) 
Others 1.01 (0.72, 1.42) 1.19* (1.02, 1.39) 1.29** (1.10, 1.51) 
Unknown 0.86 (0.74, 1.00) 0.87** (0.79, 0.96) 0.86** (0.76, 0.96) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 0.98 (0.87, 1.11) 0.65*** (0.61, 0.70) 0.71*** (0.66, 0.77) 
1.3<=CDPS<=1.9 0.79*** (0.70, 0.89) 0.48*** (0.43, 0.53) 0.52*** (0.47, 0.58) 
CDPS>1.9 0.62*** (0.56, 0.70) 0.33*** (0.29, 0.36) 0.35*** (0.31, 0.39) 
Continuous 12-month coverage 1.20* (1.04, 1.38) 1.07 (0.98, 1.17) 1.15** (1.05, 1.25) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 0.90 (0.79, 1.03) 0.83 (0.69, 1.01) 0.84 (0.69, 1.03) 
85-90% 0.88 (0.72, 1.06) 0.92 (0.74, 1.14) 0.92 (0.75, 1.13) 
>90% 0.77 (0.58, 1.04) 0.82 (0.64, 1.06) 0.92 (0.73, 1.17) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 1.07 (0.95, 1.20) 1.23 (0.95, 1.59) 1.21 (0.94, 1.57) 
$45,921-$56,813 1.22* (1.01, 1.47) 1.38* (1.04, 1.83) 1.28 (0.95, 1.73) 
>$56,813 1.20 (0.91, 1.59) 1.42* (1.02, 1.99) 1.37 (0.97, 1.93) 
No Previous Complications 0.97 (0.84, 1.12) 0.81** (0.70, 0.92) 0.78*** (0.71, 0.86) 
Eye complications in 2004 1.80*** (1.55, 2.09) 1.15 (0.99, 1.32) 0.97 (0.84, 1.12) 
Nephropathy in 2004 1.19 (0.87, 1.64) 0.98 (0.80, 1.19) 0.79 (0.60, 1.05) 
Neuropathy in 2004 1.09 (0.91, 1.30) 1.06 (0.93, 1.22) 0.80** (0.71, 0.91) 
Ischemic Heart Disease in 2004 1.03 (0.89, 1.19) 0.77*** (0.70, 0.85) 0.95 (0.85, 1.07) 
Lower-limb amputations 2004 1.22* (1.02, 1.46) 1.17* (1.03, 1.33) 0.86* (0.76, 0.97) 
Cerebrovascular diseases 2004 0.88 (0.70, 1.10) 0.85* (0.72, 0.99) 0.81 (0.66, 1.01) 
No. of outpatient visits 2004 1.08*** (1.07, 1.10) 1.18*** (1.16, 1.20) 1.15*** (1.13, 1.17) 
* p<0.05  **p<0.01 ***p<0.001       
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicaid Only 
N=22,302 Nephropathy test 2005 Eye examination 2005 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 1.76*** (1.53, 2.02) 1.62*** (1.36, 1.93) 
Bipolar disorder 1.46*** (1.30, 1.64) 1.02 (0.89, 1.17) 
Depression/ anxiety 1.11 (0.99, 1.25) 1.04 (0.95, 1.14) 
Other mental health disorders 1.05 (0.88, 1.25) 0.91 (0.75, 1.11) 
Any alcohol abuse/ dependence 1.30*** (1.14, 1.49) 0.86 (0.72, 1.01) 
Any drug abuse/ dependence 1.28*** (1.15, 1.42) 0.69*** (0.61, 0.79) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.17*** (1.11, 1.23) 1.68*** (1.58, 1.79) 
65-74 1.34** (1.13, 1.61) 2.80*** (2.30, 3342) 
75 and older 1.36** (1.12, 1.64) 3.07*** (2.49, 3.80) 
Male Gender 0.76*** (0.71, 0.82) 0.91 (0.82, 1.02) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.93 (0.83, 1.05) 0.98 (0.89, 1.08) 
Hispanic 0.85 (0.74, 0.98) 0.82*** (0.74, 0.91) 
Others 1.02 (0.88, 1.17) 0.99 (0.76, 1.28) 
Unknown 0.81** (0.71, 0.93) 0.90* (0.81, 0.99) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 0.87* (0.78, 0.97) 0.91* (0.84, 0.99) 
1.3<=CDPS<=1.9 0.77*** (0.67, 0.88) 0.70*** (0.62, 0.78) 
CDPS>1.9 0.69*** (0.62, 0.78) 0.49*** (0.43, 0.56) 
Continuous 12-month coverage 1.04 (0.96, 1.13) 1.19** (1.08, 1.31) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.90 (0.77, 1.05) 0.91 (0.78, 1.07) 
85-90% 0.98 (0.82, 1.17) 0.84* (0.71, 0.99) 
>90% 0.85 (0.70, 1.03) 0.83 (0.67, 1.04) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.15 (0.98, 1.36) 1.15 (0.94, 1.41) 
$45,921-$56,813 1.23* (1.01, 1.51) 1.29* (1.01, 1.65) 
>$56,813 1.26 (0.98, 1.62) 1.31 (1.00, 1.71) 
No Previous Complications 0.87 (0.76, 1.01) 0.88* (0.79, 0.99) 
Eye complications in 2004 0.83* (0.72, 0.96) 1.87*** (1.62, 2.17) 
Nephropathy in 2004 1.43** (1.11, 1.84) 0.86 (0.73, 1.02) 
Neuropathy in 2004 0.83* (0.69, 0.99) 1.03 (0.94, 1.14) 
Ischemic Heart Disease in 2004 0.98 (0.85, 1.14) 0.91 (0.82, 1.01) 
Lower-limb amputations 2004 1.31** (1.12, 1.52) 1.12* (1.01, 1.25) 
Cerebrovascular diseases 2004 0.83* (0.69, 0.99) 0.90 (0.77, 1.06) 
No. of outpatient visits 2004 1.12*** (1.11, 1.14) 1.11*** (1.09, 1.12) 
*p<0.05 **p<0.01 ***p<0.001     
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicaid Only 
 Any complications 2005 Eye Complications 2005 Nephropathy 2005 
 N=22,302 N=19,853 N=21,593 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.87* (0.77, 0.98) 1.04 (0.79, 1.36) 0.91 (0.49, 1.69) 
Bipolar disorder 0.94 (0.82, 1.09) 0.71* (0.55, 0.92) 0.80 (0.43, 1.48) 
Depression/ anxiety 1.07 (1.00, 1.16) 1.05 (0.91, 1.23) 0.89 (0.73, 1.08) 
Other mental health disorders 1.01 (0.85, 1.21) 0.96 (0.62, 1.48) 0.72 (0.32, 1.61) 
Any alcohol abuse/ dependence 1.01 (0.82, 1.23) 0.85 (0.65, 1.12) 0.35** (0.19, 0.66) 
Any drug abuse/ dependence 1.00 (0.90, 1.11) 0.88 (0.73, 1.06) 0.85 (0.53, 1.36) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.67*** (0.54, 1.83) 1.44*** (1.28, 1.63) 1.33* (1.04, 1.69) 
65-74 1.47* (1.07, 2.01) 1.75*** (1.29, 2.38) 1.63** (1.14, 2.35) 
75 and older 1.20 (0.92, 1.56) 1.28 (0.71, 2.33) 1.26 (0.72, 2.20) 
Male Gender 1.21*** (1.12, 1.31) 1.12 (0.99, 1.27) 1.35** (1.10, 1.65) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 0.99 (0.93, 1.06) 1.01 (0.84, 1.22) 1.66*** (1.37, 2.02) 
Hispanic 0.68*** (0.59, 0.79) 0.90 (0.68, 1.20) 0.82 (0.53, 1.25) 
Others 0.53*** (0.40, 0.71) 0.82 (0.46, 1.45) 0.72 (0.37, 1.41) 
Unknown 0.74*** (0.67, 0.82) 0.95 (0.80, 1.12) 0.60** (0.43, 0.85) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.03 (0.89, 1.21) 1.05 (0.84, 1.30) 1.04 (0.56, 1.92) 
1.3<=CDPS<=1.9 1.10 (0.94, 1.28) 0.87 (0.69, 1.09) 1.03 (0.54, 1.94) 
CDPS>1.9 1.12 (0.96, 1.32) 0.66** (0.51, 0.84) 1.67* (1.02, 2.75) 
Continuous 12-month coverage 1.04 (0.94, 1.16) 0.97 (0.77, 1.21) 1.18 (0.81, 1.72) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 0.93 (0.80, 1.09) 0.67* (0.48, 0.95) 0.90 (0.63, 1.28) 
85-90% 0.97 (0.77, 1.23) 0.68 (0.46, 1.02) 1.08 (0.67, 1.73) 
>90% 0.89 (0.69, 1.15) 0.73 (0.44, 1.22) 1.11 (0.62, 1.96) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 1.10 (0.97, 1.25) 1.29 (0.93, 1.78) 0.79 (0.55, 1.13) 
$45,921-$56,813 1.02 (0.85, 1.24) 1.32 (0.94, 1.85) 0.99 (0.64, 1.52) 
>$56,813 1.16 (0.92, 1.46) 1.29 (0.77, 2.16) 0.99 (0.59, 1.72) 
No Previous Complications 0.35*** (0.30, 0.41) 0.85 (0.67, 1.07) 0.60** (0.42, 0.85) 
Eye complications in 2004 2.85*** (2.47, 3.28) N/A  2.25*** (1.52, 3.31) 
Nephropathy in 2004 2.44*** (1.99, 2.99) 1.84** (1.22, 2.77) N/A  
Neuropathy in 2004 3.32*** (2.82, 3.90) 2.14*** (1.73, 2.64) 2.31*** (1.77, 3.00) 
Ischemic Heart Disease in 2004 2.88*** (2.51, 3.31) 1.19 (0.96, 1.48) 1.26 (0.96, 1.65) 
Lower-limb amputations 2004 1.47*** (1.25, 1.74) 1.80*** (1.35, 2.42) 1.73** (1.19, 2.52) 
Cerebrovascular diseases 2004 2.17*** (1.82, 2.58) 1.12 (0.80, 1.57) 0.59 (0.30, 1.15) 
No. of outpatient visits 2004 1.03*** (1.02, 1.03) 1.02*** (1.01, 1.03) 1.02*** (1.01, 1.03) 
*p<0.05 **p<0.01 ***p<0.001       
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicaid Only 
 Diabetic Neuropathy 
2005 
Lower-limb Amputations 
2005 
Ischemic Heart Disease 
2005 
 N=20,494 N=21,244 N=19,708 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.88 (0.64, 1.20) 1.04 (0.80, 1.35) 0.79 (0.58, 1.07) 
Bipolar disorder 0.85 (0.65, 1.10) 1.23 (0.87, 1.73) 1.12 (0.82, 1.54) 
Depression/ anxiety 1.03 (0.85, 1.24) 1.09 (0.92, 1.30) 1.09 (0.95, 1.26) 
Other mental health disorders 1.07 (0.69, 1.69) 1.40 (0.99, 1.98) 1.19 (0.89, 1.60) 
Any alcohol abuse/ dependence 1.03 (0.84, 1.26) 1.58** (1.18, 2.11) 1.17 (0.78, 1.77) 
Any drug abuse/ dependence 1.08 (0.80, 1.45) 1.43** (1.10, 1.86) 0.83 (0.62, 1.10) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.41*** (1.20, 1.65) 1.14 (1.00, 1.31) 2.45*** (2.21, 2.72) 
65-74 0.99 (0.66, 1.48) 0.92 (0.57, 1.51) 2.44*** (1.65, 3.60) 
75 and older 0.58* (0.33, 0.99) 1.22 (0.49, 3.04) 2.36** (1.44, 3.87) 
Male Gender 1.15* (1.03, 1.29) 1.24* (1.03, 1.49) 1.27*** (1.13, 1.42) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.26* (1.01, 1.57) 1.00 (0.84, 1.20) 0.86 (0.68, 1.07) 
Hispanic 0.69* (0.50, 0.95) 0.62* (0.42, 0.93) 0.67** (0.52, 0.86) 
Others 0.25*** (0.13, 0.50) 0.36 (0.13, 1.01) 0.58** (0.41, 0.83) 
Unknown 0.69*** (0.58, 0.82) 0.88 (0.69, 1.14) 0.84 (0.62, 1.14) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 0.93 (0.73, 1.19) 0.99 (0.69, 1.42) 0.94 (0.72, 1.24) 
1.3<=CDPS<=1.9 1.11 (0.86, 1.43) 1.25 (0.85, 1.83) 1.04 (0.76, 1.42) 
CDPS>1.9 1.21 (0.88, 1.66) 1.15 (0.80, 1.64) 1.43* (1.06, 1.93) 
Continuous 12-month coverage 1.19 (0.88, 1.60) 1.03 (0.78, 1.34) 1.06 (0.83, 1.35) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.08 (0.71, 1.66) 1.00 (0.74, 1.36) 1.03 (0.85, 1.23) 
85-90% 1.31 (0.63, 2.73) 1.00 (0.65, 1.52) 1.05 (0.86, 1.30) 
>90% 1.25 (0.56, 2.80) 0.57 (0.32, 1.02) 0.99 (0.76, 1.30) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 1.11 (0.70, 1.76) 1.29 (0.97, 1.73) 0.93 (0.79, 1.10) 
$45,921-$56,813 0.96 (0.52, 1.78) 1.26 (0.77, 2.06) 0.96 (0.78, 1.20) 
>$56,813 1.13 (0.53, 2.40) 1.48 (0.93, 2.36) 0.81 (0.63, 1.05) 
No Previous Complications 0.94 (0.67, 1.33) 1.00 (0.72, 1.39) 0.91 (0.65, 1.27) 
Eye complications in 2004 1.92*** (1.53, 2.42) 1.61*** (1.27, 2.05) 0.97 (0.76, 1.23) 
Nephropathy in 2004 1.95*** (1.34, 2.84) 1.44* (1.08, 1.90) 1.17 (0.71, 1.94) 
Neuropathy in 2004 N/A  2.29*** (1.72, 3.05) 1.17 (0.93, 1.47) 
Ischemic Heart Disease in 2004 1.43* (1.07, 1.90) 1.19 (0.88, 1.61) N/A  
Lower-limb amputations 2004 2.79*** (1.84, 4.25) N/A  1.01 (0.69, 1.50) 
Cerebrovascular diseases 2004 1.06 (0.77, 1.46) 1.77** (1.24, 2.51) 1.99** (1.20, 3.31) 
No. of outpatient visits 2004 1.04*** (1.02, 1.05) 1.03*** (1.02, 1.04) 1.04*** (1.03, 1.05) 
*p<0.05 **p<0.01 ***p<0.001       
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicaid Only 
 Cerebrovascular Disease 
2005 
Diabetes-related 
Hospitalizations 2005 
 N=21,512 N=22,302 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.59* (0.38, 0.90) 1.11 (0.83, 1.48) 
Bipolar disorder 0.58 (0.32, 1.05) 1.15 (0.67, 1.98) 
Depression/ anxiety 0.99 (0.78, 1.27) 1.13 (0.94, 1.35) 
Other mental health disorders 0.91 (0.44, 1.85) 0.86 (0.56, 1.30) 
Any alcohol abuse/ dependence 1.45 (0.98, 2.16) 1.10 (0.73, 1.65) 
Any drug abuse/ dependence 1.12 (0.79, 1.59) 1.45* (1.05, 2.01) 
Age Groups     
<55 (ref.) 1  1  
55-64 2.52*** (1.99, 3.21) 1.14 (0.92, 1.41) 
65-74 3.19*** (2.15, 4.75) 1.26 (0.83, 1.92) 
75 and older 3.61*** (1.98, 6.57) 1.21 (0.71, 2.05) 
Male Gender 1.01 (0.80, 1.27) 1.53*** (1.34, 1.74) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.88 (0.62, 1.26) 1.38*** (1.17, 1.64) 
Hispanic 0.40** (0.22, 0.73) 0.53*** (0.40, 0.72) 
Others 0.31** (0.14, 0.67) 0.56* (0.32, 0.98) 
Unknown 0.89 (0.68, 1.18) 0.92 (0.66, 1.28) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.23 (0.82, 1.87) 0.89 (0.62, 1.28) 
1.3<=CDPS<=1.9 1.17 (0.85, 1.60) 0.79 (0.60, 1.05) 
CDPS>1.9 1.27 (0.84, 1.91) 1.01 (0.74, 1.38) 
Continuous 12-month coverage 0.93 (0.64, 1.35) 0.80* (0.66, 0.97) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.81 (0.62, 1.05) 0.94 (0.75, 1.19) 
85-90% 0.85 (0.59, 1.21) 1.07 (0.79, 1.45) 
>90% 0.83 (0.49, 1.42) 0.73 (0.49, 1.09) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.10 (0.78, 1.54) 1.19 (0.85, 1.65) 
$45,921-$56,813 0.90 (0.60, 1.34) 1.19 (0.84, 1.70) 
>$56,813 0.96 (0.59, 1.56) 1.69** (1.17, 2.46) 
No Previous Complications 0.93 (0.67, 1.29) 0.63* (0.40, 0.97) 
Eye complications in 2004 1.43* (1.06, 1.92) 1.15 (0.91, 1.45) 
Nephropathy in 2004 0.70 (0.42, 1.15) 1.41* (1.05, 1.89) 
Neuropathy in 2004 1.00 (0.74, 1.36) 1.60*** (1.33, 1.93) 
Ischemic Heart Disease in 2004 2.11*** (1.49, 2.99) 1.71*** (1.36, 2.15) 
Lower-limb amputations 2004 1.41* (1.01, 1.98) 3.08*** (2.42, 3.94) 
Cerebrovascular diseases 2004 N/A  1.68** (1.23, 2.31) 
No. of outpatient visits 2004 1.03*** (1.01, 1.05) 1.03*** (1.02, 1.05) 
*p<0.05 **p<0.01 ***p<0.001     
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicaid Only 
 Any Complications in 2005 Eye Complications in 2005 Nephropathy in 2005 
 N=22,302 N=19,853 N=21,593 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.85** (0.75, 0.96) 0.94 (0.72, 1.22) 0.90 (0.48, 1.67) 
Bipolar disorder 0.94 (0.81, 1.09) 0.71* (0.55, 0.93) 0.81 (0.44, 1.51) 
Depression/ anxiety 1.08 (1.00, 1.16) 1.06 (0.91, 1.23) 0.90 (0.74, 1.09) 
Other mental health disorders 1.02 (0.86, 1.21) 0.98 (0.64, 1.51) 0.72 (0.32, 1.60) 
Any alcohol abuse/ dependence 1.01 (0.82, 1.24) 0.85 (0.64, 1.12) 0.35** (0.19, 0.66) 
Any drug abuse/ dependence 1.00 (0.90, 1.12) 0.89 (0.73, 1.08) 0.85 (0.53, 1.37) 
Comprehensive Diabetes Care 1.06 (0.71, 1.59) 0.87 (0.55, 1.38) 2.27* (1.08, 4.76) 
Quality Measures met in 2004       
0 (ref.) 1  1  1  
1 1.10 (0.97, 1.24) 1.80*** (1.40, 2.30) 1.09 (0.73, 1.64) 
2 1.19*** (1.09, 1.31) 2.14*** (1.71, 2.68) 1.10 (0.73, 1.66) 
3 1.30*** (1.16, 1.46) 2.85*** (2.27, 3.59) 1.26 (0.92, 1.72) 
4 1.32*** (1.14, 1.53) 2.25*** (1.66, 3.05) 1.24 (0.86, 1.79) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.64*** (1.51, 1.79) 1.35*** (1.19, 1.53) 1.31* (1.02, 1.68) 
65-74 1.40* (1.04, 1.87) 1.49* (1.10, 2.02) 1.57* (1.06, 2.33) 
75 and older 1.15 (0.89, 1.48) 1.09 (0.40, 2.01) 1.20 (0.69, 2.10) 
Male Gender 1.21*** (1.12, 1.31) 1.12 (0.98, 1.27) 1.35** (1.10, 1.67) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.00 (0.93, 1.06) 1.02 (0.84, 1.22) 1.68*** (1.38, 2.03) 
Hispanic 0.69*** (0.60, 0.80) 0.94 (0.71, 1.24) 0.82 (0.54, 1.26) 
Others 0.52*** (0.39, 0.70) 0.80 (0.45, 1.41) 0.71 (0.36, 1.40) 
Unknown 0.74*** (0.67, 0.82) 0.94 (0.80, 1.11) 0.60** (0.42, 0.85) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.05 (0.89, 1.23) 1.11 (0.88, 1.40) 1.05 (0.56, 1.98) 
1.3<=CDPS<=1.9 1.13 (0.96, 1.33) 0.97 (0.76, 1.23) 1.06 (0.54, 2.08) 
CDPS>1.9 1.19* (1.01, 1.39) 0.79 (0.61, 1.01) 1.77* (1.04, 3.03) 
Continuous 12-month coverage 1.04 (0.94, 1.16) 0.97 (0.76, 1.22) 1.17 (0.81, 1.72) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 0.94 (0.80, 1.11) 0.70* (0.49, 0.98) 0.91 (0.63, 1.30) 
85-90% 0.98 (0.77, 1.24) 0.69 (1.46, 1.04) 1.09 (0.68, 1.76) 
>90% 0.89 (0.69, 1.15) 0.73 (0.43, 1.23) 1.12 (0.62, 2.01) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 1.09 (0.96, 1.24) 1.23 (0.89, 1.69) 0.78 (0.54, 1.12) 
$45,921-$56,813 1.00 (0.83, 1.22) 1.23 (0.88, 1.72) 0.97 (0.62, 1.50) 
>$56,813 1.14 (0.90, 1.44) 1.23 (0.73, 2.06) 0.97 (0.56, 1.69) 
No Previous Complications 0.35*** (0.30, 0.41) 0.86 (0.68, 1.09) 0.60** (0.43, 0.85) 
Eye complications in 2004 2.81*** (1.44, 3.24) N/A  2.22*** (1.48, 3.35) 
Nephropathy in 2004 2.45*** (2.01, 3.00) 1.90** (1.23, 2.94) N/A  
Neuropathy in 2004 3.35*** (2.86, 3.93) 2.20*** (1.79, 2.70) 2.33*** (1.79, 3.04) 
Ischemic Heart Disease in 2004 2.91*** (2.53, 3.34) 1.21 (0.97, 1.52) 1.28 (0.98, 1.68) 
Lower-limb amputations 2004 1.47*** (1.25, 1.73) 1.80*** (1.35, 2.41) 1.72** (1.18, 2.50) 
Cerebrovascular diseases 2004 2.18*** (1.83, 2.61) 1.13 (0.81, 1.58) 0.59 (0.30, 1.15) 
No. of outpatient visits 2004 1.02*** (1.01, 1.03) 1.00 (0.99, 1.01) 1.02* (1.00, 1.03) 
*p<0.05 **p<0.01 ***p<0.001       
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicaid Only 
 Diabetic Neuropathy in 
2005 
Lower-limb Amputations in 
2005 
Ischemic Heart Disease in 
2005 
 N=20,494 N=21,244 N=19,708 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders 
(ref.) 
1  1  1  
Schizophrenia/ paranoid states 0.81 (0.58, 1.14) 0.95 (0.74, 1.21) 0.75 (0.55, 1.02) 
Bipolar disorder 0.85 (0.65, 1.10) 1.22 (0.88, 1.69) 1.11 (0.81, 1.53) 
Depression/ anxiety 1.03 (0.86, 1.24) 1.09 (0.91, 1.30) 1.09 (0.95, 1.26) 
Other mental health disorders 1.09 (0.69, 1.72) 1.43* (1.00, 2.03) 1.21 (0.90, 1.63) 
Any alcohol abuse/ dependence 1.05 (0.86, 1.28) 1.58** (1.19, 2.09) 1.18 (0.78, 1.78) 
Any drug abuse/ dependence 1.10 (0.82, 1.49) 1.45** (1.13, 1.85) 0.85 (0.63, 1.13) 
Comprehensive Diabetes Care 0.94 (0.43, 2.06) 0.73 (0.32, 1.64) 0.66 (0.27, 1.62) 
Quality Measures met in 2004       
0 (ref.) 1  1  1  
1 1.42** (1.12, 1.80) 2.10*** (1.56, 2.84) 1.21 (0.81, 1.81) 
2 1.82*** (1.40, 2.37) 1.80*** (1.30, 2.50) 1.50* (1.05, 2.14) 
3 2.07*** (1.56, 2.73) 2.27*** (1.61, 3.22) 1.45 (1.00, 2.10) 
4 2.14*** (1.43, 3.20) 2.14*** (1.43, 3.22) 1.95*** (1.43, 2.66) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.33*** (1.14, 1.56) 1.08 (0.93, 1.26) 2.36*** (2.12, 2.62) 
65-74 0.85 (0.58, 1.25) 0.79 (0.48, 1.31) 2.20*** (1.55, 3.12) 
75 and older 0.51* (0.29, 0.88) 1.06 (0.41, 2.73) 2.16** (1.37, 3.42) 
Male Gender 1.16* (1.03, 1.30) 1.23* (1.02, 1.48) 1.28*** (1.14, 1.44) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.29* (1.04, 1.61) 1.00 (0.84, 1.20) 0.86 (0.69, 1.08) 
Hispanic 0.71* (0.52, 0.99) 0.65* (0.44, 0.94) 0.68** (0.53, 0.87) 
Others 0.25*** (0.12, 0.49) 0.35* (0.12, 0.99) 0.58** (0.41, 0.82) 
Unknown 0.69*** (0.57, 0.82) 0.88 (0.68, 1.14) 0.84 (0.62, 1.14) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 0.96 (0.76, 1.22) 1.03 (0.71, 1.48) 0.96 (0.73, 1.27) 
1.3<=CDPS<=1.9 1.20 (0.93, 1.53) 1.35 (0.92, 1.97) 1.08 (0.80, 1.47) 
CDPS>1.9 1.38 (0.99, 1.91) 1.32 (0.93, 1.87) 1.55** (1.16, 2.06) 
Continuous 12-month coverage 1.19 (0.89, 1.59) 1.06 (0.80, 1.40) 1.06 (0.83, 1.34) 
Percent of High School 
Graduate 
      
<75% (ref.) 1  1  1  
75-84% 1.12 (0.74, 1.70) 1.04 (0.77, 1.41) 1.05 (0.84, 1.27) 
85-90% 1.33 (0.64, 2.78) 1.02 (0.67, 1.56) 1.06 (0.87, 1.31) 
>90% 1.27 (0.57, 2.82) 0.59 (0.33, 1.04) 1.01 (0.77, 1.32) 
Median Household income 
1999 
      
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 1.07 (0.67, 1.70) 1.22 (0.93, 1.60) 0.91 (0.77, 1.07) 
$45,921-$56,813 0.91 (0.49, 1.69) 1.16 (0.72, 1.88) 0.93 (0.75, 1.16) 
>$56,813 1.07 (0.51, 2.26) 1.38 (0.86, 2.20) 0.78 (0.61, 1.01) 
No Previous Complications 0.97 (0.68, 1.37) 1.03 (0.72, 1.46) 0.93 (0.66, 1.29) 
Eye complications in 2004 1.87*** (1.49, 2.34) 1.61*** (1.27, 2.04) 0.92 (0.72, 1.19) 
Nephropathy in 2004 1.97*** (1.35, 2.89) 1.47* (1.09, 1.96) 1.17 (0.71, 1.92) 
Neuropathy in 2004 N/A  2.33*** (1.75, 3.11) 1.18 (0.94, 1.50) 
Ischemic Heart Disease in 2004 1.46* (1.09, 1.95) 1.22 (0.89, 1.66) N/A  
Lower-limb amputations 2004 2.75*** (1.83, 4.13) N/A  1.01 (0.68, 1.49) 
Cerebrovascular diseases 2004 1.08 (0.79, 1.48) 1.81** (1.25, 2.63) 2.01** (1.22, 3.31) 
No. of outpatient visits 2004 1.02** (1.01, 1.03) 1.01* (1.00, 1.02) 1.02*** (1.01, 1.03) 
*p<0.05 **p<0.01 ***p<0.001       
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Medicaid Only 
 Cerebrovascular Disease in 2005 Diabetes-related Hospitalizations in 2005 
 N=21,217 N=22,302 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.57** (0.37, 0.87) 1.00 (0.74, 1.35) 
Bipolar disorder 0.58 (0.33, 1.04) 1.18 (0.69, 2.01) 
Depression/ anxiety 0.99 (0.77, 1.26) 1.15 (0.95, 1.40) 
Other mental health disorders 0.91 (0.45, 1.86) 0.88 (0.59, 1.31) 
Any alcohol abuse/ dependence 1.47 (0.99, 2.18) 1.07 (0.73, 1.56) 
Any drug abuse/ dependence 1.13 (0.81, 1.59) 1.43* (1.05, 1.93) 
Comprehensive Diabetes Care Dropped (Predicts failure completely) 0.48 (0.15, 1.50) 
Quality Measures met in 2004     
0 (ref.) 1  1  
1 Dropped (Predicts failure completely) 3.82*** (2.55, 5.73) 
2 1.09 (0.82, 1.44) 3.37*** (2.15, 5.29) 
3 1.06 (0.79, 1.42) 3.67*** (2.48, 5.43) 
4 1.43* (1.07, 1.93) 2.98*** (1.91, 4.67) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.28 (0.91, 1.80) 1.07 (0.86, 1.33) 
65-74 2.47*** (1.93, 3.15) 1.02 (0.69, 1.51) 
75 and older 3.02*** (2.05, 4.47) 0.98 (0.57, 1.68) 
Male Gender 3.45*** (1.89, 6.27) 1.52 (1.35, 1.72) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.02 (0.81, 1.28) 1.41*** (1.21, 1.63) 
Hispanic 0.89 (0.62, 1.27) 0.56*** (0.42, 0.75) 
Others 0.41** (0.22, 0.74) 0.55* (0.32, 0.95) 
Unknown 0.31** (0.14, 0.67) 0.92 (0.66, 1.28) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 0.90 (0.68, 1.19) 0.95 (0.65, 1.39) 
1.3<=CDPS<=1.9 1.22 (0.81, 1.84) 0.89 (0.67, 1.19) 
CDPS>1.9 1.17 (0.85, 1.61) 1.24 (0.89, 1.73) 
Continuous 12-month coverage 1.42* (1.02, 1.99) 0.85 (0.70, 1.04) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.92 (0.63, 1.35) 0.98 (0.76, 1.26) 
85-90% 0.82 (0.63, 1.07) 1.10 (0.79, 1.51) 
>90% 0.86 (0.60, 1.22) 0.75 (0.51, 1.12) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.82 (0.48, 1.40) 1.11 (0.79, 1.58) 
$45,921-$56,813 1.08 (0.77, 1.52) 1.07 (0.74, 1.56) 
>$56,813 0.87 (0.58, 1.31) 1.55* (1.06, 2.26) 
No Previous Complications 1.29 (0.86, 1.93) 0.65 (0.42, 1.01) 
Eye complications in 2004 0.95 (0.69, 1.32) 1.21 (0.97, 1.53) 
Nephropathy in 2004 1.39* (1.04, 1.85) 1.49** (1.11, 1.99) 
Neuropathy in 2004 0.71 (0.42, 1.18) 1.65*** (1.36, 1.99) 
Ischemic Heart Disease in 2004 1.01 (0.75, 1.37) 1.77*** (1.41, 2.21) 
Lower-limb amputations 2004 2.13*** (1.51, 3.02) 3.06*** (2.41, 3.89) 
Cerebrovascular diseases 2004 N/A  1.73** (1.26, 2.37) 
No. of outpatient visits 2004 0.95 (0.58, 1.55) 1.02* (1.00, 1.03) 
*p<0.05 **p<0.01 ***p<0.001     
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Dual Eligibles 
N=23,735 Full Adherence 2005 HbA1c test 2005 LDL-c test 2005 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 1.17* (1.03, 1.34) 1.20* (1.00, 1.45) 1.30** (1.07, 1.57) 
Bipolar disorder 1.17 (0.98, 1.39) 0.85* (0.74, 0.97) 0.97 (0.85, 1.10) 
Depression/ anxiety 1.05 (0.96, 1.15) 0.89** (0.82, 0.96) 0.91** (0.85, 0.98) 
Other mental health disorders 1.01 (0.85, 1.19) 0.90 (0.77, 1.06) 0.71*** (0.62, 0.82) 
Any alcohol abuse/ dependence 0.83** (0.73, 0.93) 0.79* (0.66, 0.95) 0.70*** (0.62, 0.79) 
Any drug abuse/ dependence 0.72** (0.57, 0.92) 0.76*** (0.66, 0.87) 0.77* (0.63, 0.95) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.23*** (1.11, 1.36) 1.45*** (1.30, 1.61) 1.38*** (1.24, 1.54) 
65-74 1.28*** (1.17, 1.40) 1.35*** (1.22, 1.50) 1.28*** (1.13, 1.44) 
75 and older 1.15* (1.03, 1.28) 1.06 (0.95, 1.18) 0.78*** (0.71, 0.87) 
Male Gender 0.93 (0.87, 1.00) 0.88** (0.82, 0.95) 1.03 (0.96, 1.10) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.01 (0.88, 1.17) 0.99 (0.88, 1.12) 0.88* (0.78, 1.00) 
Hispanic 1.22** (1.06, 1.41) 0.97 (0.82, 1.16) 1.00 (0.89, 1.12) 
Others 1.24*** (1.10, 1.40) 1.28*** (1.14, 1.45) 1.27*** (1.12, 1.43) 
Unknown 0.36* (0.14, 0.92) 0.95 (0.54, 1.65) 1.11 (0.69, 1.77) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.31*** (1.20, 1.42) 1.03 (0.94, 1.12) 0.97 (0.89, 1.05) 
1.3<=CDPS<=1.9 1.20** (1.06, 1.36) 0.965 (0.84, 1.07) 0.77*** (0.71, 0.83) 
CDPS>1.9 1.22* (1.04, 1.43) 0.76*** (0.66, 0.88) 0.62*** (0.56, 0.69) 
Continuous 12-month coverage 1.41*** (1.20, 1.64) 1.35*** (1.18, 1.54) 1.61*** (1.41, 1.85) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.01 (0.85, 1.19) 1.05 (0.91, 1.22) 1.00 (0.87, 1.15) 
85-90% 1.10 (0.83, 1.44) 1.03 (0.85, 1.25) 0.99 (0.82, 1.21) 
>90% 1.10 (0.82, 1.47) 1.11 (0.90, 1.36) 1.02 (0.79, 1.32) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 0.91 (0.83, 1.00) 1.01 (0.86, 1.20) 1.01 (0.87, 1.18) 
$45,921-$56,813 0.86 (0.68, 1.08) 0.99 (0.85, 1.15) 1.00 (0.78, 1.28) 
>$56,813 0.91 (0.73, 1.13) 0.89 (0.74, 1.06) 0.96 (0.75, 1.23) 
No Previous Complications 0.98 (0.91, 1.06) 0.87** (0.79, 0.96) 0.93 (0.82, 1.05) 
Eye complications in 2004 1.70*** (1.57, 1.85) 2.29*** (1.95, 2.69) 1.35*** (1.22, 1.49) 
Nephropathy in 2004 1.10 (1.00, 1.22) 1.55*** (1.24, 1.93) 0.75*** (0.67, 0.85) 
Neuropathy in 2004 1.36*** (1.26, 1.46) 1.95*** (1.67, 2.28) 1.16* (1.01, 1.33) 
Ischemic Heart Disease in 2004 1.11* (1.02, 1.20) 0.88** (0.80, 0.97) 1.19*** (1.08, 1.30) 
Lower-limb amputations 2004 0.92 (0.84, 1.01) 1.32*** (1.14, 1.52) 0.82*** (0.73, 0.91) 
Cerebrovascular diseases 2004 0.97 (0.86, 1.11) 0.89* (0.80, 0.98) 1.01 (0.92, 1.10) 
No. of outpatient visits 2004 1.04*** (1.04, 1.05) 1.02*** (1.02, 1.03) 1.03*** (1.03, 1.04) 
*p<0.05 **p<0.01 ***p<0.001       
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Dual Eligibles 
N=23,735 Nephropathy test 2005 Eye examination 2005 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 1.14* (1.03, 1.26) 1.12 (0.99, 1.26) 
Bipolar disorder 1.22** (1.06, 1.40) 1.07 (0.92, 1.26) 
Depression/ anxiety 1.14*** (1.06, 1.21) 1.02 (0.93, 1.13) 
Other mental health disorders 1.08 (0.94, 1.25) 1.08 (0.95, 1.24) 
Any alcohol abuse/ dependence 1.07 (0.93, 1.23) 0.78*** (0.71, 0.86) 
Any drug abuse/ dependence 1.20* (1.05, 1.39) 0.65*** (0.55, 0.78) 
Age Groups     
<55 (ref.) 1  1  
55-64 0.95 (0.87, 1.04) 1.38*** (1.29, 1.47) 
65-74 0.95 (0.86, 1.05) 1.75*** (1.63, 1.87) 
75 and older 0.99 (0.90, 1.09) 1.70*** (1.57, 1.84) 
Male Gender 0.87*** (0.81, 0.94) 0.91*** (0.87, 0.95) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.06 (0.96, 1.17) 1.27** (1.10, 1.45) 
Hispanic 1.24*** (1.11, 1.39) 1.27*** (1.11, 1.44) 
Others 1.19** (1.05, 1.36) 1.00 (0.91, 1.11) 
Unknown 0.57* (0.37, 0.88) 0.60* (0.39, 0.94) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.40*** (1.31, 1.50) 1.13* (1.02, 1.26) 
1.3<=CDPS<=1.9 1.63*** (1.43, 1.86) 1.01 (0.90, 1.13) 
CDPS>1.9 2.11*** (1.80, 2.47) 0.96 (0.82, 1.11) 
Continuous 12-month coverage 1.04 (0.90, 1.19) 1.29*** (1.17, 1.43) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.98 (0.83, 1.15) 1.07 (0.96, 1.20) 
85-90% 0.99 (0.80, 1.22) 1.09 (0.95, 1.26) 
>90% 0.96 (0.76, 1.22) 1.10 (0.96, 1.27) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.89* (0.81, 0.98) 0.94 (0.86, 1.02) 
$45,921-$56,813 0.96 (0.85, 1.09) 0.95 (0.85, 1.06) 
>$56,813 1.00 (0.84, 1.21) 0.87 (0.75, 1.00) 
No Previous Complications 1.04 (0.96, 1.12) 0.93 (0.85, 1.02) 
Eye complications in 2004 1.06 (0.98, 1.14) 2.65*** (2.41, 2.91) 
Nephropathy in 2004 1.64*** (1.41, 1.91) 1.00 (0.89, 1.12) 
Neuropathy in 2004 1.04 (0.94, 1.14) 1.31*** (1.20, 1.43) 
Ischemic Heart Disease in 2004 1.14** (1.05, 1.24) 0.87*** (0.81, 0.94) 
Lower-limb amputations 2004 1.08 (0.98, 1.19) 0.85** (0.77, 0.93) 
Cerebrovascular diseases 2004 1.02 (0.91, 1.16) 0.93* (0.86, 1.00) 
No. of outpatient visits 2004 1.04*** (1.04, 1.05) 1.04*** (1.03, 1.05) 
*p<0.05 **p<0.01 ***p<0.001     
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Appendix I.  Analyses of diabetes outcomes by type of health coverage: Dual Eligibles 
 Any complications 2005 Eye Complications 2005 Nephropathy 2005 
 N=23,735 N=19,349 N=22,122 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.61*** (0.52, 0.70) 0.70** (0.56, 0.87) 0.52*** (0.39, 0.71) 
Bipolar disorder 0.65*** (0.55, 0.77) 0.57*** (0.43, 0.77) 0.73 (0.52, 1.03) 
Depression/ anxiety 0.88* (0.79, 0.98) 0.85* (0.74, 0.99) 0.74* (0.58, 0.94) 
Other mental health disorders 0.79* (0.64, 0.97) 0.85 (0.68, 1.06) 0.48* (0.26, 0.88) 
Any alcohol abuse/ dependence 1.16* (1.01, 1.34) 0.74* (0.59, 0.93) 0.87 (0.64, 1.20) 
Any drug abuse/ dependence 0.99 (0.83, 1.18) 1.01 (0.74, 1.38) 0.90 (0.63, 1.28) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.58*** (1.43, 1.75) 1.17 (0.98, 1.40) 1.27** (1.06, 1.53) 
65-74 1.75*** (1.53, 2.00) 1.26** (1.07, 1.47) 1.14 (0.97, 1.34) 
75 and older 1.91*** (1.68, 2.18) 0.99 (0.83, 1.18) 1.04 (0.86, 1.25) 
Male Gender 1.10* (1.02, 1.18) 0.83* (0.71, 0.97) 1.40*** (1.20, 1.63) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.03 (0.95, 1.12) 1.45*** (1.25, 1.68) 1.61*** (1.40, 1.85) 
Hispanic 0.88* (0.78, 0.98) 1.44** (1.11, 1.86) 1.25* (1.02, 1.54) 
Others 0.77*** (0.70, 0.86) 1.09 (0.93, 1.27) 1.39** (1.10, 1.74) 
Unknown 0.60 (0.34, 1.05) 0.57 (0.15, 2.17) 1.16 (0.34, 4.00) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.29*** (1.21, 1.39) 1.01 (0.90, 1.14) 1.21 (1.00, 1.47) 
1.3<=CDPS<=1.9 1.57*** (1.43, 1.72) 1.05 (0.88, 1.25) 1.61*** (1.31, 1.97) 
CDPS>1.9 1.80*** (1.63, 1.97) 1.08 (0.90, 1.31) 3.43*** (2.76, 4.27) 
Continuous 12-month coverage 1.02 (0.89, 1.17) 0.92 (0.74, 1.16) 0.98 (0.74, 1.30) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.06 (0.98, 1.15) 0.83* (0.71, 0.97) 1.30 (0.98, 1.72) 
85-90% 1.03 (0.91, 1.15) 0.83* (0.69, 0.99) 1.21 (0.91, 1.59) 
>90% 1.05 (0.87, 1.27) 0.84 (0.65, 1.07) 1.22 (0.81, 1.84) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 0.99 (0.89, 1.09) 1.07 (0.91, 1.25) 0.79* (0.65, 0.97) 
$45,921-$56,813 1.01 (0.87, 1.18) 1.08 (0.88, 1.32) 0.90 (0.72, 1.13) 
>$56,813 0.94 (0.78, 1.14) 1.09 (0.86, 1.39) 0.85 (0.61, 1.18) 
No Previous Complications 0.47*** (0.42, 0.52) 1.06 (0.88, 1.27) 0.84 (0.66, 1.08) 
Eye complications in 2004 2.60*** (2.30, 2.93) N/A  2.19*** (1.85, 2.59) 
Nephropathy in 2004 2.55*** (2.09, 3.10) 1.97*** (1.69, 2.29) N/A  
Neuropathy in 2004 3.04*** (2.63, 3.52) 1.74*** (1.52, 1.99) 1.70*** (1.46, 1.98) 
Ischemic Heart Disease in 2004 3.61*** (3.27, 3.99) 1.24** (1.08, 1.42) 1.34** (1.12, 1.61) 
Lower-limb amputations 2004 1.22* (1.01, 1.46) 1.52*** (1.24, 1.85) 1.50*** (1.25, 1.79) 
Cerebrovascular diseases 2004 1.68*** (1.49, 1.90) 1.12 (0.91, 1.37) 1.05 (0.88, 1.25) 
No. of outpatient visits 2004 1.02*** (1.01, 1.02) 1.00 (0.99, 1.01) 1.00 (0.99, 1.02) 
*p<0.05 **p<0.01 ***p<0.001       
 
 132 
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 Diabetic Neuropathy 
2005 
Lower-limb Amputations 
2005 
Ischemic Heart Disease 
2005 
 N=19,898 N=22,054 N=16,560 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.66*** (0.54, 0.81) 0.70** (0.55, 0.89) 0.58*** (0.48, 0.70) 
Bipolar disorder 0.88 (0.67, 1.17) 0.64* (0.45, 0.90) 0.76* (0.59, 0.99) 
Depression/ anxiety 0.95 (0.84, 1.09) 0.99 (0.86, 1.15) 0.99 (0.87, 1.12) 
Other mental health disorders 0.80 (0.60, 1.08) 0.88 (0.62, 1.23) 0.95 (0.68, 1.32) 
Any alcohol abuse/ dependence 1.22 (0.96, 1.55) 1.49*** (1.20, 1.85) 1.05 (0.85, 1.29) 
Any drug abuse/ dependence 1.04 (0.78, 1.39) 1.47* (1.05, 2.05) 1.02 (0.75, 1.38) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.27** (1.11, 1.46) 1.02 (0.84, 1.23) 2.05*** (1.80, 2.33) 
65-74 1.05 (0.90, 1.23) 1.05 (0.87, 1.27) 2.56*** (2.22, 2.95) 
75 and older 0.95 (0.80, 1.13) 1.22 (0.94, 1.60) 3.27*** (2.81, 3.80) 
Male Gender 0.87 (0.78, 0.98) 1.02 (0.91, 1.14) 1.23*** (1.12, 1.34) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.15 (0.93, 1.41) 0.98 (0.85, 1.12) 0.90 (0.77, 1.06) 
Hispanic 0.88 (0.70, 1.09) 0.93 (0.75, 1.14) 0.86 (0.73, 1.01) 
Others 0.66** (1.49, 0.89) 0.79 (0.59, 1.06) 0.67*** (0.57, 0.79) 
Unknown 0.70 (0.32, 1.51) 1.00 (0.41, 2.44) 0.22** (0.07, 0.68) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.58*** (1.36, 1.84) 1.52*** (1.23, 1.87) 1.44*** (1.27, 1.63) 
1.3<=CDPS<=1.9 2.13*** (1.85, 2.45) 2.24*** (1.72, 2.90) 2.03*** (1.72, 2.41) 
CDPS>1.9 2.18*** (1.73, 2.74) 3.56*** (2.67, 4.75) 2.40*** (2.00, 2.88) 
Continuous 12-month coverage 0.75 (0.56, 1.00) 0.68*** (0.55, 0.84) 0.82 (0.64, 1.06) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.13 (1.00, 1.29) 1.07 (0.86, 1.34) 1.09 (0.92, 1.28) 
85-90% 121 (0.99, 1.48) 0.85 (0.62, 1.17) 0.94 (0.80, 1.09) 
>90% 1.43** (1.14, 1.79) 0.93 (0.59, 1.47) 0.89 (0.70, 1.13) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 0.91 (0.75, 1.11) 1.02 (0.86, 1.22) 1.04 (0.92, 1.18) 
$45,921-$56,813 0.85 (0.70, 1.04) 1.09 (0.87, 1.36) 1.12 (0.92, 1.34) 
>$56,813 0.79 (0.58, 1.09) 0.88 (0.63, 1.18) 1.10 (0.88, 1.38) 
No Previous Complications 0.85* (0.72, 1.00) 0.90 (0.76, 1.06) 1.04 (0.88, 1.24) 
Eye complications in 2004 1.68*** (1.45, 1.96) 1.63*** (1.40, 1.90) 1.10 (0.94, 1.29) 
Nephropathy in 2004 1.70*** (1.33, 2.18) 1.20 (1.00, 1.44) 1.39*** (1.17, 1.65) 
Neuropathy in 2004 N/A  1.70*** (1.44, 2.01) 1.14 (0.99, 1.32) 
Ischemic Heart Disease in 2004 0.99 (0.89, 1.11) 1.15 (1.00, 1.32) N/A  
Lower-limb amputations 2004 1.88*** (1.54, 2.31) N/A  0.99 (0.77, 1.27) 
Cerebrovascular diseases 2004 1.06 (0.91, 1.24) 1.12 (0.95, 1.32) 1.33** (1.12, 1.57) 
No. of outpatient visits 2004 1.01 (0.99, 1.02) 1.00 (0.99, 1.01) 1.02*** (1.01, 1.02) 
*p<0.05 **p<0.01 ***p<0.001       
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 Cerebrovascular Disease 
2005 
Diabetes-related 
Hospitalizations 2005 
 N=21,584 N=23,735 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.45*** (0.32, 0.62) 0.52*** (0.41, 0.66) 
Bipolar disorder 1.00 (0.76, 1.31) 0.88 (0.69, 1.12) 
Depression/ anxiety 0.97 (0.85, 1.10) 0.97 (0.84, 1.10) 
Other mental health disorders 0.86 (0.60, 1.23) 0.94 (0.67, 1.32) 
Any alcohol abuse/ dependence 1.35 (0.92, 1.97) 1.09 (0.87, 1.36) 
Any drug abuse/ dependence 0.90 (0.60, 1.36) 1.75*** (1.35, 2.26) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.79*** (1.45, 2.21) 0.93 (0.81, 1.08) 
65-74 2.32*** (1.86, 2.89) 1.01 (0.86, 1.18) 
75 and older 2.95*** (2.42, 3.58) 1.03 (0.87, 1.23) 
Male Gender 0.92 (0.80, 1.06) 1.12* (1.01, 1.24) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.80** (0.70, 0.92) 0.95 (0.77, 1.16) 
Hispanic 0.93 (0.77, 1.11) 0.91 (0.72, 1.14) 
Others 0.70*** (0.59, 0.82) 0.93 (0.71, 1.22) 
Unknown 0.56 (0.17, 1.86) 1.20 (0.60, 2.40) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 0.24* (1.03, 1.49) 1.23** (1.07, 1.41) 
1.3<=CDPS<=1.9 1.42*** (1.22, 1.67) 1.47*** (1.25, 1.72) 
CDPS>1.9 1.77*** (1.48, 2.11) 1.81*** (1.55, 2.11) 
Continuous 12-month coverage 0.74* (0.57, 0.96) 0.75** (0.61, 0.91) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.96 (0.79, 1.17) 0.95 (0.81, 1.11) 
85-90% 0.87 (0.73, 1.04) 0.85* (0.72, 0.99) 
>90% 0.90 (0.68, 1.18) 0.77 (0.59, 1.02) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.02 (0.82, 1.27) 1.07 (0.89, 1.29) 
$45,921-$56,813 1.16 (0.91, 1.48) 1.38** (1.11, 1.71) 
>$56,813 1.21 (0.92, 1.58) 1.15 (0.87, 1.51) 
No Previous Complications 1.01 (0.86, 1.20) 0.72*** (0.60, 0.86) 
Eye complications in 2004 1.19* (1.04, 1.37) 1.32*** (1.15, 1.52) 
Nephropathy in 2004 1.14 (0.96, 1.37) 1.62*** (1.38, 1.91) 
Neuropathy in 2004 1.14 (0.97, 1.35) 1.25*** (1.11, 1.40) 
Ischemic Heart Disease in 2004 1.50*** (1.33, 1.68) 2.14*** (1.81, 2.52) 
Lower-limb amputations 2004 1.34** (1.10, 1.62) 2.04*** (1.77, 2.34) 
Cerebrovascular diseases 2004 N/A  1.33*** (1.13, 1.55) 
No. of outpatient visits 2004 1.01*** (1.01, 1.02) 1.00 (1.00, 1.01) 
*p<0.05 **p<0.01 ***p<0.001     
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 Any Complications in 2005 Eye Complications in 2005 Nephropathy in 2005 
 N=23,735 N=19,349 N=22,122 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.60*** (0.51, 0.69) 0.69** (0.55, 0.86) 0.52*** (0.38, 0.70) 
Bipolar disorder 0.65*** (0.55, 0.77) 0.57*** (0.43, 0.76) 0.73 (0.52, 1.03) 
Depression/ anxiety 0.87* (0.79, 0.98) 0.85* (0.74, 0.98) 0.74* (0.58, 0.94) 
Other mental health disorders 0.79* (0.65, 0.97) 0.86 (0.69, 1.07) 0.48* (0.26, 0.89) 
Any alcohol abuse/ dependence 1.18* (1.2, 1.36) 0.75* (0.59, 0.94) 0.88 (0.64, 1.21) 
Any drug abuse/ dependence 1.02 (0.85, 1.21) 1.04 (0.76, 1.42) 0.92 (0.65, 1.29) 
Comprehensive Diabetes Care 0.75* (0.57, 0.97) 0.87 (0.57, 1.33) 1.00 (0.62, 1.63) 
Quality Measures met in 2004       
0 (ref.) 1  1  1  
1 1.21* (1.02, 1.44) 1.33 (0.91, 1.94) 1.24 (0.62, 2.49) 
2 1.44*** (1.22, 1.70) 1.52* (1.04, 2.21) 1.34 (0.70, 2.56) 
3 1.62*** (1.40, 1.87) 1.52* (1.06, 2.19) 1.48 (0.75, 2.93) 
4 1.63*** (1.40, 1.91) 1.93*** (1.37, 2.73) 1.54 (0.78, 3.06) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.56*** (1.41, 1.72) 1.15 (0.97, 1.37) 1.26* (1.05, 1.51) 
65-74 1.72*** (1.51, 1.97) 1.23* (1.05, 1.44) 1.13 (0.96, 1.33) 
75 and older 1.90*** (1.66, 2.16) 0.97 (0.82, 1.15) 1.03 (0.85, 1.24) 
Male Gender 1.11** (1.03, 1.19) 0.84* (0.72, 0.98) 1.41*** (1.20, 1.65) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.03 (0.95, 1.12) 1.45*** (1.25, 1.67) 1.61*** (1.40, 1.85) 
Hispanic 0.87* (0.77, 0.98) 1.42** (1.10, 1.83) 1.25* (1.02, 1.53) 
Others 0.76*** (0.68, 0.85) 1.07 (0.92, 1.25) 1.37** (1.09, 1.72) 
Unknown 0.59 (0.34, 1.05) 0.56 (0.15, 2.15) 1.17 (0.34, 4.02) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.28*** (1.19, 1.38) 1.00 (0.89, 1.12) 1.20 (0.98, 1.46) 
1.3<=CDPS<=1.9 1.56*** (1.43, 1.71) 1.03 (0.87, 1.24) 1.60*** (1.30, 1.96) 
CDPS>1.9 1.80*** (1.64, 1.97) 1.08 (0.89, 1.29) 3.42*** (2.76, 4.25) 
Continuous 12-month coverage 1.00 (0.87, 1.15) 0.90 (0.72, 1.13) 0.97 (0.74, 1.29) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.06 (0.98, 1.15) 0.83* (0.71, 0.97) 1.30 (0.99, 1.72) 
85-90% 1.02 (0.91, 1.15) 0.82* (0.68, 0.98) 1.20 (0.91, 1.58) 
>90% 1.05 (0.87, 1.26) 0.83 (0.64, 1.06) 1.22 (0.81, 1.83) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 0.98 (0.89, 1.08) 1.07 (0.91, 1.25) 0.79* (0.65, 0.97) 
$45,921-$56,813 1.01 (0.87, 1.18) 1.09 (0.89, 1.32) 0.90 (0.72, 1.13) 
>$56,813 0.94 (0.78, 1.14) 1.10 (0.87, 1.39) 0.85 (0.61, 1.18) 
No Previous Complications 0.47*** (0.42, 0.52) 1.07 (0.89, 1.28) 0.84 (0.66, 1.08) 
Eye complications in 2004 2.47*** (2.19, 2.78) N/A  2.10*** (1.73, 2.54) 
Nephropathy in 2004 2.50*** (2.05, 3.05) 1.93*** (1.65, 2.25) N/A  
Neuropathy in 2004 3.00*** (2.61, 3.46) 1.72*** (1.51, 1.97) 1.68*** (1.45, 1.95) 
Ischemic Heart Disease in 2004 3.64*** (3.30, 4.01) 1.25** (1.09, 1.43) 1.35** (1.13, 1.61) 
Lower-limb amputations 2004 1.22* (1.01, 1.47) 1.52*** (1.24, 1.87) 1.50*** (1.26, 1.80) 
Cerebrovascular diseases 2004 1.70*** (1.51, 1.92) 1.12 (0.91, 1.38) 1.06 (0.89, 1.26) 
No. of outpatient visits 2004 1.01** (1.00, 1.02) 1.00 (0.99, 1.01) 1.00 (0.99, 1.02) 
*p<0.05 **p<0.01 ***p<0.001       
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 Diabetic Neuropathy in 
2005 
Lower-limb Amputations in 
2005 
Ischemic Heart Disease in 
2005 
 N=19,898 N=22,054 N=16,560 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.65*** (0.53, 0.80) 0.69** (0.54, 0.89) 0.58*** (0.48, 0.69) 
Bipolar disorder 0.87 (0.66, 1.16) 0.63** (0.45, 0.89) 0.76* (0.59, 0.99) 
Depression/ anxiety 0.94 (0.83, 1.08) 0.99 (0.85, 1.15) 0.99 (0.87, 1.12) 
Other mental health disorders 0.81 (0.60, 1.09) 0.87 (0.53, 1.23) 0.95 (0.68, 1.32) 
Any alcohol abuse/ dependence 1.23 (0.97, 1.58) 1.50*** (1.20, 1.86) 1.05 (0.85, 1.30) 
Any drug abuse/ dependence 1.07 (0.80, 1.42) 1.47* (1.05, 2.05) 1.02 (0.75, 1.38) 
Comprehensive Diabetes Care 0.46** (0.27, 0.81) 0.29* (0.11, 0.77) 0.74 (0.49, 1.14) 
Quality Measures met in 2004       
0 (ref.) 1  1  1  
1 1.00 (0.66, 1.52) 1.34 (0.86, 2.08) 1.10 (0.74, 1.65) 
2 1.03 (0.74, 1.45) 1.45 (0.99, 2.13) 1.21 (0.80, 1.83) 
3 1.32 (0.89, 1.95) 1.41 (0.96, 2.06) 1.22 (0.84, 1.77) 
4 1.38 (0.95, 2.00) 1.29 (0.87, 1.89) 1.16 (0.80, 1.70) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.25** (1.09, 1.44) 1.01 (0.84, 1.23) 2.04*** (1.80, 2.32) 
65-74 1.03 (0.88, 1.21) 1.05 (0.86, 1.28) 2.56*** (2.22, 2.95) 
75 and older 0.94 (0.79, 1.12) 1.22 (0.93, 1.60) 3.27*** (2.81, 3.80) 
Male Gender 0.88* (0.78, 0.99) 1.02 (0.91, 1.14) 1.23*** (1.12, 1.35) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 1.15 (0.93, 1.42) 0.98 (0.85, 1.12) 0.91 (0.77, 1.06) 
Hispanic 0.87 (0.70, 1.09) 0.92 (0.75, 1.13) 0.86 (0.72, 1.01) 
Others 0.66** (0.48, 0.90) 0.80 (0.59, 1.08) 0.67*** (0.57, 0.79) 
Unknown 0.70 (0.33, 1.51) 0.99 (0.41, 2.40) 0.22** (0.07, 0.67) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.56*** (1.35, 1.80) 1.52*** (1.23, 1.88) 1.44*** (1.27, 1.63) 
1.3<=CDPS<=1.9 2.10*** (1.83, 2.40) 2.25*** (1.73, 2.92) 2.04*** (1.73, 2.40) 
CDPS>1.9 2.16*** (1.73, 2.69) 3.58*** (2.67, 4.78) 2.41*** (2.00, 2.91) 
Continuous 12-month coverage 0.73* (0.55, 0.99) 0.67*** (0.54, 0.83) 0.82 (0.63, 1.06) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 1.14 (1.00, 1.29) 1.08 (0.86, 1.35) 1.09 (0.92, 1.28) 
85-90% 1.21 (0.98, 1.49) 0.86 (0.63, 1.18) 0.94 (0.80, 1.10) 
>90% 1.41** (1.13, 1.78) 0.93 (0.59, 1.47) 0.89 (0.70, 1.14) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 0.91 (0.75, 1.11) 1.02 (0.85, 1.22) 1.04 (0.92, 1.17) 
$45,921-$56,813 0.86 (0.70, 1.05) 1.08 (0.86, 1.36) 1.11 (0.92, 1.34) 
>$56,813 0.80 (0.58, 1.09) 0.88 (0.65, 1.18) 1.10 (0.87, 1.38) 
No Previous Complications 0.85* (0.73, 1.00) 0.90 (0.76, 1.06) 1.05 (0.88, 1.24) 
Eye complications in 2004 1.57*** (1.36, 1.81) 1.65*** (1.43, 1.90) 1.09 (0.93, 1.28) 
Nephropathy in 2004 1.67*** (1.29, 2.16) 1.20 (1.00, 1.44) 1.39*** (1.17, 1.64) 
Neuropathy in 2004 N/A  1.70*** (1.44, 2.01) 1.14 (0.99, 1.31) 
Ischemic Heart Disease in 2004 0.99 (0.89, 1.11) 1.15* (1.00, 1.32) N/A  
Lower-limb amputations 2004 1.87*** (1.53, 2.29) N/A  0.99 (0.77, 1.26) 
Cerebrovascular diseases 2004 1.06 (0.91, 1.24) 1.12 (0.95, 1.32) 1.33** (1.12, 1.58) 
No. of outpatient visits 2004 1.00 (0.99, 1.02) 1.00 (0.99, 1.01) 1.02*** (1.01, 1.02) 
*p<0.05 **p<0.01 ***p<0.001       
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 Cerebrovascular Disease in 
2005 
Diabetes-related Hospitalizations 
in 2005 
 N=21,584 N=23,735 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.45*** (0.32, 0.62) 0.52*** (0.41, 0.67) 
Bipolar disorder 0.99 (0.75, 1.31) 0.88 (0.69, 1.12) 
Depression/ anxiety 0.97 (0.85, 1.10) 0.97 (0.85, 1.10) 
Other mental health disorders 0.86 (0.60, 1.23) 0.93 (0.66, 1.32) 
Any alcohol abuse/ dependence 1.35 (0.92, 1.97) 1.09 (0.86, 1.37) 
Any drug abuse/ dependence 0.90 (0.60, 1.35) 1.72*** (1.33, 2.22) 
Comprehensive Diabetes Care 0.85 (0.38, 1.88) 0.76 (0.33, 1.73) 
Quality Measures met in 2004     
0 (ref.) 1  1  
1 0.96 (0.64, 1.44) 0.74 (0.54, 1.01) 
2 0.94 (0.64, 1.38) 0.83 (0.64, 1.09) 
3 0.89 (0.59, 1.34) 0.78* (0.61, 0.99) 
4 0.96 (0.67, 1.37) 0.68*** (0.55, 0.83) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.80*** (1.46, 2.21) 0.94 (0.81, 1.08) 
65-74 2.32*** (1.87, 2.89) 1.02 (0.87, 1.19) 
75 and older 2.94*** (2.42, 3.58) 1.04 (0.87, 1.24) 
Male Gender 0.92 (0.80, 1.06) 1.11* (1.01, 1.23) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.80** (0.70, 0.92) 0.95 (0.77, 1.16) 
Hispanic 0.92 (0.77, 1.11) 0.91 (0.72, 1.15) 
Others 0.70*** (0.59, 0.82) 0.94 (0.72, 1.23) 
Unknown 0.56 (0.17, 1.84) 1.20 (0.60, 2.39) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.24* (1.03, 1.48) 1.24** (1.08, 1.42) 
1.3<=CDPS<=1.9 1.42*** (1.22, 1.66) 1.49*** (1.27, 1.74) 
CDPS>1.9 1.76*** (1.47, 2.10) 1.83*** (1.56, 2.14) 
Continuous 12-month coverage 0.74* (0.56, 0.96) 0.75** (0.62, 0.91) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.96 (0.79, 1.17) 0.95 (0.81, 1.12) 
85-90% 0.87 (0.73, 1.04) 0.85* (0.73, 1.00) 
>90% 0.90 (0.68, 1.18) 0.78 (0.59, 1.02) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.02 (0.82, 1.28) 1.07 (0.89, 1.29) 
$45,921-$56,813 1.16 (0.91, 1.48) 1.37** (1.11, 1.69) 
>$56,813 1.21 (0.92, 1.59) 1.15 (0.87, 1.51) 
No Previous Complications 1.01 (0.86, 1.19) 0.72*** (0.60, 0.86) 
Eye complications in 2004 1.19* (1.04, 1.37) 1.38*** (1.21, 1.58) 
Nephropathy in 2004 1.15 (0.96, 1.37) 1.63*** (1.39, 1.92) 
Neuropathy in 2004 1.14 (0.97, 1.34) 1.25*** (1.11, 1.40) 
Ischemic Heart Disease in 2004 1.49*** (1.33, 1.68) 2.13*** (1.81, 2.51) 
Lower-limb amputations 2004 1.34** (1.10, 1.62) 2.03*** (1.76, 2.34) 
Cerebrovascular diseases 2004 N/A  1.33** (1.13, 1.55) 
No. of outpatient visits 2004 1.01*** (1.01, 1.02) 1.01 (1.00, 1.01) 
*p<0.05 **p<0.01 ***p<0.001     
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Appendix II.  ICD-9 and CPT codes for study measures 
Disorders/ Procedures ICD-9 / CPT codes 
Diabetes 250.00, 357.2, 362.0, 362.01, 362.02, 366.41, 648.0 
Type 1 Diabetes 250.41, 250.43, 250.51, 250.53, 250.61, 250.63, 250.01, 250.03, 
250.21, 250.23, 250.31, 250.33 
Type 2 Diabetes 250.20, 250.22, 250.30, 250.32, 250.1, 250.2, 250.3, 250.4, 
250.40, 250.42, 250.5, 250.50, 250.52, 250.6, 250.60, 250.62, 
250.0, 250.00, 250.02, 250.7, 250.70, 250.72, 250.8, 250.80, 
250.82, 250.9, 250.90, 250.92 
Schizophrenia/ paranoid states  
Schizophrenia 295 
Paranoid states 297 
Bipolar disorder 296.0, 296.1, 296.4, 296.5, 296.6, 296.7 
Depression/ anxiety  
Major Depression 296.2, 296.3 
Other Depressions 298.0, 300.4, 309.0, 309.1, 311 
Anxiety states 300.01, 300.02 
Post-Traumatic Stress Disorder 309.81 
Other mental health disorders  
Psychosis ex. Schizophrenia, Paranoid states 298.1-298.4, 298.8-298.9 
Hysteria 300.1 
Phobic disorders 300.2 
Obsessive Compulsive Disorders 300.3 
Neurasthenia 300.5 
Depersonalization syndrome 300.6 
Neurotic disorders 300.7-300.9 
Personality disorders 301 
Sexual deviations and disorders 302 
Physiological malfunction from mental factors 306 
Special syndrome, NOS 307 
Adjustment reactions 308, 309.2-309.4, 309.82, 309.83, 309.89, 309.9 
Disturbance of conduct or emotions 312, 313 
Hyperkinetic syndrome of childhood 314 
Specific delays in development 315 
Psychic factors  316 
Alcohol abuse/ dependence  
Alcoholic psychoses 291 
Alcohol abuse 305.0 
Alcohol gastritis 303 
Alcoholic liver diseases 571.0-571.3 
Drug abuse/ dependence  
Drug psychoses 292 
Drug abuse  305.2-305.9 
Drug dependence 304, 648.3 
Quality Measures for Diabetes Care (CPT)  
HbA1c test 83036 
LDL-c test 80061, 83715, 83716, 83721 
Nephropathy test 81050, 84156, 84160, 84165, 84166, 83518 
Eye examination (CPT) 67101, 67105, 67107, 67108, 67110, 67112, 67141, 67145, 
67208, 67210, 67218, 67227, 67228, 92002, 92004, 92012, 
92014, 92018, 92019, 92225, 92226, 92230, 92235, 92240, 
92250, 92260, 92287, S0625, S3000, S0620, S0621 
If providers are optometrists or ophthalmologists: 99203, 99204, 
99205, 99213, 99214, 99215, 99242, 99243, 99244, 99245 
Eye examination (ICD-9 procedure codes) 14.1-14.5, 14.9, 95.02-95.04, 95.11, 95.12, 95.16, V720 
Diabetes complications  
Eye complications 250.5, 362.0 
Neuropathy 250.6 
Nephropathy 250.4 
Ischemic Heart Disease 410, 411, 412, 413, 414 
Cerebrovascular Disease 431, 432, 433, 434, 435, 436, v1254 
Lower-limb amputations ICD-9: 250.8, v497; CPT: 27880, 27882, 27886, 28800, 28805, 
28810, 28820, 28825  
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Appendix III.  Description of sub-analysis using Medicaid Rx models 
In this analysis, the mental disorder categories, i.e., psychotic/bipolar disorders 
(mrx40) and depression/anxiety disorders (mrx9), generated by Medicaid Rx are 
hierarchical.  This means that individuals identified with psychotic/bipolar disorders and 
depression or an anxiety disorder would not be classified as having depression/anxiety 
under Medicaid Rx classification and vice versa.  Individuals who were in neither of the 
groups were classified as having ‘No mental health disorders’ because the Medicaid Rx 
models cannot identify people with other types of mental health disorders, such as 
personality disorders, which do not use distinct medications (e.g., antipsychotics for 
schizophrenia or bipolar disorder and antidepressants for depression).   The main purpose 
of this analysis was to compare the rates of full adherence to quality measures of diabetes 
care assessed among the three methods of classifying mental health disorders: 1) ICD-9 
codes only; 2) Medicaid Rx models only and 3) combination of both. 
Selection Criteria for sub-analysis: 
 Beneficiaries with Medicaid only were enrolled in Medicaid for at least 10 
months during both years.  For dual-eligibility, beneficiaries were enrolled in Medicare 
Part A and Medicaid for at least 10 months during both years.  Beneficiaries with 
Medicare Advantage or in nursing homes for 90 days or more were excluded.  
Beneficiaries with Medicare only were also excluded because there were no medication 
data available for them in CY2005. This analysis included 46,073 individuals. 
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Classification of Mental health disorders with the combination method, ICD-9 and 
Medicaid Rx  
 In this classification scheme (see Appendix IV on next page), individuals with 
any diagnoses of psychotic/bipolar disorders identified by either method were labeled as 
such while those identified as having depression/ anxiety did not have any 
Psychotic/Bipolar disorders identified by either method. Individuals were classified as 
having ‘other mental health disorders’ if they only had other mental health disorders 
identified by ICD-9 codes but no psychotic/bipolar or depression/anxiety disorders 
detected by either method.  Individuals without any diagnoses by both methods were 
considered as having ‘No mental health disorders’.  
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Appendix IV.  Classification System of Mental health disorders with the combination 
method 
ICD-9 Diagnosis Medicaid Rx Group Decision on mental health 
disorder 
Schizophrenia, bipolar 
disorder 
Psychotic/ bipolar, depression/ 
anxiety, or none 
Psychotic/ bipolar disorders 
Depression/ anxiety Psychotic/ bipolar Psychotic/ bipolar disorders 
Depression/ anxiety Depression/ anxiety, or none  Depression/ anxiety 
Other mental health 
disorders 
Depression/ anxiety Depression/ anxiety 
Other mental health 
disorders 
None Other mental health 
disorders 
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Appendix V.  Results from sub-analysis using Medicaid Rx models 
 Unadjusted analyses showed a general trend for higher rates of full adherence to 
quality measures among people with psychotic/bipolar or depression/anxiety disorders, 
than those of people with diabetes alone, regardless of the method used for identifying 
mental health disorders (see Appendices VII to IX).  Further, such associations remained 
statistically significant even after adjusting for substance use disorders and other 
covariates in the logistic models, regardless of the methods used in assessing mental 
health disorders (see Appendix X). 
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Appendix VI.  Comparison of Mental Disorder Prevalence among the Three Methods 
N= 46,037 Case Detection Methods 
 ICD-9 only Medicaid Rx only ICD-9 & 
Medicaid Rx 
No mental health disorders (%) 26,026 (57) 24,929 (54) 19,267 (42) 
Psychotic/bipolar disorder (%) 5,999 (13) 7,270 (16) 8,861 (19) 
Depression/ anxiety (%) 12,485 (27) 13,838 (30) 17,072 (37) 
Other mental health disorders (%) 1,527 (3) NA 837 (2) 
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Appendix VII. Adherence to Quality Measures in Condensed Mental Disorder Groups by 
ICD-9 codes* 
 Condensed Mental Disorder Groups 
 No mental 
health 
disorders 
Psychotic/ 
bipolar 
Depression/ 
anxiety 
Other mental 
health disorders 
Overall 
No. of beneficiaries 26,026  5,999  12,485  1,527  46,037 
Full adherence in 2005 (%)a,3 4,426 (17) 1,085 (18)5 2,234 (18)5,11 254 (17)7,9,14 7,999 (17) 
Any HbA1c test 2005 (%)a,1 17,467 (67) 4,071 (68)6 7,855 (63)4,8 952 (62)4,8,15 30,345 (66) 
Any Nephropathy test 2005 
(%)a,1 
10,198 (39) 2,965 (49)4 5,555 (44)4,8 642 (42)5,8,13 19,360 (42) 
Any LDL-c test 2005 (%)a,1 15,814 (61) 3,834 (64)4 7,186 (58)4,8 831 (54)4,8,12 27,665 (60) 
Any Eye exam 2005 (%)a,1 11,603 (45) 2,454 (41)4 5,173 (41)4,10 633 (41)5,11,16 19,863 (43) 
* Beneficiaries with Medicare only excluded. 
a  !2test 
Across all mental disorder categories: 
1 p<0.001, 2 p<0.01, 3 p=0.06 
In pairwise comparisons, No mental health disorders vs. Psychotic/Bipolar, depression/ anxiety or other mental health disorders:  
4 p<0.001, 5 p<0.05, 6p=0.3, 7p=0.7 
In pairwise comparisons, Psychotic/Bipolar vs. depression/ anxiety or other mental health disorders: 
8 p<0.001, 9p=0.2, 10p=0.5, 11p=0.7 
In pairwise comparisons between depression/ anxiety and other mental health disorders: 
12 p<0.05, 13 p=0.06, 14p=0.2, 15p=0.7, 16p=1.0 
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Appendix VIII. Adherence to Quality Measures in Mental Disorder Groups by Medicaid 
Rx only* 
 Medicaid Rx Mental Disorder Groups 
 No mental 
health disorders 
Psychotic/ 
bipolar 
Depression/ 
anxiety 
Overall 
No. of beneficiaries (%) 24,929  7,270   13,838  46,037 
Full adherence in 2005 (%)a,1 3,555 (14) 1,444 (20)2 3,000 (22)2,4 7,999 (17) 
Any HbA1c test 2005 (%)a,1 14,516 (58) 5,393 (74)2 10,436 (75)2,5 30,345 (66) 
Any Nephropathy test 2005 
(%)a,1 
8,478 (34) 3,873 (53)2 7,009 (51)2,3 19,360 (42) 
Any LDL-c test 2005 (%)a,1 13,079 (52) 5,007 (69)2 9,579 (69)2,6 27,665 (60) 
Any Eye exam 2005 (%)a,1 9,549 (54) 3,293 (45)2 7,021 (51)2,3 19,863 (43) 
* Beneficiaries with Medicare only excluded.  
a !2 test 
Across all mental disorder categories: 
1  p<0.001 
In pairwise comparisons, i.e., Psychotic/Bipolar vs. No mental health disorders or depression/ anxiety vs. No mental health disorders:  
2 p<0.001 
In pairwise comparisons between Psychotic/Bipolar and depression/ anxiety:  
3 p<0.001, 4 p<0.01, 5p<0.05, 6 p=0.6 
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Appendix IX. Adherence to Quality Measures in Mental Disorder Groups by 
Combination Method of ICD-9 and Medicaid Rx* 
 Medicaid Rx/ICD-9 Mental Disorder Groups 
 No mental 
health 
disorders 
Psychotic/ 
bipolar 
Depression/ 
anxiety 
Other mental 
health 
disorders 
Overall 
No. of beneficiaries 19,267  8,861  17,072  837 46,037 
Full adherence in 2005 (%)a,1 3,002 (16) 1,646 (19)2 3,237 (19)2,7 114 (14)3,6,8 7,999 (17) 
Any HbA1c test 2005 (%)a,1 12,331 (64) 6,159 (70)2 11,426 (67)2,6 429 (51)2,6,8 30,345 (66) 
Any Nephropathy test 2005 
(%)a,1 
6,933 (36) 4,470 (50)2 7,659 (45)2,6 298 (36)4,6,8 19,360 (42) 
Any LDL-c test 2005 (%)a,1 11,136 (58) 5,740 (65)2 10,416 (61)2,6 373 (45)2,6,8 27,665 (60) 
Any Eye exam 2005 (%)a,1 8,153 (42) 3,746 (42)5 7,670 (45)2,6 294 (35)2,6,8 19,863 (43) 
* Beneficiaries with Medicare only excluded. 
a  !2 test 
Across all mental disorder categories: 
1 p<0.001 
In pairwise comparisons, No mental health disorders vs. Psychotic/Bipolar, depression/ anxiety or other mental health disorders: 
2 p<0.001, 3 p=0.1, 4p=0.8, 5p=0.9 
In pairwise comparisons, Psychotic/Bipolar vs. depression/ anxiety or other mental health disorders:  
6 p<0.001, 7p=0.5 
In pairwise comparisons between depression/ anxiety and other mental health disorders:  
8 p<0.001 
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Appendix X. Comparisons of logistic models using different case detection methods with Full Adherence 
in 2005 as outcome 
N=46,037 ICD-9 only Medicaid Rx Only ICD-9 & Medicaid Rx 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Psychotic/ bipolar disorders 1.35*** (1.22, 1.50) 1.50*** (1.33, 1.70) 1.36*** (1.23, 1.51) 
Depression/ anxiety 1.10* (1.02, 1.17) 1.27*** (1.17, 1.39) 1.12** (1.05, 1.19) 
Other mental health disorders 1.01 (0.85, 1.20) N/A  0.95 (0.74, 1.21) 
Any alcohol abuse/ dependence 0.87** (0.79, 0.97) 0.87** (0.78, 0.96) 0.87** (0.78, 0.96) 
Any drug abuse/ dependence 0.66*** (0.56, 0.79) 0.66*** (0.55, 0.79) 0.66*** (0.55, 0.79) 
Age Groups       
<55 (ref.) 1  1  1  
55-64 1.47*** (1.38, 1.57) 1.46*** (1.37, 1.57) 1.47*** (1.37, 1.57) 
65-74 1.50*** (1.39, 1.62) 1.55*** (1.43, 1.67) 1.52*** (1.40, 1.64) 
75 and older 1.33*** (1.22, 1.46) 1.39*** (1.27, 1.52) 1.35*** (1.24, 1.47) 
Male Gender 0.90* (0.82, 0.98) 0.91* (0.83, 1.00) 0.90* (0.83, 0.98) 
Race/ethnicity       
Non-Hispanic white (ref.) 1  1  1  
African American 0.97 (0.87, 1.08) 0.99 (0.88, 1.11) 0.988 (0.88, 1.09) 
Hispanic 1.087 (0.94, 1.24) 1.09 (0.94, 1.25) 1.08 (0.94, 1.24) 
Others 1.20*** (1.09, 1.32) 1.22*** (1.11, 1.35) 1.21*** (1.10, 1.33) 
Unknown 0.82** (0.71, 0.95) 0.82** (0.72, 0.95) 0.82** (0.71, 0.95) 
CDPS score in 2004       
CDPS<0.8 (ref.) 1  1  1  
0.8<=CDPS<1.3 1.19*** (1.10, 1.30) 1.19*** (1.09, 1.29) 1.19*** (1.10, 1.30) 
1.3<=CDPS<=1.9 1.04 (0.91, 1.18) 1.04 (0.91, 1.18) 1.04 (0.91, 1.19) 
CDPS>1.9 0.92 (0.80, 1.06) 0.93 (0.81, 1.06) 0.93 (0.81, 1.06) 
Health coverage type       
Medicaid only (ref.) 1  1  1  
Dual-eligible 1.76*** (1.59, 1.95) 1.70*** (1.55, 1.87) 1.75*** (1.58, 1.93) 
Continuous 12-month coverage 1.37*** (1.24, 1.51) 1.35*** (1.22, 1.49) 1.36*** (1.23, 1.50) 
Percent of High School Graduate       
<75% (ref.) 1  1  1  
75-84% 0.97 (0.84, 1.11) 0.97 (0.84, 1.12) 0.97 (0.84, 1.12) 
85-90% 1.01 (0.81, 1.26) 1.01 (0.82, 1.26) 1.02 (0.82, 1.26) 
>90% 0.98 (0.78, 1.22) 0.99 (0.79, 1.23) 0.99 (0.79, 1.23) 
Median Household income 1999       
<$36,448 (ref.) 1  1  1  
$36,448-$45,920 0.96 (0.90, 1.03) 0.96 (0.90, 1.03) 0.96 (0.90, 1.03) 
$45,921-$56,813 0.96 (0.81, 1.14) 0.96 (0.81, 1.13) 0.96 (0.80, 1.14) 
>$56,813 0.99 (0.83, 1.18) 0.99 (0.83, 1.18) 0.99 (0.82, 1.18) 
No Previous Complications 0.98 (0.92, 1.05) 0.98 (0.92, 1.05) 0.98 (0.92, 1.05) 
Eye complications in 2004 1.74*** (1.61, 1.88) 1.76*** (1.62, 1.90) 1.74*** (1.62, 1.88) 
Nephropathy in 2004 1.19*** (1.09, 1.30) 1.19*** (1.09, 1.30) 1.19*** (1.09, 1.30) 
Neuropathy in 2004 1.30*** (1.20, 1.41) 1.29*** (1.19, 1.39) 1.29*** (1.20, 1.40) 
Ischemic Heart Disease in 2004 1.09* (1.00, 1.19) 1.09* (1.00, 1.18) 1.09* (1.00, 1.18) 
Lower-limb amputations 2004 1.03 (0.94, 1.12) 1.02 (0.94, 1.11) 1.02 (0.94, 1.11) 
Cerebrovascular diseases 2004 0.96 (0.86, 1.07) 0.95 (0.86, 1.06) 0.96 (0.86, 1.06) 
No. of outpatient visits 2004 1.06*** (1.06, 1.07) 1.06*** (1.05, 1.06) 1.06*** (1.05, 1.06) 
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XI. Cross-tabulation of Cases between ICD-9 codes and Medicaid Rx  
Key 
Frequency (N) 
Row percentage 
Column percentage 
           
 Mental health disorders by Medicaid Rx  
Mental health 
disorders by 
ICD-9 codes 
No mental 
health disorders 
Psychotic/ 
bipolar disorder 
Depression/ 
anxiety 
disorder 
Total 
19,694 481 6,409 26,584 
74.08 1.81 24.11 100.00 
No mental 
health disorders 
77.22 6.44 45.31 56.43 
922 4,513 727 6,162 
14.96 73.24 11.80 100.00 
Psychotic/ 
bipolar disorder 
3.61 60.46 5.14 13.08 
4,027 2,301 6,470 12,798 
31.47 17.98 50.55 100.00 
Depression/ 
anxiety disorder 
15.79 30.83 45.74 27.16 
862 169 538 1,569 
54.94 10.77 34.29 100.00 
Other mental 
health disorders 
3.38 2.26 3.80 3.33 
25,505 7,464 14,144 47,113 
54.14 15.84 30.02 100.00 
Total 
100.00 100.00 100.00 100.00 
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Appendix XII. Analytic models used in the study (Outcome: Full Adherence in 2005) 
N=106,174 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.80*** (0.72, 0.88) 1.15* (1.02, 1.29) 1.02 (0.91, 1.14) 
Bipolar disorder 0.81*** (0.72, 0.90) 1.06 (0.97, 1.17) 0.98 (0.90, 1.07) 
Depression/ anxiety 0.86** (0.79, 0.94) 0.97 (0.92, 1.03) 0.96 (0.91, 1.01) 
Other mental health disorders 0.86** (0.77, 0.95) 0.89* (0.81, 0.99) 0.88* (0.79, 0.97) 
Any alcohol abuse/ dependence 0.67*** (0.61, 0.73) 0.71*** (0.65, 0.78) 0.71*** (0.65, 0.78) 
Any drug abuse/ dependence 0.48*** (0.42, 0.54) 0.65*** (0.57, 0.73) 0.67*** (0.59, 0.76) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   1.83*** (1.72, 1.95) 1.56*** (1.47, 1.66) 
65-74   2.76*** (2.50, 3.05) 1.69*** (1.58, 1.80) 
75 and older   2.34*** (2.09, 2.61) 1.41*** (1.31, 1.51) 
Male Gender N/A  1.07* (1.02, 1.12) 1.02 (0.98, 1.07) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   0.78*** (0.68, 0.90) 0.82** (0.72, 0.94) 
Hispanic   0.78*** (0.69, 0.89) 0.91 (0.79, 1.04) 
Others   0.87** (0.79, 0.96) 0.93 (0.85, 1.00) 
Unknown   0.42*** (0.38, 0.47) 0.66*** (0.57, 0.77) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.55*** (1.49, 1.62) 1.57*** (1.50, 1.65) 
1.3<=CDPS<=1.9   1.72*** (1.60, 1.85) 1.80*** (1.66, 1.95) 
CDPS>1.9   1.82*** (1.71, 1.95) 1.96*** (1.83, 2.10) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.46*** (0.38, 0.55) 
Dual-eligible     0.97 (0.90, 1.05) 
Continuous 12-month coverage N/A  N/A  1.79*** (1.63, 1.96) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     0.99 (0.90, 1.09) 
85-90%     1.00 (0.85, 1.19) 
>90%     1.06 (0.89, 1.28) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     0.94 (0.87, 1.02) 
$45,921-$56,813     1.00 (0.90, 1.11) 
>$56,813     1.02 (0.89, 1.16) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Full Adherence in 2005) 
N=106,174 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 1.13* (1.01, 1.27) 1.22** (1.08, 1.37) 
Bipolar disorder 1.07 (0.98, 1.18) 1.05 (0.95, 1.15) 
Depression/ anxiety 0.99 (0.94, 1.04) 0.95* (0.90, 1.00) 
Other mental health disorders 0.90* (0.81, 1.00) 0.88* (0.79, 0.98) 
Any alcohol abuse/ dependence 0.75*** (0.69, 0.83) 0.79*** (0.71, 0.86) 
Any drug abuse/ dependence 0.69*** (0.60, 0.78) 0.67*** (0.59, 0.76) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.46*** (1.38, 1.55) 1.42*** (1.34, 1.51) 
65-74 1.61*** (1.51, 1.72) 1.62*** (1.52, 1.73) 
75 and older 1.38*** (1.28, 1.48) 1.39*** (1.30, 1.49) 
Male Gender 1.01 (0.96, 1.06) 1.04 (0.98, 1.10) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.79*** (0.69, 0.90) 0.91* (0.84, 0.99) 
Hispanic 0.92 (0.79, 1.06) 1.03 (0.90, 1.19) 
Others 0.94 (0.87, 1.02) 1.03 (0.94, 1.13) 
Unknown 0.68*** (0.58, 0.79) 0.77*** (0.67, 0.89) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.42*** (1.36, 1.48) 1.27*** (1.21, 1.32) 
1.3<=CDPS<=1.9 1.51*** (1.40, 1.62) 1.20*** (1.10, 1.30) 
CDPS>1.9 1.50*** (1.42, 1.60) 1.08 (1.00, 1.16) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.50*** (0.42, 0.60) 0.53*** (0.46, 0.61) 
Dual-eligible 0.93* (0.87, 0.99) 0.91* (0.84, 1.00) 
Continuous 12-month coverage 1.74*** (1.58, 1.91) 1.66*** (1.52, 1.83) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.00 (0.90, 1.10) 1.00 (0.90, 1.10) 
85-90% 1.02 (0.85, 1.21) 1.00 (0.86, 1.17) 
>90% 1.09 (0.90, 1.32) 1.07 (0.90, 1.26) 
Median Household income 1999     
<$36,44 (ref.) 1  1  
$36,448-$45,920 0.95 (0.87, 1.04) 0.95 (0.88, 1.02) 
$45,921-$56,813 1.00 (0.90, 1.11) 1.00 (0.90, 1.11) 
>$56,813 1.01 (0.88, 1.17) 1.02 (0.89, 1.17) 
No Previous Complications 0.97 (0.92, 1.02) 0.96 (0.92, 1.01) 
Eye complications in 2004 1.64*** (1.54, 1.74) 1.63*** (1.53, 1.73) 
Nephropathy in 2004 1.29*** (1.22, 1.35) 1.29*** (1.21, 1.37) 
Neuropathy in 2004 1.36*** (1.30, 1.42) 1.31*** (1.25, 1.38) 
Ischemic Heart Disease in 2004 1.10** (1.03, 1.17) 1.01 (0.95, 1.08) 
Lower-limb amputations 2004 0.92** (0.86, 0.97) 0.88*** (0.83, 0.94) 
Cerebrovascular diseases 2004 0.97 (0.93, 1.02) 0.94* (0.90, 0.99) 
No. of outpatient visits 2004 N/A  1.05*** (1.05, 1.06) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having at least 1 HbA1c test in 2005) 
N=106,174 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.94 (0.86, 1.02) 1.66*** (1.50, 1.84) 1.28*** (1.16, 1.41) 
Bipolar disorder 0.66*** (0.59, 0.74) 1.11 (0.98, 1.25) 0.92 (0.83, 1.02) 
Depression/ anxiety 0.70*** (0.61, 0.81) 0.98 (0.90, 1.06) 0.91** (0.85, 0.98) 
Other mental health disorders 0.80*** (0.72, 0.89) 1.00 (0.91, 1.09) 0.95 (0.87, 1.04) 
Any alcohol abuse/ dependence 0.75*** (0.68, 0.82) 0.88* (0.80, 0.97) 0.85** (0.77, 0.94) 
Any drug abuse/ dependence 0.53*** (0.49, 0.58) 0.85** (0.76, 0.95) 0.89 (0.78, 1.01) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   2.33*** (2.21, 2.46) 2.01*** (1.90, 2.12) 
65-74   3.62*** (3.14, 4.17) 1.99*** (1.87, 2.12) 
75 and older   2.93*** (2.48, 3.46) 1.57*** (1.46, 1.68) 
Male Gender N/A  1.11*** (1.05, 1.16) 1.05* (1.00, 1.09) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   0.99** (0.84, 0.97) 0.90* (0.84, 0.98) 
Hispanic   0.58*** (0.52, 0.65) 0.64*** (0.58, 0.70) 
Others   1.07 (0.98, 1.17) 1.03 (0.94, 1.14) 
Unknown   0.45*** (0.41, 0.49) 0.69*** (0.62, 0.77) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.07** (1.03, 1.11) 1.15*** (1.11, 1.19) 
1.3<=CDPS<=1.9   1.00 (0.93, 1.08) 1.16*** (1.10, 1.23) 
CDPS>1.9   0.84*** (0.78, 0.90) 1.02 (0.97, 1.08) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.41*** (0.37, 0.49) 
Dual-eligible     1.30*** (1.20, 1.40) 
Continuous 12-month coverage N/A  N/A  1.48*** (1.33, 1.65) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     0.94 (0.85, 1.05) 
85-90%     0.97 (0.85, 1.11) 
>90%     0.93 (0.76, 1.14) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     1.10 (0.97, 1.24) 
$45,921-$56,813     1.14 (0.99, 1.30) 
>$56,813     1.07 (0.88, 1.30) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
 
 151 
Appendix XII. Analytic models used in the study (Outcome: Having at least 1 HbA1c test in 2005) 
N=106,174 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 1.45*** (1.32, 1.59) 1.51*** (1.38, 1.66) 
Bipolar disorder 1.02 (0.92, 1.12) 0.98 (0.89, 1.07) 
Depression/ anxiety 0.94 (0.88, 1.01) 0.89** (0.83, 0.96) 
Other mental health disorders 0.96 (0.87, 1.06) 0.94 (0.86, 1.02) 
Any alcohol abuse/ dependence 0.89* (0.81, 0.98) 0.92 (0.84, 1.01) 
Any drug abuse/ dependence 0.91 (0.79, 1.05) 0.90 (0.79, 1.02) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.84*** (1.75, 1.94) 1.74*** (1.65, 1.84) 
65-74 1.92*** (1.79, 2.05) 1.89*** (1.76, 2.03) 
75 and older 1.55*** (1.44, 1.66) 1.52*** (1.41, 1.64) 
Male Gender 1.02 (0.98, 1.07) 1.05* (1.00, 1.10) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.85*** (0.78, 0.93) 1.00 (0.93, 1.07) 
Hispanic 0.66*** (0.60, 0.72) 0.75*** (0.69, 0.83) 
Others 1.08 (0.98, 1.19) 1.19*** (1.08, 1.31) 
Unknown 0.72*** (0.64, 0.80) 0.82*** (0.74, 0.91) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.00 (0.96, 1.05) 0.88*** (0.85, 0.91) 
1.3<=CDPS<=1.9 0.92* (0.87, 0.98) 0.73*** (0.68, 0.79) 
CDPS>1.9 0.71*** (0.67, 0.75) 0.52*** (0.48, 0.55) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.46*** (0.38, 1.56) 0.48*** (0.41, 0.57) 
Dual-eligible 1.22*** (1.14, 1.31) 1.23*** (1.12, 1.35) 
Continuous 12-month coverage 1.42*** (1.27, 1.60) 1.32*** (1.18, 1.47) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.95 (0.84, 1.06) 0.95 (0.85, 1.08) 
85-90% 0.98 (0.84, 1.14) 0.97 (0.82, 1.14) 
>90% 0.96 (0.77, 1.19) 0.94 (0.76, 1.17) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.11 (0.96, 1.28) 1.10 (0.94, 1.28) 
$45,921-$56,813 1.14 (0.98, 1.33) 1.12 (0.96, 1.32) 
>$56,813 1.07 (0.86, 1.32) 1.06 (0.86, 1.30) 
No Previous Complications 0.93* (0.88, 0.98) 0.92** (0.87, 0.97) 
Eye complications in 2004 2.20*** (1.98, 2.45) 2.19*** (0.98, 2.43) 
Nephropathy in 2004 1.59*** (1.44, 1.75) 1.60*** (1.43, 1.79) 
Neuropathy in 2004 2.01*** (1.85, 2.18) 1.93*** (1.77, 2.10) 
Ischemic Heart Disease in 2004 1.04 (0.98, 1.10) 0.94* (0.88, 0.99) 
Lower-limb amputations 2004 1.27*** (1.18, 1.36) 1.21*** (1.13, 1.31) 
Cerebrovascular diseases 2004 0.98 (0.93, 1.03) 0.93** (0.88, 0.98) 
No. of outpatient visits 2004 N/A  1.07*** (1.06, 1.08) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having at least 1 LDL-c test in 2005) 
N=106,174 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.94 (0.87, 1.01) 1.68*** (1.51, 1.87) 1.39*** (1.27, 1.52) 
Bipolar disorder 0.70*** (0.63, 0.78) 1.21*** (1.09, 1.34) 1.07 (0.96, 1.18) 
Depression/ anxiety 0.69*** (0.60, 0.79) 0.98 (0.91, 1.06) 0.95 (0.88, 1.02) 
Other mental health disorders 0.69*** (0.63, 0.77) 0.88** (0.81, 0.97) 0.86** (0.78, 0.94) 
Any alcohol abuse/ dependence 0.66*** (0.62, 0.71) 0.79*** (0.73, 0.84) 0.77*** (0.72, 0.83) 
Any drug abuse/ dependence 0.48*** (0.43, 0.53) 0.79*** (0.70, 0.90) 0.83** (0.72, 0.95) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   2.18*** (2.10, 2.26) 1.86*** (1.77, 1.95) 
65-74   4.09*** (3.61, 4.62) 2.07*** (1.94, 2.20) 
75 and older   2.46*** (2.17, 2.80) 1.20*** (1.13, 1.29) 
Male Gender N/A  1.18*** (1.13, 1.23) 1.10*** (1.06, 1.15) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   0.67*** (0.62, 0.73) 0.72*** (0.65, 0.81) 
Hispanic   0.55*** (0.50, 0.61) 0.66*** (0.58, 0.76) 
Others   0.98 (0.89, 1.07) 1.06 (0.97, 1.16) 
Unknown   0.44*** (0.40, 0.49) 0.70*** (0.61, 0.81) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.09*** (1.04, 1.14) 1.13*** (1.08, 1.18) 
1.3<=CDPS<=1.9   0.91** (0.84, 0.97) 0.99 (0.94, 1.05) 
CDPS>1.9   0.67*** (0.62, 0.73) 0.77*** (0.72, 0.82) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.36*** (0.31, 0.43) 
Dual-eligible     0.95 (0.89, 1.01) 
Continuous 12-month coverage N/A  N/A  1.76*** (1.62, 1.91) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     0.86 (0.73, 1.01) 
85-90%     0.84 (0.68, 1.03) 
>90%     0.83 (0.64, 1.07) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     1.22 (0.99, 1.50) 
$45,921-$56,813     1.28* (1.00, 1.63) 
>$56,813     1.31 (0.99, 1.73) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Having at least 1 LDL-c test in 2005) 
N=106,174 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 1.49*** (1.37, 1.62) 1.55*** (1.42, 1.69) 
Bipolar disorder 1.11* (1.00, 1.23) 1.08 (0.97, 1.19) 
Depression/ anxiety 0.96 (0.89, 1.03) 0.91* (0.85, 0.98) 
Other mental health disorders 0.86** (0.78, 0.94) 0.84*** (0.76, 0.92) 
Any alcohol abuse/ dependence 0.79*** (0.74, 0.85) 0.82*** (0.76, 0.89) 
Any drug abuse/ dependence 0.85* (0.74, 0.98) 0.84** (0.74, 0.95) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.73*** (1.65, 1.82) 1.65*** (1.57, 1.73) 
65-74 1.92*** (1.80, 2.04) 1.90*** (1.79, 2.03) 
75 and older 1.10** (1.03, 1.18) 1.08* (1.01, 1.17) 
Male Gender 1.06** (1.03, 1.10) 1.09*** (1.04, 1.13) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.73*** (0.65, 0.82) 0.85*** (0.79, 0.92) 
Hispanic 0.68*** (0.59, 0.79) 0.77*** (0.67, 0.89) 
Others 1.11* (1.01, 1.21) 1.22*** (1.12, 1.34) 
Unknown 0.72*** (0.62, 0.83) 0.82** (0.73, 0.93) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.03 (0.99, 1.07) 0.92** (0.88, 0.97) 
1.3<=CDPS<=1.9 0.86*** (0.81, 0.90) 0.69*** (0.65, 0.73) 
CDPS>1.9 0.64*** (0.60, 0.67) 0.47*** (0.44, 0.51) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.39*** (0.33, 0.46) 0.41*** (0.36, 0.47) 
Dual-eligible 0.92* (0.87, 0.98) 0.93 (0.86, 1.00) 
Continuous 12-month coverage 1.73*** (1.60, 1.88) 1.63*** (1.51, 1.76) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.86 (0.73, 1.01) 0.87 (0.73, 1.02) 
85-90% 0.85 (0.69, 1.04) 0.83 (0.69, 1.01) 
>90% 0.85 (0.66, 1.09) 0.83 (0.66, 1.03) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.22 (0.99, 1.49) 1.22 (0.98, 1.51) 
$45,921-$56,813 1.27 (1.00, 1.60) 1.26 (0.97, 1.63) 
>$56,813 1.30 (0.99, 1.70) 1.30 (0.98, 1.72) 
No Previous Complications 0.90*** (0.86, 0.94) 0.89*** (0.85, 0.93) 
Eye complications in 2004 1.25*** (1.17, 1.32) 1.22*** (1.15, 1.30) 
Nephropathy in 2004 0.88*** (0.81, 0.94) 0.86** (0.79, 0.95) 
Neuropathy in 2004 1.16*** (1.10, 1.22) 1.10** (1.03, 1.17) 
Ischemic Heart Disease in 2004 1.31*** (1.23, 1.39) 1.20*** (1.13, 1.28) 
Lower-limb amputations 2004 0.82*** (0.77, 0.88) 0.78*** (0.74, 0.83) 
Cerebrovascular diseases 2004 1.04 (0.99, 1.10) 1.00 (0.95, 1.05) 
No. of outpatient visits 2004 N/A  1.07*** (1.06, 1.07) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having at least 1 Nephropathy test in 2005) 
N=106,174 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 1.13** (1.05, 1.23) 1.48*** (1.37, 1.61) 1.26*** (1.17, 1.36) 
Bipolar disorder 1.19** (1.06, 1.34) 1.46*** (1.32, 1.62) 1.31*** (1.20, 1.43) 
Depression/ anxiety 1.06 (0.96, 1.18) 1.17*** (1.11, 1.23) 1.13*** (1.07, 1.19) 
Other mental health disorders 1.05 (0.98, 1.13) 1.06 (0.98, 1.15) 1.03 (0.95, 1.11) 
Any alcohol abuse/ dependence 0.99 (0.93, 1.05) 1.01 (0.95, 1.08) 1.00 (0.93, 1.07) 
Any drug abuse/ dependence 0.94 (0.87, 1.00) 1.12** (1.03, 1.21) 1.17*** (1.07, 1.27) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   1.48*** (1.41, 1.56) 1.29*** (1.24, 1.35) 
65-74   1.99*** (1.78, 2.22) 1.28*** (1.21, 1.34) 
75 and older   1.98*** (1.76, 2.23) 1.25*** (1.18, 1.32) 
Male Gender N/A  1.07* (1.01, 1.13) 1.03 (0.98, 1.08) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   0.85*** (0.78, 0.93) 0.87*** (0.80, 0.94) 
Hispanic   0.74*** (0.69, 0.79) 0.81*** (0.74, 0.88) 
Others   0.92 (0.81, 1.04) 0.91 (0.83, 1.00) 
Unknown   0.45*** (0.41, 0.50) 0.64*** (0.54, 0.75) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.37*** (1.31, 1.43) 1.42*** (1.35, 1.49) 
1.3<=CDPS<=1.9   1.59*** (1.48, 1.71) 1.72*** (1.59, 1.85) 
CDPS>1.9   1.95*** (1.82, 2.08) 2.18*** (2.05, 2.33) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.50*** (0.42, 0.59) 
Dual-eligible     1.12*** (1.07, 1.18) 
Continuous 12-month coverage N/A  N/A  1.21*** (1.12, 1.30) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     0.98 (0.85, 1.12) 
85-90%     0.95 (0.79, 1.15) 
>90%     1.00 (0.83, 1.22) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     0.97 (0.87, 1.09) 
$45,921-$56,813     1.03 (0.92, 1.17) 
>$56,813     1.09 (0.95, 1.26) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Having at least 1 Nephropathy test in 2005) 
N=106,174 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 1.31*** (1.22, 1.42) 1.39*** (1.28, 1.50) 
Bipolar disorder 1.36*** (1.24, 1.49) 1.34*** (1.23, 1.45) 
Depression/ anxiety 1.14*** (1.09, 1.20) 1.10*** (1.05, 1.15) 
Other mental health disorders 1.04 (0.96, 1.12) 1.02 (0.94, 1.11) 
Any alcohol abuse/ dependence 1.01 (0.95, 1.09) 1.06 (1.00, 1.14) 
Any drug abuse/ dependence 1.18*** (1.08, 1.29) 1.18*** (1.09, 1.28) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.26*** (1.21, 1.31) 1.20*** (1.15, 1.25) 
65-74 1.26*** (1.20, 1.32) 1.24*** (1.18, 1.31) 
75 and older 1.24*** (1.17, 1.31) 1.23*** (1.16, 1.30) 
Male Gender 1.01 (0.96, 1.07) 1.04 (0.97, 1.10) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.86*** (0.79, 0.93) 1.00 (0.94, 1.05) 
Hispanic 0.82*** (0.75, 0.89) 0.93 (0.86, 1.01) 
Others 0.92 (0.84, 1.01) 1.01 (0.91, 1.12) 
Unknown 0.65*** (0.55, 0.76) 0.74*** (0.64, 0.85) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.37*** (1.31, 1.43) 1.22*** (1.16, 1.28) 
1.3<=CDPS<=1.9 1.61*** (1.51, 1.72) 1.29*** (1.18, 1.40) 
CDPS>1.9 1.91*** (1.79, 2.04) 1.41*** (1.30, 1.53) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.52*** (0.43, 0.62) 0.55*** (0.48, 0.63) 
Dual-eligible 1.10*** (1.05, 1.15) 1.09** (1.02, 1.17) 
Continuous 12-month coverage 1.20*** (1.11, 1.29) 1.12** (1.04, 1.20) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.97 (0.85, 1.11) 0.97 (0.85, 1.11) 
85-90% 0.95 (0.79, 1.14) 0.94 (0.79, 1.11) 
>90% 1.00 (0.82, 1.22) 0.98 (0.82, 1.17) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.98 (0.88, 1.10) 0.97 (0.88, 1.08) 
$45,921-$56,813 1.04 (0.92, 1.18) 1.03 (0.91, 1.16) 
>$56,813 1.10 (0.95, 1.27) 1.09 (0.95, 1.27) 
No Previous Complications 1.02 (0.97, 1.06) 1.01 (0.97, 1.05) 
Eye complications in 2004 1.02 (0.97, 1.08) 1.00 (0.95, 1.05) 
Nephropathy in 2004 1.65*** (1.53, 1.78) 1.67*** (1.52, 1.83) 
Neuropathy in 2004 1.07** (1.02, 1.13) 1.03 (0.97, 1.08) 
Ischemic Heart Disease in 2004 1.11*** (1.05, 1.17) 1.02 (0.96, 1.08) 
Lower-limb amputations 2004 1.05 (0.99, 1.11) 1.01 (0.95, 1.07) 
Cerebrovascular diseases 2004 1.01 (0.96, 1.06) 0.97 (0.91, 1.02) 
No. of outpatient visits 2004 N/A  1.06*** (1.05, 1.07) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having at least 1 Eye Examination in 2005) 
N=106,174 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.59*** (0.54, 0.65) 1.18** (1.06, 0.31) 1.01 (0.91, 1.12) 
Bipolar disorder 0.56*** (0.50, 0.64) 0.99 (0.89, 1.10) 0.89** (0.82, 0.97) 
Depression/ anxiety 0.70*** (0.62, 0.79) 0.95 (0.89, 1.01) 0.94* (0.89, 0.99) 
Other mental health disorders 0.77*** (0.71, 0.83) 0.93* (0.87, 0.99) 0.91** (0.85, 0.98) 
Any alcohol abuse/ dependence 0.59*** (0.55, 0.63) 0.74*** (0.69, 0.79) 0.73*** (0.68, 0.78) 
Any drug abuse/ dependence 0.41*** (0.38, 0.44) 0.68*** (0.63, 0.74) 0.71*** (0.65, 0.77) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   2.07*** (1.95, 2.20) 1.75*** (1.64, 1.87) 
65-74   4.31*** (3.86, 4.81) 2.18*** (2.07, 2.31) 
75 and older   4.41*** (3.90, 4.98) 2.16*** (2.04, 2.29) 
Male Gender N/A  0.93*** (0.90, 0.96) 0.86*** (0.84, 0.88) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   0.88** (0.80, 0.97) 0.98 (0.88, 1.08) 
Hispanic   0.68*** (0.62, 0.76) 0.86** (0.78, 0.95) 
Others   0.73*** (0.68, 0.79) 0.83*** (0.76, 0.90) 
Unknown   0.43*** (0.40, 0.46) 0.72*** (0.65, 0.80) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.38*** (1.33, 1.44) 1.40*** (1.35, 1.46) 
1.3<=CDPS<=1.9   1.44*** (1.36, 1.51) 1.53*** (1.46, 1.61) 
CDPS>1.9   1.26*** (1.19, 1.33) 1.40*** (1.33, 1.46) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.34*** (0.29, 0.40) 
Dual-eligible     0.85*** (0.79, 0.92) 
Continuous 12-month coverage N/A  N/A  1.67*** (1.57, 1.77) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     1.02 (0.95, 1.10) 
85-90%     1.06 (0.97, 1.16) 
>90%     1.14* (1.01, 1.28) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     0.99 (0.93, 1.05) 
$45,921-$56,813     1.02 (0.94, 1.10) 
>$56,813     0.98 (0.88, 1.08) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Having at least 1 Eye Examination in 2005) 
N=106,174 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 1.12* (1.01, 1.24) 1.19** (1.06, 1.33) 
Bipolar disorder 0.98 (0.90, 1.06) 0.94 (0.87, 1.03) 
Depression/ anxiety 0.97 (0.92, 1.03) 0.93* (0.87, 0.99) 
Other mental health disorders 0.93* (0.87, 1.00) 0.91* (0.85, 0.98) 
Any alcohol abuse/ dependence 0.77*** (0.72, 0.82) 0.80*** (0.75, 0.86) 
Any drug abuse/ dependence 0.73*** (0.67, 0.80) 0.71*** (0.65, 0.78) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.66*** (1.56, 1.76) 1.59*** (1.50, 1.69) 
65-74 2.15*** (2.03, 2.27) 2.16*** (2.04, 2.29) 
75 and older 2.20*** (2.08, 2.34) 2.23*** (2.11, 2.37) 
Male Gender 0.86*** (0.84, 0.89) 0.88*** (0.86, 0.91) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.93 (0.84, 1.02) 1.09* (1.01, 1.18) 
Hispanic 0.86** (0.78, 0.94) 0.98 (0.89, 1.08) 
Others 0.83*** (0.77, 0.90) 0.91* (0.84, 0.99) 
Unknown 0.73*** (0.66, 0.81) 0.84*** (0.77, 0.92) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.28*** (1.23, 1.34) 1.14*** (1.08, 1.20) 
1.3<=CDPS<=1.9 1.33*** (1.27, 1.40) 1.06 (0.98, 1.14) 
CDPS>1.9 1.14*** (1.07, 1.20) 0.83*** (0.76, 0.90) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.36*** (0.30, 0.43) 0.38*** (0.33, 0.43) 
Dual-eligible 0.81*** (0.75, 0.88) 0.81*** (0.73, 0.89) 
Continuous 12-month coverage 1.61*** (1.51, 1.72) 1.52*** (1.42, 1.62) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.04 (0.96, 1.12) 1.04 (0.96, 1.14) 
85-90% 1.08 (0.98, 1.20) 1.07 (0.97, 1.18) 
>90% 1.18* (1.03, 1.34) 1.16** (1.04, 1.30) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.00 (0.93, 1.08) 0.99 (0.92, 1.07) 
$45,921-$56,813 1.02 (0.93, 1.12) 1.01 (0.91, 1.12) 
>$56,813 0.98 (0.86, 1.11) 0.97 (0.86, 1.10) 
No Previous Complications 0.99 (0.94, 1.03) 0.98 (0.94, 1.03) 
Eye complications in 2004 2.51*** (2.38, 2.66) 2.52*** (2.39, 2.67) 
Nephropathy in 2004 1.11** (1.04, 1.20) 1.12** (1.04, 1.20) 
Neuropathy in 2004 1.34*** (1.29, 1.40) 1.29*** (1.23, 1.35) 
Ischemic Heart Disease in 2004 0.97 (0.93, 1.00) 0.88*** (0.85, 0.92) 
Lower-limb amputations 2004 0.88*** (0.82, 0.95) 0.84*** (0.79, 0.91) 
Cerebrovascular diseases 2004 0.97 (0.93, 1.01) 0.93*** (0.89, 0.97) 
No. of outpatient visits 2004 N/A  1.06*** (1.06, 1.07) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having Any Diabetes Complications in 2005) 
N=106,174 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.42*** (0.38, 0.46) 0.62*** (0.57, 0.67) 0.47*** (0.43, 0.51) 
Bipolar disorder 0.52*** (0.46, 0.59) 0.71*** (0.63, 0.79) 0.58*** (0.53, 0.64) 
Depression/ anxiety 0.82*** (0.76, 0.89) 0.96 (0.92, 1.00) 0.89*** (0.86, 0.92) 
Other mental health disorders 0.99 (0.90, 1.10) 0.95 (0.85, 1.07) 0.90 (0.80, 1.01) 
Any alcohol abuse/ dependence 0.98 (0.89, 1.08) 0.91 (0.81, 1.02) 0.86* (0.76, 0.98) 
Any drug abuse/ dependence 0.66*** (0.61, 0.71) 0.83*** (0.78, 0.90) 0.87** (0.81, 0.95) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   2.78*** (2.66, 2.90) 2.39*** (2.26, 2.52) 
65-74   3.88*** (3.65, 4.14) 2.41*** (2.23, 2.59) 
75 and older   4.51*** (4.24, 4.81) 2.75*** (2.58, 2.94) 
Male Gender N/A  1.56*** (1.49, 1.63) 1.53*** (1.46, 1.60) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   1.02 (0.92, 1.13) 0.98 (0.91, 1.04) 
Hispanic   0.63*** (0.55, 0.71) 0.64*** (0.59, 0.70) 
Others   0.68*** (0.61, 0.75) 0.61*** (0.54, 0.69) 
Unknown   0.38*** (0.24, 0.42) 0.59*** (0.55, 0.64) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   2.10*** (2.00, 2.19) 2.24*** (2.16, 2.33) 
1.3<=CDPS<=1.9   3.26*** (3.00, 3.54) 3.77*** (3.54, 4.02) 
CDPS>1.9   4.89*** (4.44, 5.39) 6.07*** (5.62, 6.55) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.43*** (0.39, 0.47) 
Dual-eligible     1.45*** (1.39, 1.51) 
Continuous 12-month coverage N/A  N/A  1.10* (1.01, 1.19) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     0.98 (0.90, 1.06) 
85-90%     0.94 (0.84, 1.05) 
>90%     0.90 (0.79, 1.02) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     1.02 (0.93, 1.12) 
$45,921-$56,813     1.06 (0.94, 1.20) 
>$56,813     1.08 (0.94, 1.25) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Having Any Diabetes Complications in 2005) 
N=106,174 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.71*** (0.65, 0.77) 0.72*** (0.67, 0.78) 
Bipolar disorder 0.77*** (0.70, 0.85) 0.76*** (0.69, 0.84) 
Depression/ anxiety 0.96* (0.92, 1.00) 0.94** (0.90, 0.98) 
Other mental health disorders 0.89* (0.78, 1.00) 0.88* (0.78, 1.00) 
Any alcohol abuse/ dependence 1.02 (0.91, 1.13) 1.04 (0.93, 1.15) 
Any drug abuse/ dependence 0.98 (0.90, 1.05) 0.97 (0.90, 1.05) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.68*** (1.57, 1.80) 1.65*** (1.54, 1.77) 
65-74 1.70*** (1.56, 1.86) 1.69*** (1.55, 1.85) 
75 and older 1.90*** (1.78, 2.04) 1.90*** (1.77, 2.04) 
Male Gender 1.27*** (1.22, 1.31) 1.28*** (1.24, 1.33) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.96 (0.91, 1.01) 1.02 (0.95, 1.09) 
Hispanic 0.73*** (0.66, 0.80) 0.76*** (0.69, 0.85) 
Others 0.69*** (0.63, 0.76) 0.72*** (0.66, 0.79) 
Unknown 0.67*** (0.62, 0.73) 0.71*** (0.65, 0.78) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.27*** (1.20, 1.34) 1.20*** (1.15, 1.26) 
1.3<=CDPS<=1.9 1.47*** (1.39, 1.56) 1.33*** (1.28, 1.39) 
CDPS>1.9 1.60*** (1.51, 1.70) 1.41*** (1.33, 1.48) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.62*** (0.57, 0.68) 0.64*** (0.59, 0.69) 
Dual-eligible 1.18*** (1.13, 1.23) 1.17*** (1.12, 1.23) 
Continuous 12-month coverage 0.96 (0.88, 1.05) 0.93 (0.85, 1.02) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.01 (0.94, 1.07) 1.01 (0.94, 1.08) 
85-90% 1.01 (0.92, 1.11) 1.01 (0.90, 1.12) 
>90% 1.01 (0.90, 1.13) 1.00 (0.89, 1.13) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.01 (0.95, 1.08) 1.01 (0.94, 1.09) 
$45,921-$56,813 1.01 (0.92, 1.11) 1.01 (0.91, 1.12) 
>$56,813 1.02 (0.90, 1.15) 1.01 (0.89, 1.15) 
No Previous Complications 0.43*** (0.40, 0.47) 0.43*** (0.39, 0.47) 
Eye complications in 2004 3.00*** (2.76, 3.26) 2.99*** (2.75, 3.26) 
Nephropathy in 2004 2.58*** (2.34, 2.85) 2.59*** (2.35, 2.85) 
Neuropathy in 2004 3.45*** (3.17, 3.75) 3.39*** (3.11, 3.69) 
Ischemic Heart Disease in 2004 4.20*** (3.82, 4.61) 4.07*** (3.73, 4.45) 
Lower-limb amputations 2004 1.24*** (1.11, 1.39) 1.22** (1.09, 1.37) 
Cerebrovascular diseases 2004 1.86*** (1.72, 2.01) 1.84*** (1.70, 1.98) 
No. of outpatient visits 2004 N/A  1.02*** (1.02, 1.03) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having Eye Complications in 2005) 
N=88,876 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.72*** (0.62, 0.83) 0.85* (0.73, 0.99) 0.72*** (0.62, 0.85) 
Bipolar disorder 0.63*** (0.52, 0.75) 0.73** (0.61, 0.88) 0.65*** (0.54, 0.78) 
Depression/ anxiety 0.92 (0.84, 1.00) 0.97 (0.90, 1.04) 0.92* (0.85, 1.00) 
Other mental health disorders 0.90 (0.75, 1.09) 0.91 (0.76, 1.11) 0.89 (0.73, 1.08) 
Any alcohol abuse/ dependence 0.78** (0.66, 0.92) 0.78** (0.66, 0.92) 0.76** (0.64, 0.90) 
Any drug abuse/ dependence 0.78** (0.67, 0.91) 0.91 (0.78, 1.06) 0.92 (0.78, 1.08) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   1.79*** (1.59, 2.01) 1.58*** (1.40, 1.78) 
65-74   1.99*** (1.76, 2.26) 1.49*** (1.32, 1.67) 
75 and older   1.63*** (1.45, 1.83) 1.21** (1.07, 1.37) 
Male Gender N/A  1.00 (0.92, 1.08) 0.98 (0.91, 1.07) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   1.47*** (1.27, 1.69) 1.40*** (1.23, 1.60) 
Hispanic   1.10 (0.83, 1.47) 1.10 (0.86, 1.40) 
Others   1.07 (0.92, 1.25) 1.01 (0.86, 1.19) 
Unknown   0.67*** (0.59, 0.77) 0.89 (0.77, 1.03) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.08* (1.00, 1.16) 1.13** (1.05, 1.21) 
1.3<=CDPS<=1.9   1.21*** (1.11, 1.32) 1.32*** (1.22, 1.42) 
CDPS>1.9   1.37*** (1.25, 1.50) 1.53*** (1.41, 1.66) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.60*** (0.50, 0.71) 
Dual-eligible     1.22*** (1.13, 1.32) 
Continuous 12-month coverage N/A  N/A  1.13 (0.98, 1.30) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     0.84 (0.71, 1.00) 
85-90%     0.82* (0.70, 0.97) 
>90%     0.76* (0.62, 0.94) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     1.08 (0.94, 1.24) 
$45,921-$56,813     1.08 (0.91, 1.28) 
>$56,813     1.20 (0.97, 1.47) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Having Eye Complications in 2005) 
N=88,876 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.81* (0.69, 0.95) 0.82* (0.69, 0.96) 
Bipolar disorder 0.71*** (0.59, 0.85) 0.70*** (0.59, 0.84) 
Depression/ anxiety 0.94 (0.87, 1.01) 0.93 (0.86, 1.01) 
Other mental health disorders 0.87 (0.71, 1.05) 0.87 (0.71, 1.05) 
Any alcohol abuse/ dependence 0.78** (0.66, 0.92) 0.79** (0.67, 0.92) 
Any drug abuse/ dependence 0.92 (0.78, 1.09) 0.92 (0.78, 1.08) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.46*** (1.30, 1.65) 1.45*** (1.29, 1.64) 
65-74 1.39*** (1.24, 1.56) 1.39*** (1.24, 1.56) 
75 and older 1.11 (0.99, 1.26) 1.12 (0.99, 1.26) 
Male Gender 0.94 (0.86, 1.01) 0.94 (0.87, 1.02) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.34*** (1.17, 1.53) 1.36*** (1.20, 1.55) 
Hispanic 1.17 (0.91, 1.50) 1.19 (0.93, 1.52) 
Others 1.06 (0.91, 1.24) 1.08 (0.92, 1.25) 
Unknown 0.95 (0.83, 1.10) 0.97 (0.84, 1.12) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 0.98 (0.90, 1.07) 0.97 (0.89, 1.05) 
1.3<=CDPS<=1.9 1.01 (0.92, 1.12) 0.99 (0.90, 1.08) 
CDPS>1.9 0.98 (0.89, 1.09) 0.94 (0.85, 1.05) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.67*** (0.56, 0.80) 0.68*** (0.57, 0.81) 
Dual-eligible 1.12** (1.04, 1.22) 1.12** (1.04, 1.22) 
Continuous 12-month coverage 1.11 (0.97, 1.28) 1.10 (0.96, 1.27) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.83* (0.69, 0.99) 0.83* (0.69, 0.99) 
85-90% 0.81* (0.68, 0.95) 0.80* (0.68, 0.95) 
>90% 0.75** (0.60, 0.92) 0.74** (0.60, 0.92) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.09 (0.95, 1.25) 1.09 (0.94, 1.25) 
$45,921-$56,813 1.08 (0.92, 1.27) 1.08 (0.91, 1.27) 
>$56,813 1.20 (0.98, 1.47) 1.20 (0.98, 1.48) 
No Previous Complications 0.97 (0.87, 1.07) 0.97 (0.87, 1.07) 
Eye complications in 2004 N/A  N/A  
Nephropathy in 2004 2.03*** (1.83, 2.25) 2.03*** (1.83, 2.25) 
Neuropathy in 2004 1.89*** (1.75, 2.04) 1.88*** (1.74, 2.04) 
Ischemic Heart Disease in 2004 1.20*** (1.12, 1.29) 1.19*** (1.11, 1.28) 
Lower-limb amputations 2004 1.51*** (1.34, 1.69) 1.50*** (1.34, 1.68) 
Cerebrovascular diseases 2004 1.13* (1.02, 1.25) 1.12* (1.01, 1.25) 
No. of outpatient visits 2004 N/A  1.01* (1.00, 1.01) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having Nephropathy in 2005) 
N=100,810 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.60** (0.45, 0.81) 0.63** (0.47, 0.86) 0.48*** (0.34, 0.67) 
Bipolar disorder 0.75* (0.58, 0.97) 0.75* (0.58, 0.97) 0.61*** (0.47, 0.80) 
Depression/ anxiety 0.90 (0.80, 1.01) 0.84* (0.74, 0.96) 0.77*** (0.69, 0.87) 
Other mental health disorders 0.89 (0.72, 1.12) 0.74* (0.58, 0.94) 0.70** (0.55, 0.89) 
Any alcohol abuse/ dependence 0.82 (0.64, 1.04) 0.62*** (0.49, 0.79) 0.59*** (0.46, 0.75) 
Any drug abuse/ dependence 0.86 (0.68, 1.09) 0.79* (0.63, 0.99) 0.81 (0.64, 1.02) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   2.00*** (1.75, 2.29) 1.60*** (1.36, 1.87) 
65-74   2.04*** (1.76, 2.36) 1.33** (1.12, 1.59) 
75 and older   1.73*** (1.47, 2.03) 1.12 (0.93, 1.35) 
Male Gender N/A  1.43*** (1.33, 1.54) 1.41 (1.32, 1.35) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   1.76*** (1.54, 2.00) 1.69*** (1.50, 1.90) 
Hispanic   0.96 (0.75, 1.22) 0.98 (0.81, 1.20) 
Others   1.37** (1.12, 1.66) 1.24* (1.02, 1.50) 
Unknown   0.36*** (0.27, 0.50) 0.57** (0.41, 0.81) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.62*** (1.35, 1.94) 1.76*** (1.46, 2.11) 
1.3<=CDPS<=1.9   2.40*** (2.03, 2.85) 2.78*** (2.36, 3.27) 
CDPS>1.9   5.11*** (4.41, 5.93) 6.24*** (5.42, 7.20) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.48*** (0.38, 0.61) 
Dual-eligible     1.61*** (1.48, 1.76) 
Continuous 12-month coverage N/A  N/A  1.01 (0.85, 1.21) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     1.20 (0.98, 1.46) 
85-90%     1.16 (0.93, 1.44) 
>90%     1.19 (0.90, 1.57) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     0.83* (0.71, 0.97) 
$45,921-$56,813     0.90 (0.75, 1.08) 
>$56,813     0.87 (0.68, 1.10) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Having Nephropathy in 2005) 
N=100,810 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.58** (0.42, 0.81) 0.58** (0.42, 0.81) 
Bipolar disorder 0.70* (0.53, 0.92) 0.70** (0.53, 0.91) 
Depression/ anxiety 0.80*** (0.71, 0.90) 0.79*** (0.70, 0.90) 
Other mental health disorders 0.70** (0.55, 0.88) 0.69** (0.55, 0.88) 
Any alcohol abuse/ dependence 0.63*** (0.50, 0.80) 0.64*** (0.50, 0.81) 
Any drug abuse/ dependence 0.81 (0.64, 1.03) 0.81 (0.64, 1.03) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.38*** (1.20, 1.58) 1.37*** (1.20, 1.57) 
65-74 1.17 (1.00, 1.37) 1.17 (1.00, 1.37) 
75 and older 1.01 (0.86, 1.19) 1.01 (0.86, 1.19) 
Male Gender 1.39*** (1.28, 1.50) 1.39*** (1.28, 1.50) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.61*** (1.44, 1.80) 1.64*** (1.47, 1.84) 
Hispanic 1.02 (0.85, 1.21) 1.03 (0.86, 1.24) 
Others 1.33** (1.10, 1.61) 1.34** (1.11, 1.63) 
Unknown 0.61** (0.43, 0.86) 0.62** (0.44, 0.88) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.38** (1.13, 1.67) 1.36** (1.13, 1.64) 
1.3<=CDPS<=1.9 1.86*** (1.59, 2.22) 1.82*** (1.55, 2.12) 
CDPS>1.9 3.82*** (3.26, 4.47) 3.67*** (3.18, 4.24) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.58*** (0.46, 0.74) 0.59*** (0.47, 0.74) 
Dual-eligible 1.50*** (1.38, 1.64) 1.51*** (1.38, 1.64) 
Continuous 12-month coverage 0.96 (0.80, 1.15) 0.95 (0.79, 1.14) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.23* (1.02, 1.49) 1.23* (1.02, 1.49) 
85-90% 1.20 (0.97, 1.47) 1.19 (0.97, 1.47) 
>90% 1.27 (0.96, 1.67) 1.26 (0.96, 1.67) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.83* (0.72, 0.96) 0.83* (0.72, 0.96) 
$45,921-$56,813 0.88 (0.75, 1.04) 0.88 (0.74, 1.04) 
>$56,813 0.84 (0.67, 1.06) 0.84 (0.67, 1.06) 
No Previous Complications 0.78*** (0.69, 0.88) 0.78*** (0.69, 0.88) 
Eye complications in 2004 2.10*** (1.92, 2.29) 2.09*** (1.92, 2.28) 
Nephropathy in 2004 N/A   N/A  
Neuropathy in 2004 1.75*** (1.60, 1.91) 1.74*** (1.59, 1.90) 
Ischemic Heart Disease in 2004 1.18** (1.06, 1.31) 1.17** (1.05, 1.29) 
Lower-limb amputations 2004 1.53*** (1.35, 1.74) 1.53*** (1.34, 1.73) 
Cerebrovascular diseases 2004 0.90 (0.81, 1.01) 0.90 (0.81, 1.00) 
No. of outpatient visits 2004 N/A  1.01 (1.00, 1.01) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having Diabetic Neuropathy in 2005) 
N=90,986 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.81** (0.70, 0.94) 0.87 (0.74, 1.01) 0.68*** (0.58, 0.80) 
Bipolar disorder 1.02 (0.86, 1.20) 1.05 (0.90, 1.23) 0.88 (0.75, 1.04) 
Depression/ anxiety 1.02 (0.96, 1.09) 1.01 (0.95, 1.07) 0.95 (0.89, 1.00) 
Other mental health disorders 1.13 (0.96, 1.32) 1.05 (0.89, 1.23) 1.00 (0.84, 1.18) 
Any alcohol abuse/ dependence 1.12 (0.98, 1.28) 1.03 (0.91, 1.18) 0.98 (0.87, 1.11) 
Any drug abuse/ dependence 0.89 (0.73, 1.07) 0.96 (0.80, 1.15) 1.00 (0.83, 1.21) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   1.81*** (1.65, 1.99) 1.53*** (1.39, 1.68) 
65-74   1.73*** (1.54, 1.94) 1.16* (1.04, 1.61) 
75 and older   1.65*** (1.48, 1.85) 1.10 (0.98, 1.23) 
Male Gender N/A  1.07* (1.02, 1.14) 1.05 (0.99, 1.11) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   1.23 (1.00, 1.52) 1.21* (1.01, 1.44) 
Hispanic   0.73** (0.58, 0.92) 0.76** (0.64, 0.91) 
Others   0.62*** (0.49, 0.79) 0.57*** (0.44, 0.73) 
Unknown   0.42*** (0.35, 0.50) 0.62*** (0.52, 0.74) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.51*** (1.37, 1.67) 1.61*** (1.46, 1.77) 
1.3<=CDPS<=1.9   2.02*** (1.79, 2.28) 2.28*** (2.07, 2.52) 
CDPS>1.9   2.54*** (2.20, 2.92) 2.97*** (2.63, 3.36) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.50*** (0.45, 0.56) 
Dual-eligible     1.44*** (1.34, 1.55) 
Continuous 12-month coverage N/A  N/A  1.00 (0.81, 1.23) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     1.12 (0.95, 1.33) 
85-90%     1.30 (0.99, 1.71) 
>90%     1.36* (1.05, 1.76) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     0.90 (0.76, 1.05) 
$45,921-$56,813     0.85 (0.72, 1.00) 
>$56,813     0.79* (0.64, 0.97) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Having Diabetic Neuropathy in 2005) 
N=90,986 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.78** (0.66, 0.92) 0.79** (0.67, 0.94) 
Bipolar disorder 1.01 (0.85, 1.18) 0.99 (0.84, 1.17) 
Depression/ anxiety 1.00 (0.95, 1.07) 0.99 (0.93, 1.05) 
Other mental health disorders 1.01 (0.86, 1.18) 1.00 (0.85, 1.18) 
Any alcohol abuse/ dependence 1.04 (0.91, 1.18) 1.05 (0.92, 1.21) 
Any drug abuse/ dependence 1.04 (0.86, 1.27) 1.04 (0.85, 1.27) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.42*** (1.29, 1.55) 1.40*** (1.27, 1.53) 
65-74 1.08 (0.97, 1.21) 1.08 (0.96, 1.21) 
75 and older 1.05 (0.94, 1.18) 1.05 (0.94, 1.17) 
Male Gender 1.02 (0.97, 1.08) 1.03 (0.97, 1.10) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.15 (0.95, 1.40) 1.22 (1.00, 1.49) 
Hispanic 0.76** (0.63, 0.91) 0.79** (0.66, 0.94) 
Others 0.56*** (0.43, 0.72) 0.58*** (0.45, 0.74) 
Unknown 0.64*** (0.53, 0.76) 0.67*** (0.56, 0.80) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.42*** (1.29, 1.56) 1.36*** (1.24, 1.49) 
1.3<=CDPS<=1.9 1.87*** (1.68, 2.07) 1.71*** (1.56, 1.88) 
CDPS>1.9 2.09*** (1.85, 2.37) 1.86*** (1.64, 2.11) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.56*** (0.50, 0.62) 0.57*** (0.51, 0.64) 
Dual-eligible 1.35*** (1.25, 1.45) 1.34*** (1.25, 1.44) 
Continuous 12-month coverage 0.97 (0.79, 1.20) 0.95 (0.77, 1.18) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.14 (0.96, 1.36) 1.15 (0.96, 1.37) 
85-90% 1.35* (1.02, 1.79) 1.35* (1.00, 1.80) 
>90% 1.45** (1.10, 1.89) 1.43* (1.08, 1.89) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.90 (0.77, 1.05) 0.90 (0.77, 1.05) 
$45,921-$56,813 0.84* (0.72, 0.98) 0.84* (0.72, 0.98) 
>$56,813 0.77* (0.63, 0.94) 0.77* (0.64, 0.94) 
No Previous Complications 0.86** (0.78, 0.95) 0.86** (0.78, 0.95) 
Eye complications in 2004 1.88*** (1.71, 2.08) 1.87*** (1.69, 2.07) 
Nephropathy in 2004 1.83*** (1.61, 2.08) 1.82*** (1.60, 2.07) 
Neuropathy in 2004 N/A  N/A  
Ischemic Heart Disease in 2004 1.05 (0.96, 1.15) 1.01 (0.92, 1.11) 
Lower-limb amputations 2004 1.81*** (1.60, 2.05) 1.79*** (1.58, 2.03) 
Cerebrovascular diseases 2004 0.99 (0.91, 1.07) 0.97 (0.89, 1.06) 
No. of outpatient visits 2004 N/A  1.02*** (1.01, 1.03) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having Lower-limb Amputations in 2005) 
N=100,390 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.85* (0.73, 0.99) 0.90 (0.77, 1.05) 0.71*** (0.60, 0.85) 
Bipolar disorder 0.93 (0.76, 1.13) 0.92 (0.73, 1.15) 0.78* (0.63, 0.97) 
Depression/ anxiety 1.11* (1.02, 1.20) 1.04 (0.96, 1.13) 0.96 (0.89, 1.04) 
Other mental health disorders 1.15 (0.97, 1.37) 1.01 (0.84, 1.21) 0.97 (0.81, 1.17) 
Any alcohol abuse/ dependence 1.65*** (1.39, 1.96) 1.47*** (1.25, 1.73) 1.39*** (1.17, 1.65) 
Any drug abuse/ dependence 1.35*** (1.16, 1.58) 1.32** (1.12, 1.55) 1.35*** (1.15, 1.60) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   1.52*** (1.38, 1.68) 1.33*** (1.20, 1.47) 
65-74   1.37*** (1.21, 1.56) 1.14 (0.98, 1.33) 
75 and older   1.68*** (1.45, 1.94) 1.41*** (1.22, 1.63) 
Male Gender N/A  1.12*** (1.06, 1.19) 1.14*** (1.07, 1.20) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   1.23*** (1.13, 1.35) 1.08 (0.96, 1.22) 
Hispanic   0.81* (0.68, 0.96) 0.73** (0.60, 0.87) 
Others   0.93 (0.78, 1.11) 0.76** (0.64, 0.91) 
Unknown   0.59*** (0.45, 0.76) 0.75* (0.58, 0.98) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.43*** (1.26, 1.63) 1.56*** (1.37, 1.78) 
1.3<=CDPS<=1.9   2.19*** (1.84, 2.60) 2.54*** (2.14, 3.03) 
CDPS>1.9   3.40*** (2.80, 4.13) 4.09*** (3.38, 4.96) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.66*** (0.56, 0.78) 
Dual-eligible     1.76*** (1.57, 1.98) 
Continuous 12-month coverage N/A  N/A  0.75*** (0.66, 0.86) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     1.02 (0.86, 1.20) 
85-90%     0.89 (0.73, 1.09) 
>90%     0.85 (0.67, 1.08) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     1.01 (0.88, 1.17) 
$45,921-$56,813     1.05 (0.89, 1.24) 
>$56,813     1.01 (0.84, 1.20) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Having Lower-limb Amputations in 2005) 
N=100,390 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.84* (0.71, 1.00) 0.85 (0.72, 1.00) 
Bipolar disorder 0.88 (0.70, 1.11) 0.87 (0.70, 1.10) 
Depression/ anxiety 1.00 (0.93, 1.09) 1.00 (0.92, 1.08) 
Other mental health disorders 1.00 (0.83, 1.19) 0.99 (0.83, 1.19) 
Any alcohol abuse/ dependence 1.52*** (1.28, 1.81) 1.53*** (1.29, 1.82) 
Any drug abuse/ dependence 1.42*** (1.20, 1.67) 1.41*** (1.20, 1.66) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.17** (1.04, 1.30) 1.16** (1.04, 1.29) 
65-74 1.00 (0.86, 1.18) 1.00 (0.86, 1.18) 
75 and older 1.29** (1.10, 1.50) 1.29** (1.11, 1.50) 
Male Gender 1.11*** (1.05, 1.17) 1.11*** (1.05, 1.17) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 1.01 (0.89, 1.14) 1.03 (0.92, 1.16) 
Hispanic 0.74** (0.62, 0.90) 0.76** (0.63, 0.91) 
Others 0.79** (0.67, 0.95) 0.81* (0.68, 0.96) 
Unknown 0.80 (0.63, 1.03) 0.81 (0.63, 1.06) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.27*** (1.13, 1.44) 1.25*** (1.11, 1.41) 
1.3<=CDPS<=1.9 1.80*** (1.54, 2.10) 1.74*** (1.49, 2.03) 
CDPS>1.9 2.53*** (2.13, 3.00) 2.41*** (2.03, 2.86) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.79** (0.66, 0.94) 0.80* (0.67, 0.96) 
Dual-eligible 1.64*** (1.46, 1.86) 1.65*** (1.46, 1.85) 
Continuous 12-month coverage 0.71*** (0.62, 0.81) 0.70*** (0.61, 0.81) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.01 (0.86, 1.20) 1.01 (0.86, 1.20) 
85-90% 0.88 (0.72, 1.08) 0.88 (0.72, 1.08) 
>90% 0.86 (0.68, 1.10) 0.86 (0.67, 1.09) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.04 (0.89, 1.20) 1.04 (0.89, 1.20) 
$45,921-$56,813 1.05 (0.88, 1.26) 1.05 (0.88, 1.26) 
>$56,813 1.01 (0.83, 1.22) 1.01 (0.83, 1.22) 
No Previous Complications 0.88** (0.80, 0.96) 0.87** (0.79, 0.96) 
Eye complications in 2004 1.70*** (1.54, 1.88) 1.70*** (1.54, 1.88) 
Nephropathy in 2004 1.41*** (1.25, 1.59) 1.40*** (1.24, 1.59) 
Neuropathy in 2004 1.76*** (1.59, 1.95) 1.75*** (1.58, 1.94) 
Ischemic Heart Disease in 2004 1.17*** (1.10, 1.26) 1.16*** (1.08, 1.24) 
Lower-limb amputations 2004 N/A  N/A  
Cerebrovascular diseases 2004 1.13* (1.02, 1.24) 1.12* (1.01, 1.24) 
No. of outpatient visits 2004 N/A  1.01*** (1.00, 1.01) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having Ischemic Heart Disease in 2005) 
N=72,600 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.49*** (0.43, 0.57) 0.82* (0.71, 0.96) 0.69*** (0.58, 0.81) 
Bipolar disorder 0.62*** (0.51, 0.75) 0.96 (0.81, 1.13) 0.83* (0.71, 0.98) 
Depression/ anxiety 0.84*** (0.78, 0.91) 1.06 (1.00, 1.14) 1.01 (0.95, 1.08) 
Other mental health disorders 0.96 (0.86, 1.08) 1.04 (0.92, 1.17) 1.00 (0.89, 1.12) 
Any alcohol abuse/ dependence 0.99 (0.86, 1.14) 0.99 (0.85, 1.15) 0.96 (0.82, 1.11) 
Any drug abuse/ dependence 0.61*** (0.51, 0.74) 0.88 (0.73, 1.07) 0.91 (0.75, 1.10) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   2.70*** (2.47, 2.94) 2.46*** (2.25, 2.68) 
65-74   3.62*** (3.29, 3.98) 2.76*** (1.50, 3.05) 
75 and older   4.68*** (4.24, 5.17) 3.55*** (3.19, 3.94) 
Male Gender N/A  1.38*** (1.31, 1.46) 1.38*** (1.31, 1.46) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   0.87* (0.76, 0.99) 0.82** (0.71, 0.95) 
Hispanic   0.72*** (0.63, 0.81) 0.70*** (0.61, 0.80) 
Others   0.74*** (0.63, 0.83) 0.66*** (0.57, 0.77) 
Unknown   0.51*** (0.41, 0.63) 0.67** (0.53, 0.85) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.33*** (1.26, 1.40) 1.40*** (1.32, 1.48) 
1.3<=CDPS<=1.9   1.72*** (1.60, 1.84) 1.89*** (1.76, 2.02) 
CDPS>1.9   2.26*** (2.12, 2.41) 2.57*** (2.38, 2.77) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.58*** (0.51, 0.65) 
Dual-eligible     1.39*** (1.26, 1.53) 
Continuous 12-month coverage N/A  N/A  0.75*** (0.65, 0.85) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     1.04 (0.94, 1.14) 
85-90%     0.93 (0.82, 1.05) 
>90%     0.94 (0.80, 1.09) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     1.00 (0.93, 1.08) 
$45,921-$56,813     1.08 (0.98, 1.18) 
>$56,813     1.10 (0.97, 1.26) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Having Ischemic Heart Disease in 2005) 
N=72,600 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.72*** (0.61, 0.84) 0.74*** (0.63, 0.87) 
Bipolar disorder 0.86 (0.73, 1.02) 0.86 (0.73, 1.01) 
Depression/ anxiety 1.02 (0.95, 1.09) 1.00 (0.94, 1.07) 
Other mental health disorders 0.99 (0.88, 1.11) 0.98 (0.87, 1.11) 
Any alcohol abuse/ dependence 0.97 (0.84, 1.13) 0.99 (0.85, 1.16) 
Any drug abuse/ dependence 0.91 (0.75, 1.11) 0.91 (0.75, 1.10) 
Age Groups     
<55 (ref.) 1  1  
55-64 2.39*** (2.19, 2.61) 2.34*** (2.15, 2.56) 
65-74 2.69*** (2.43, 2.96) 2.68*** (2.42, 2.97) 
75 and older 3.45*** (3.10, 3.84) 3.46*** (3.09, 3.86) 
Male Gender 1.37*** (1.30, 1.45) 1.39*** (1.32, 1.47) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.81** (0.69, 0.94) 0.86* (0.76, 0.98) 
Hispanic 0.70*** (0.61, 0.81) 0.74*** (0.64, 0.85) 
Others 0.67*** (0.57, 0.77) 0.70*** (0.60, 0.81) 
Unknown 0.68** (0.54, 0.87) 0.73** (0.58, 0.92) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.33*** (1.26, 1.41) 1.26*** (1.19, 1.34) 
1.3<=CDPS<=1.9 1.73*** (1.61, 1.85) 1.55*** (1.45, 1.66) 
CDPS>1.9 2.22*** (2.04, 2.40) 1.92*** (1.75, 2.11) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.60*** (0.54, 0.68) 0.62*** (0.56, 0.70) 
Dual-eligible 1.36*** (1.23, 1.50) 1.35*** (1.22, 1.51) 
Continuous 12-month coverage 0.74*** (0.64, 0.84) 0.71*** (0.62, 0.82) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.04 (0.94, 1.14) 1.04 (0.94, 1.15) 
85-90% 0.94 (0.83, 1.06) 0.93 (0.82, 1.05) 
>90% 0.94 (0.81, 1.10) 0.93 (0.80, 1.09) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.01 (0.93, 1.09) 1.00 (0.93, 1.09) 
$45,921-$56,813 1.08 (0.98, 1.18) 1.08 (0.97, 1.19) 
>$56,813 1.10 (0.97, 1.26) 1.10 (0.96, 1.27) 
No Previous Complications 1.01 (0.90, 1.13) 1.01 (0.90, 1.13) 
Eye complications in 2004 1.13** (1.05, 1.22) 1.12** (1.04, 1.21) 
Nephropathy in 2004 1.31*** (1.18, 1.46) 1.30*** (1.15, 1.46) 
Neuropathy in 2004 1.12** (1.05, 1.20) 1.10* (1.02, 1.18) 
Ischemic Heart Disease in 2004 N/A  N/A  
Lower-limb amputations 2004 1.05 (0.91, 1.22) 1.04 (0.89, 1.21) 
Cerebrovascular diseases 2004 1.38*** (1.23, 1.56) 1.37*** (1.21, 1.54) 
No. of outpatient visits 2004 N/A  1.02*** (1.02, 1.03) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having Cerebrovascular Diseases in 2005) 
N=95,068 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.32*** (0.26, 0.41) 0.61*** (0.47, 0.77) 0.55*** (0.44, 0.70) 
Bipolar disorder 0.61*** (0.50, 0.74) 0.97 (0.79, 1.20) 0.90 (0.74, 1.10) 
Depression/ anxiety 0.88** (0.82, 0.96) 1.09 (0.99, 1.20) 1.06 (0.97, 1.17) 
Other mental health disorders 1.01 (0.84, 1.21) 1.09 (0.92, 1.30) 1.07 (0.90, 1.28) 
Any alcohol abuse/ dependence 1.06 (0.88, 1.28) 1.20 (0.98, 1.47) 1.17 (0.97, 1.41) 
Any drug abuse/ dependence 0.57*** (0.48, 0.68) 0.94 (0.77, 1.16) 0.96 (0.78, 1.18) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   2.91*** (2.52, 3.36) 2.53*** (2.17, 2.95) 
65-74   4.50*** (3.84, 5.27) 3.07*** (2.62, 3.59) 
75 and older   5.94*** (5.20, 5.80) 4.01*** (3.44, 4.66) 
Male Gender N/A  1.14*** (1.07, 1.22) 1.12** (1.05, 1.20) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   0.79*** (0.71, 0.87) 0.78*** (0.70, 0.86) 
Hispanic   0.71*** (0.61, 0.81) 0.72*** (0.63, 0.83) 
Others   0.68*** (0.58, 0.79) 0.67*** (0.57, 0.78) 
Unknown   0.55*** (0.43, 0.70) 0.80 (0.61, 1.04) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.43*** (1.31, 1.56) 1.47*** (1.34, 1.60) 
1.3<=CDPS<=1.9   1.75*** (1.58, 1.92) 1.83*** (1.66, 2.02) 
CDPS>1.9   2.25*** (2.02, 2.51) 2.39*** (2.14, 2.67) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.46*** (0.39, 0.53) 
Dual-eligible     1.11* (1.01, 1.22) 
Continuous 12-month coverage N/A  N/A  0.65*** (0.54, 0.77) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     0.99 (0.91, 1.08) 
85-90%     1.01 (0.94, 1.10) 
>90%     1.01 (0.90, 1.14) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     0.94 (0.81, 1.08) 
$45,921-$56,813     0.94 (0.80, 1.10) 
>$56,813     0.97 (0.82, 1.15) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Having Cerebrovascular Diseases in 2005) 
N=95,068 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.62*** (0.49, 0.78) 0.63*** (0.50, 0.80) 
Bipolar disorder 0.97 (0.79, 1.20) 0.97 (0.78, 1.19) 
Depression/ anxiety 1.08 (0.98, 1.18) 1.07 (0.97, 1.17) 
Other mental health disorders 1.08 (0.91, 1.27) 1.08 (0.91, 1.27) 
Any alcohol abuse/ dependence 1.23* (1.01, 1.50) 1.26* (1.04, 1.53) 
Any drug abuse/ dependence 0.97 (0.78, 1.20) 0.96 (0.78, 1.19) 
Age Groups     
<55 (ref.) 1  1  
55-64 2.30*** (1.98, 2.67) 2.27*** (1.96, 2.64) 
65-74 2.77*** (2.37, 3.22) 2.76*** (2.37, 3.21) 
75 and older 3.58*** (3.08, 4.15) 3.58*** (3.09, 4.15) 
Male Gender 1.05 (0.98, 1.12) 1.05 (0.98, 1.13) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.79*** (0.72, 0.88) 0.83*** (0.75, 0.92) 
Hispanic 0.75*** (0.65, 0.86) 0.77*** (0.67, 0.89) 
Others 0.70*** (0.60, 0.82) 0.72*** (0.61, 0.84) 
Unknown 0.83 (0.64, 1.09) 0.87 (0.66, 1.13) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.31*** (1.19, 1.43) 1.26*** (1.15, 1.38) 
1.3<=CDPS<=1.9 1.49*** (1.35, 1.65) 1.39*** (1.25, 1.54) 
CDPS>1.9 1.74*** (1.56, 1.95) 1.57*** (1.41, 1.76) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.51*** (0.44, 0.60) 0.53*** (0.45, 0.61) 
Dual-eligible 1.05 (0.95, 1.16) 1.05 (0.96, 1.15) 
Continuous 12-month coverage 0.65*** (0.55, 0.77) 0.64*** (0.54, 0.76) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 0.99 (0.91, 1.08) 0.99 (0.91, 1.09) 
85-90% 1.03 (0.95, 1.12) 1.02 (0.94, 1.12) 
>90% 1.04 (0.92, 1.18) 1.03 (0.91, 1.17) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 0.93 (0.80, 1.08) 0.93 (0.81, 1.08) 
$45,921-$56,813 0.92 (0.78, 1.08) 0.92 (0.78, 1.08) 
>$56,813 0.95 (0.80, 1.13) 0.95 (0.80, 1.12) 
No Previous Complications 1.01 (0.92, 1.12) 1.01 (0.91, 1.12) 
Eye complications in 2004 1.13** (1.05, 1.22) 1.12* (1.05, 1.21) 
Nephropathy in 2004 1.23*** (1.12, 1.36) 1.23*** (1.11, 1.36) 
Neuropathy in 2004 1.14*** (1.07, 1.22) 1.13*** (1.06, 1.21) 
Ischemic Heart Disease in 2004 1.64*** (1.51, 1.79) 1.61*** (1.48, 1.75) 
Lower-limb amputations 2004 1.21*** (1.09, 1.34) 1.20** (1.08, 1.33) 
Cerebrovascular diseases 2004 N/A  N/A  
No. of outpatient visits 2004 N/A  1.02*** (1.01, 1.02) 
* p<0.05  **p<0.01 ***p<0.001     
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Appendix XII. Analytic models used in the study (Outcome: Having Diabetes-related Hospitalizations in 
2005) 
N=106,174 Model 1 Model 2 Model 3 
 OR 95%CI OR 95%CI OR 95%CI 
Mental health disorders       
No mental health disorders (ref.) 1  1  1  
Schizophrenia/ paranoid states 0.54*** (0.46, 0.63) 0.69*** (0.59, 0.81) 0.57*** (0.48, 0.67) 
Bipolar disorder 0.89 (0.76, 1.04) 1.04 (0.88, 1.24) 0.91 (0.77, 1.07) 
Depression/ anxiety 1.02 (0.96, 1.08) 1.07 (1.00, 1.14) 1.01 (0.94, 1.08) 
Other mental health disorders 1.20* (1.03, 1.42) 1.10 (0.96, 1.26) 1.06 (0.92, 1.22) 
Any alcohol abuse/ dependence 1.13 (0.92, 1.38) 1.03 (0.84, 1.27) 0.98 (0.78, 1.23) 
Any drug abuse/ dependence 1.37*** (1.20, 1.57) 1.51*** (1.31, 1.74) 1.57*** (1.35, 1.82) 
Age Groups       
<55 (ref.) N/A  1  1  
55-64   1.67*** (1.49, 1.88) 1.42*** (1.26, 1.59) 
65-74   2.01*** (1.76, 2.29) 1.45*** (1.27, 1.65) 
75 and older   2.27*** (1.99, 2.60) 1.64*** (1.42, 1.88) 
Male Gender N/A  1.34*** (1.28, 1.41) 1.33*** (1.26, 1.40) 
Race/ethnicity       
Non-Hispanic white (ref.) N/A  1  1  
African American   1.02 (0.92, 1.12) 0.96 (0.87, 1.05) 
Hispanic   0.71*** (0.62, 0.81) 0.69*** (0.60, 0.80) 
Others   0.89 (0.75, 1.06) 0.78* (0.65, 0.95) 
Unknown   0.51*** (0.40, 0.64) 0.74* (0.55, 0.99) 
CDPS score in 2004       
CDPS<0.8 (ref.) N/A  1  1  
0.8<=CDPS<1.3   1.44*** (1.32, 1.57) 1.53*** (1.40, 1.66) 
1.3<=CDPS<=1.9   2.01*** (1.81, 2.23) 2.24*** (2.03, 2.47) 
CDPS>1.9   3.17*** (2.89, 3.48) 3.62*** (3.31, 3.95) 
Health coverage type       
Medicare only (ref.) N/A  N/A  1  
Medicaid only     0.48*** (0.38, 0.60) 
Dual-eligible     1.50*** (1.41, 1.60) 
Continuous 12-month coverage N/A  N/A  0.56*** (0.49, 0.63) 
Percent of High School Graduate       
<75% (ref.) N/A  N/A  1  
75-84%     0.99 (0.89, 1.11) 
85-90%     0.91 (0.81, 1.03) 
>90%     0.84* (0.74, 0.97) 
Median Household income 1999       
<$36,448 (ref.) N/A  N/A  1  
$36,448-$45,920     1.02 (0.89, 1.16) 
$45,921-$56,813     1.14 (0.99, 1.32) 
>$56,813     1.18* (1.03, 1.35) 
No Previous Complications N/A  N/A  N/A  
Eye complications in 2004 N/A  N/A  N/A  
Nephropathy in 2004 N/A  N/A  N/A  
Neuropathy in 2004 N/A  N/A  N/A  
Ischemic Heart Disease in 2004 N/A  N/A  N/A  
Lower-limb amputations 2004 N/A  N/A  N/A  
Cerebrovascular diseases 2004 N/A  N/A  N/A  
No. of outpatient visits 2004 N/A  N/A  N/A  
* p<0.05  **p<0.01 ***p<0.001       
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Appendix XII. Analytic models used in the study (Outcome: Having Diabetes-related Hospitalizations in 
2005) 
N=106,174 Model 4 Model 5 
 OR 95%CI OR 95%CI 
Mental health disorders     
No mental health disorders (ref.) 1  1  
Schizophrenia/ paranoid states 0.74** (0.63, 0.88) 0.75** (0.63, 0.89) 
Bipolar disorder 1.08 (0.91, 1.27) 1.07 (0.91, 1.26) 
Depression/ anxiety 1.04 (0.97, 1.11) 1.03 (0.96, 1.10) 
Other mental health disorders 1.01 (0.87, 1.17) 1.01 (0.87, 1.17) 
Any alcohol abuse/ dependence 1.07 (0.87, 1.32) 1.08 (0.88, 1.33) 
Any drug abuse/ dependence 1.60*** (1.38, 1.87) 1.60*** (1.38, 1.86) 
Age Groups     
<55 (ref.) 1  1  
55-64 1.12 (0.99, 1.26) 1.11 (0.98, 1.25) 
65-74 1.13 (1.00, 1.28) 1.13 (1.00, 1.28) 
75 and older 1.26*** (1.11, 1.43) 1.26*** (1.11, 1.44) 
Male Gender 1.17*** (1.10, 1.23) 1.17*** (1.11, 1.24) 
Race/ethnicity     
Non-Hispanic white (ref.) 1  1  
African American 0.97 (0.88, 1.08) 1.00 (0.91, 1.11) 
Hispanic 0.75*** (0.65, 0.87) 0.77*** (0.66, 0.89) 
Others 0.87 (0.72, 1.05) 0.88 (0.73, 1.07) 
Unknown 0.83 (0.62, 1.11) 0.85 (0.64, 1.13) 
CDPS score in 2004     
CDPS<0.8 (ref.) 1  1  
0.8<=CDPS<1.3 1.11* (1.02, 1.21) 1.09 (1.00, 1.18) 
1.3<=CDPS<=1.9 1.28*** (1.15, 1.42) 1.23*** (1.10, 1.37) 
CDPS>1.9 1.56*** (1.42, 1.72) 1.47*** (1.33, 1.63) 
Health coverage type     
Medicare only (ref.) 1  1  
Medicaid only 0.64*** (0.51, 0.80) 0.65*** (0.52, 0.80) 
Dual-eligible 1.32*** (1.24, 1.41) 1.32*** (1.24, 1.41) 
Continuous 12-month coverage 0.55*** (0.49, 0.63) 0.55*** (0.48, 0.62) 
Percent of High School Graduate     
<75% (ref.) 1  1  
75-84% 1.00 (0.90, 1.11) 1.00 (0.90, 1.11) 
85-90% 0.94 (0.83, 1.06) 0.93 (0.83, 1.05) 
>90% 0.88 (0.77, 1.01) 0.87 (0.76, 1.00) 
Median Household income 1999     
<$36,448 (ref.) 1  1  
$36,448-$45,920 1.01 (0.88, 1.16) 1.01 (0.89, 1.16) 
$45,921-$56,813 1.11 (0.96, 1.30) 1.12 (0.96, 1.30) 
>$56,813 1.14 (0.99, 1.31) 1.14 (0.99, 1.31) 
No Previous Complications 0.70*** (0.63, 0.78) 0.70*** (0.63, 0.78) 
Eye complications in 2004 1.25*** (1.16, 1.35) 1.24*** (1.15, 1.34) 
Nephropathy in 2004 1.45*** (1.34, 4.56) 1.45*** (1.34, 1.57) 
Neuropathy in 2004 1.26*** (1.16, 1.36) 1.25*** (1.15, 1.35) 
Ischemic Heart Disease in 2004 1.91*** (1.78, 2.06) 1.89*** (1.75, 2.03) 
Lower-limb amputations 2004 1.98*** (1.85, 2.12) 1.97*** (1.84, 2.11) 
Cerebrovascular diseases 2004 1.48*** (1.36, 1.62) 1.47*** (1.35, 1.61) 
No. of outpatient visits 2004 N/A  1.01*** (1.01, 1.01) 
* p<0.05  **p<0.01 ***p<0.001     
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